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Summary 
Earth’s accessible freshwater resources are under constant pressure. Most of the 35 million cubic 
kilometers freshwater are bound in glaciers (over 68 %), permanent snow und not accessible 
groundwater resources. Accessible freshwater is crucial for mankind as well as ecosystems functions in 
general. At the same time, over 50 % of all renewable and accessible freshwater flows are already used 
by mankind. In Europe only 21 % of the available freshwater are used and most of it is not consumed but 
restored. Therefore, Europe’s problems related to freshwater supply do not depend on absolute quantity 
but on distribution, alterations of the hydromorpholgy and an increasing number of (anthropogenic) 
pollutants. Because of their potential to disrupt the reproduction over altering the endocrine system one 
important and heavy discussed group of micropollutants are the endocrine disruptive compounds 
(EDCs). In the last years more and more (potential) EDCs have been detected in the environment as well 
as organic tissues of humans and wildlife.  
For the prediction of a substance’s endocrine activity a first screening with QSAR tools (e.g. OECD QSAR 
Toolbox, VirtualToxLab) is useful. These predictions actually are good in case of receptor binding 
properties if the chemical structure is known. To screen samples for known EDCs, chemical analysis is a 
fast and sensitive approach. For example, to date it is possible to detect estrogens in the low ng∙L-1 range 
(e.g. 0.3 ng∙L-1 17ß-Estradiol) in groundwater samples with a LC system coupled to a triple-stage 
quadrupole mass spectrometer with electrospray ion source (LC-ESI-MS2). Nevertheless, to detect 
unknown endocrine disruptive potentials of a substance or to screen an environmental sample with 
unknown composition, bioassays are the methods of choice.  
In the present study, the two recombinant receptor-reporter assays lyticase assisted yeast estrogen 
screen (LYES) and “estrogen receptor mediated chemical activated luciferase gene expression” (ER 
CALUX®) assay as well as the H295R steroidogenesis assay, that allows the detection of effects on the 
whole steroid synthesis pathway, were applied. Additionally, a variation of the in vivo reproduction test 
with the New Zealand mudsnail Potamopyrgus antipodarum (Pa-Repro) has been used. This bioassay 
battery therefore covers receptor-mediated activities as well as activities on the process of steroid 
genesis and impacts on whole organisms as well as populations.  
To get insights into the development as well as international validation of knew test systems for the 
detection of EDCs the validation of the newly developed H295R was scientifically attended. It could be 
shown that the H295R successfully detected all suspected or known EDCs with good correlations 
between the different laboratories. Nevertheless, beside the number of advantages of this test system 
some disadvantages were also figured. Those were the high variability of steroid concentration between 
different passages as well as the high costs for the detection of produced steroids. To overcome the 
disadvantages several approaches to improve the test system were pursued. At first cells were adapted 
to chemical defined media which lead to a more stable production of steroids. With the development of 
a new ELISA method for the detection of steroids in the exposure medium both costs as well as working 
time could be saved. Hereafter, the selected bioassay battery was applied to various sample matrices as 
well as single substances. Both LYES and ER CALUX® were used to assess the estrogenic activity of 
heterocyclic aromatic hydrocarbons (hetero-PAHs). While none of the hetero-PAHs showed estrogenicity 
in the LYES, nine (indole, 1-benzothiophene, benzofuran, 2-methylbenzofuran, 2,3-dimethylbenzofuran, 
quinoline, 6-methylquinoline, carbazole, dibenzothiophene, dibenzofuran, acridine, and xanthene) out of 
twelve showed significant estrogenic activity in the ER CALUX®. With the help of liquid chromatography 
with diode array detection (LC-DAD) and high resolution tandem mass spectrometry (LC-HRMS2), it could 
be demonstrated that the used T47Dluc cell line was capable for metabolizing of the parent substances. 
To assess the endocrine disrupting potential of the biological larvicide VectoBac®, which is extracted out 
of Bacillus thuringienses var. israelensis (Bti), the whole bioassay battery was used. With both receptor-
mediated assays LYES and ER CALUX® the previously detected estrogenic activity of three commercial 
available tablet formulas could be confirmed. From the subsequently investigated active substance 
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VectoBac® TP as well as the formula WDG only TP showed dose-dependent estrogenic activity in both 
assays. Neither for TP nor WDG clear influences on the steroidogenesis could be detected in the H295R. 
The investigation of surface and groundwater samples which were taken after the application of both TP 
and WDG also showed no estrogenic activity in the receptor-mediated bioassays. To elucidate the 
potential effect of the suspected xenoestrogen VectoBac® TP on a complex aquatic community a 
microcosm study was performed. Within this microcosm, the impact on phytoplankton and zooplankton 
as well as the grazer P. antipodarum could be studied. While no effects on the zooplankton were 
detected, a clear shift from green to blue algae could be detected at concentrations which also showed 
significant estrogenic activity in the LYES. No clear effects on the reproduction of P. antipodarum could 
be observed, but it is assumed that this was a result of the limited food supply due to the community 
shift within the phytoplankton. Nevertheless, the concentrations used in the microcosm study were ten 
to 50 times higher than it would be expected in the field and therefore, a shift in the ecosystem structure 
of routinely treated areas seems unlikely. In the last approach the three selected in vitro bioassays were 
used to assess the performance of advanced sewage treatment processes with regard to the removal of 
pharmaceuticals from hospital sewage before discharge into the public sewerage. The high estrogenic 
activity of the raw sewage sample detected in the LYES could be significantly reduced by a full scale 
membrane bioreactor (MBR). After subsequent ozonation the estrogenicity was reduced to the level of 
the solvent controls in both receptor-mediated assays. By means of liquid chromatography-tandem mass 
spectrometry (LC-MS2) it could be verified that after ozonation concentrations of estrone (E1) were 
significantly reduced. In contrast, there was a significant increase of 17ß-estradiol production as well as 
aromatase activity in H295R cells after ozonation. It is hypothesized that this is partly due to formation of 
active by-products during ozonation.  
Overall, the selected in vitro bioassays were suitable for the detection of endocrine activity in various 
sample matrices as well as single substances. The receptor-mediated bioassay ER CALUX® was able to 
detect estrogenic activity in all matrices used. These included groundwater, surface water and sewage as 
well as single substances (hetero-PAHs). Additionally, in case of the hetero-PAHs, the estrogenic activity 
of single substances which require metabolic activation could be detected. With the LYES investigation of 
medium to highly contaminated water samples was possible, low contaminated water samples could not 
be investigated due to the high limit of detection (LOD) as well as the relatively high estrogenicity of the 
solvent controls. The H295R was applicable for medium contaminated samples as well as single 
substances. Performance of the bioassays markedly varied throughout the present study. The ER CALUX® 
provided the most stable performance (very good), followed by the H295R (good), the LYES (good to 
moderate) and P. antipodarum (moderate). Problems occurred with the consistent production of 
testosterone (H295R), the background of the solvent controls (LYES) as well as food supply and response 
to the positive control (P. antipodarum).  
Concluding, it can be stated that the selected bioassay battery is suitable to detect (potential) endocrine 
disrupting substances in different water sample matrices such as groundwater, surface water and 
wastewater. Additionally, even single substances that require metabolic activation to exert their 
estrogenic activity can be investigated.  
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Zusammenfassung 
Die verfügbaren Süßwasserressourcen der Erde sind stark begrenzt. Der Großteil der 35 Millionen 
Kubikmeter Süßwasser ist in Gletschern (über 68 %), permanenten Schneedecken und als nicht 
verwertbares Grundwasser gebunden. Dabei ist verfügbares Süßwasser nicht nur überlebenswichtig für 
die Menschheit sondern auch für die Aufrechterhaltung des globalen Ökosystems. Nichtsdestotrotz 
werden weltweit bereits über 50 % des verfügbaren Süßwassers durch den Menschen genutzt. In Europa 
werden lediglich 21 % genutzt, wobei ein Großteil nicht verbraucht sondern wieder aufbereitet wird. 
Infolgedessen, bezieht sich die Problematik in Europa nicht auf die generelle Verfügbarkeit des Wassers 
sondern auf dessen Verteilung, Eingriffe in die hydromorphologischen Bedingungen sowie die 
Verschmutzung durch anthropogene Schadstoffe. In diesem Kontext wird einer Gruppe der 
Mikroschadstoffe besondere Aufmerksamkeit zuteil, den endokrinen Disruptoren (EDs), welche über 
Veränderungen des endokrinen Systems die Reproduktion beeinträchtigen können. In den letzten Jahren 
wurden immer mehr (potentielle) EDs sowohl in der Umwelt als auch in Geweben von Menschen und 
Nutz- sowie Wildtieren detektiert.  
Ein erster Schritt, um eine Substanz anhand ihrer chemischen Eigenschaften als potentiellen ED zu 
entlarven, ist die Anwendung von QSAR Programmen wie der OECD QSAR Toolbox. In einem weiteren 
Schritt können (Umwelt)Proben mittels chemischer Analytik auf bekannte Substanzen mit endokriner 
Aktivität untersucht werden. Unter Verwendung eines Flüssigchromatographie-Systems mit 
angeschlossenem Massenspektrometer (LC-ESI-MS2) ist es bereits möglich, EDs im niedrigen ng/L-
Bereich (z.B. 0,3 ng/L 17ß-Estradiol) zu detektieren. Um jedoch eine Substanz mit unbekannter oder 
vermuteter endokriner Wirksamkeit oder eine komplexe Umweltprobe auf ihr Wirkpotential hin zu 
untersuchen bedarf es der Anwendung von Biotestverfahren. 
In der vorliegenden Studie wurden deshalb die zwei Reportergentestverfahren „lyticase assisted yeast 
estrogen Screen“ (LYES) und “estrogen receptor mediated chemical activated luciferase gene expression 
assay“ (ER CALUX®) für die Detektion endokriner Disruptoren in komplexen Umweltproben angewendet. 
Zusätzlich wurde der H295R „steroidogenesis assay“ verwendet, der es ermöglicht, Effekte im gesamten 
Steroidgeneseweg der Nebennierenrinde abzubilden. Darüber hinaus wurde der Testorganismus 
Potamopyrgus antipodarum (Neuseeländische Zwergdeckelschnecke) in einer Mikrokosmosstudie 
eingesetzt. Mit dieser Auswahl an Testverfahren ist es möglich, neben Rezeptor-vermittelten Wirkungen 
auch (negative) Wirkungen auf die Steroidgenese sowie auf der Ebene von Einzelorganismen und sogar 
ganzen Populationen zu ermitteln. 
Zunächst wurde die Entwicklung sowie Validierung des erst kürzlich entwickelten H295R wissenschaftlich 
begleitet. Dabei konnte gezeigt werden, dass der H295R in unterschiedlichen Laboratorien alle 
bekannten und vermuteten EDCs zuverlässig und mit einer guten Korrelation ermitteln konnte. Es 
zeigten sich allerdings auch einige Nachteile des Testsystems, wie etwa die hohe Variabilität in der 
Steroidproduktion zwischen einzelnen Passagen sowie die hohen Kosten für die Messung der 
Steroidkonzentrationen im Testmedium. Aus diesem Grund wurde eine Adaption der Zelllinie an 
chemisch definiertes Medium durchgeführt sowie ein neues sensitives und kostengünstiges ELISA-
Verfahren entwickelt. Im Anschluss wurde die ausgewählte Testbatterie eingesetzt, um verschiedene 
Probenmatrices sowie Einzelsubstanzen auf ihr endokrines Wirkpotential zu untersuchen. Sowohl der 
LYES als auch der ER CALUX® wurden verwendet, um das estrogene Wirkpotential von heterozyklischen 
aromatischen Kohlenwasserstoffen (hetero-PAKs) zu ermitteln. Dabei konnte für keinen der eingesetzten 
PAKs estrogene Aktivität im LYES detektiert werden. Im ER CALUX® hingegen konnte für neun von zwölf 
untersuchten PAKs (darunter Acridin, Benzofuran, Xanthen und Chinolin) signifikante estrogene Aktivität 
ermittelt werden. Mittels chemischer Analytik (LC-DAD und LC-HRMS2) konnte gezeigt werden, dass die 
verwendete Zelllinie T47Dluc dazu in der Lage ist, die Ausgangssubstanzen zu metabolisieren. Um das 
endokrine Wirkpotential des biologischen Larvizids VectoBac®, das aus dem grampositiven Bacillus 
thuringinesis var. israelensis gewonnen wird, zu untersuchen, wurde die gesamte Biotestbatterie 
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eingesetzt. Die bereits bekannte estrogene Aktivität verschiedener kommerziell erhältlicher 
Feststoffformulierungen konnte mit dem LYES und dem ER CALUX® verifiziert werden. Der untersuchte 
Reinwirkstoff VectoBac® TP (TP) erwies sich ebenfalls als estrogen aktiv. Jedoch konnte keine klare 
Auswirkung auf die Steroidgenese im H295R nachgewiesen werden. Auch nach Applikation im Freiland 
konnte weder für TP noch für die Formulierung VectoBac® WDG rezeptor-vermittelte estrogene Aktivität 
des Oberflächen- sowie des assoziierten Grundwassers ermittelt werden. Um die Auswirkungen von TP 
auf eine komplexe aquatische Lebensgemeinschaft zu untersuchen wurde eine Mikrokosmosstudie mit 
der Indikatorspezies Potamopyrgus antipodarum durchgeführt. Für das Phytoplankton konnte eine 
signifikante Verschiebung der Arten von Grünalgen hin zu Blaualgen detektiert werden. Sowohl für das 
Zooplankton als auch für P. antipodarum konnten keine klaren Effekte ermittelt werden. Allerdings 
wurden die Ergebnisse wahrscheinlich durch die Zunahme des Blaualgenwachstums und damit 
einhergehend einer Abnahme des Futterangebots beeinflusst. Da jedoch die eingesetzten 
Konzentrationen Bti zehn bis 50-mal höher waren, als die tatsächlich im Feld ausgebrachten Mengen, 
erscheint ein negativer Einfluss auf aquatische Ökosysteme eher unwahrscheinlich. Im letzten Teil der 
vorliegenden Studie wurden die drei ausgewählten in vitro Testsysteme verwendet, um die 
Eliminationsleistung erweiterter Abwasserbehandlung am Beispiel eines mittelgroßen Krankenhauses zu 
untersuchen. Die hohe estrogene Aktivität des Rohabwassers konnte durch den Einsatz eines 
Membranbioreaktors signifikant verringert werden. Nach einer anschließenden Ozonierung des 
vorgereinigten Wassers konnte die verbliebene estrogene Aktivität auf ein Minimum reduziert werden. 
Mittels chemischer Analytik konnte nachgewiesen werden, dass die vorhandenen Konzentrationen an 
Estron durch die Behandlungsmethoden signifikant reduziert wurden. Allerdings wurde nach der 
Ozonierung eine erhöhte Produktion von Estradiol im H295R ermittelt, die mit einem Anstieg der 
Aromatase-Aktivität korrelierte. Dies wurde auf eine Bildung von Transformationsprodukten 
zurückgeführt, die allerdings nicht chemisch verifiziert werden konnten. 
Insgesamt zeigte sich die in der vorliegenden Studie ausgewählte Biotestbatterie als sehr geeignet, 
endokrin aktive Substanzen in der aquatischen Umwelt zu detektieren. Der Rezeptor-Reportergen-Test 
ER CALUX® konnte in allen untersuchten Probenmatrices estrogene Aktivität detektieren. Darüber hinaus 
konnte die Möglichkeit der Metabolisierung von Substanzen durch die verwendete Zelllinie T47Dluc 
nachgewiesen werden. Mit dem LYES konnten Proben mit mittlerer und hoher Belastung untersucht 
werden, wobei die hohe Detektionsgrenze des Testsystems keine Untersuchung von niedrig belasteten 
Proben erlaubt. Mit dem H295R konnten sowohl Proben mittlerer Belastung als auch Einzelsubstanzen 
zuverlässig auf ihre endokrine Wirksamkeit hin untersucht werden. Die Leistungsstärke der einzelnen 
Testsysteme wurde wie folgt kategorisiert: (1) ER CALUX® (sehr gut), (2) H295R (gut), (3) LYES (gut bis 
mittelmäßig), (4) P. antipodarum (mittelmäßig). Hauptprobleme waren dabei die ungleichmäßige 
Produktion von Testosteron (H295R), die hohe Hintergrundbelastung der Negativkontrolle (LYES) sowie 
ein eingeschränktes Nahrungsangebot (P. antipodarum).  
Grundsätzlich konnte in der vorliegenden Studie belegt werden, dass die ausgewählte Biotestbatterie 
sehr geeignet ist, um (potentielle) EDs in verschiedenen Wasserproben wie Grundwasser, 
Oberflächenwasser und Abwasser zu untersuchen. Außerdem konnte die Eignung für die Untersuchung 
von Einzelsubstanzen, auch solche mit benötigter metabolischer Aktivierung, verifiziert werden.  
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1.1 Water pollution 
Earth’s total water resources add up to 1.4 billion cubic kilometers. The majority of this 
water (97 %) is salt water, while 35 million cubic kilometers (2.5 %) are classified as 
freshwater only. Furthermore, most of it is bound in glaciers (over 68 %), permanent snow 
und not accessible groundwater resources (Gleick & Palaniappan 2010). To date, from all 
renewable and accessible freshwater flows over 50 % are already used by mankind (Postel et 
al. 1996). Concurrently, accessible freshwater is not only crucial for human drinking water 
supply, sanitation facilities as well as industry and agriculture but also for the ecosystems 
functions in general. The so called provisioning functions of water are inseparably linked to 
healthy ecosystems. Availability of water for human needs is therefore depending on a good 
ecological status of the water providing ecosystems (Werner 2012). 
In Europe only 21 % of the available freshwater are used. The abstracted water is used for 
agriculture (33 %), public water supply (18 %), industry (14 %; without cooling water) and 
power generation and non-defined uses (38 %) (Nixon et al. 2000). Additionally, most of the 
abstracted water is not consumed but restored. Apparently, Europe’s problems related to 
freshwater supply do not depend on absolute quantity but on distribution (Nixon et al. 
2000), alterations of the hydromorpholgy (Werner 2012) and pollution (Collins et al. 2011). 
Since the industrial revolution, freshwater resources are exposed to an increasing number of 
(anthropogenic) pollutants like fertilizers, pesticides, pharmaceuticals, personal care 
products, metals and other industrial chemicals. They originate from industry, agriculture, 
mining, waste disposal and sewage treatment plants and other sources from the urban 
environment but also from accidental release during transport and production. In the 
European Union (EU) approximately 200 million tons of toxic chemicals (subject to the EU 
Dangerous Substances Directive) are produced every year (Collins et al. 2011). According to 
data reported under the Water Framework Directive (WFD), European surface waters are 
polluted by high levels of heavy metals (e.g. in the Czech Republic, Germany, Sweden and 
the United Kingdom), Polycyclic Aromatic Hydrocarbons (PAHs; e.g. in the rivers Elbe and 
Rhine) and diethylhexyl phthalate (DEHP; e.g. in the river Danube) (Collins et al. 2011). 
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Schwarzenbach et al. (2010) stated that there are two major classes of chemical pollutants 
regarding their concentrations in the environment: macropollutants occur in the milligram 
per liter range while micropollutants occur in the range of nanogram (ng·L-1) to microgram 
(µg·L-1) per liter. The former include pollutants such as nitrogen, phosphorous and salt, the 
latter a vast number of synthetic and natural substances found in the aquatic environment. 
In most cases micropollutants do not exert adverse effects in an acute but chronic manner 
and therefore pose a longterm threat to humans and biota.  
Because of their potential to disrupt the reproduction over altering the endocrine system 
one important and heavy discussed group of micropollutants are the endocrine disruptive 
compounds (EDCs), which include natural as well as synthetic steroids, pharmaceuticals, 
pesticides, organotin compounds, polychlorinated biphenyls (PCBs), phthalates, dioxins, 
phenol derivatives etc. (Falconer et al. 2006). 
 
 
 
 
 
Excursus: Water Framework Directive 
The Water Framework Directive (WFD; 2000 / 60 / EC)) of the European Union (EU) was adopted 
in 2000 and represents a framework for water protection and management covering all types of 
water bodies from groundwater to coastal waters. The ultimate objective of the directive is to 
achieve “good ecological and chemical status” for all waters by 2015. In case of the ecological 
status biological factors like abundance of aquatic flora and fish fauna are monitored. 
Additionally, chemical and physical factors like salinity, temperature and availability of nutrients 
as well as pollution by chemicals are considered. Furthermore, the hydromorphological features 
like water flow and structures of the riverbed are covered. The classification scheme includes five 
categories: high, good, moderate, poor and bad. In terms of the chemical status environmental 
quality standards for 53 substances of high concern have been established (Environmental 
Quality Standards Directive; 2008 / 105 / EC) (European Commission 2012). In case of 
groundwater resources the objectives lie on a good chemical and quantitative status 
(Groundwater Directive; 2006 / 118 / EC). 
(European Parliament 2000) 
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1.2 The vertebrate endocrine system 
The endocrine system is one of the two fundamental communication and regulatory systems 
in the body. Communication occurs via hormones that are excreted in the blood or lymph by 
a number of ductless glands. The hormones are then transported to their targets, mostly 
cells with specified hormone receptors. The main functions of this internal communication 
system are the control of reproduction as well as growth and development and the 
maintenance of the metabolism. There are three types of hormones which can be 
distinguished by their chemical structure conformity, the protein- or peptide hormones, the 
steroid hormones and the amino acid derivates (Bartke & Constanti 2003, Kleine & 
Rossmanith 2010). This study will deal only with the steroid hormones, wherefore they 
solely will be described in the next paragraph. 
 
1.2.1 Steroids 
Steroid hormones are derivates of the steran skeleton differing in altered functional group 
composition and grade of ring condensation. Primary substance of the vertebrate 
steroidogenesis is cholesterol which is the precursor of pregnenolone from which over 
various steps the five main steroid classes, gestagens, glucocorticosteroids, mineral 
corticosteroids, androgens and estrogens, derive (Tab. 1.1) (Kleine & Rossmanith 2010).  
 
Table 1.1 Steroid classes1 
Steroid class Example Function References 
Gestagens Progesterone Nidation, maintenance of 
pregnancy 
1 
Glucocorticosteroids Cortisol Gluconeogenesis, inhibition 
of the hypothalamic-pituitary 
and the hypothalamic-
pituitary-gonadal systems, 
control of inflammatory 
responses 
1 
Mineral corticosteroids Aldosterone Control of the sodium 
reabsorption and potassium 
secretion in the kidney 
1 
Androgens Testosterone Development of males, 
osteogenesis 
1 
Estrogens Estradiol Key regulator of growth, 
differentiation and function 
in e.g. the reproductive tract, 
mammary gland, skeletal 
system and cardiovascular 
system 
1, 2 
1(Kleine & Rossmanith 2010); 2(Hall et al. 2001) 
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The steroidogenesis (Fig. 1.1) takes place in the cells of different organs and tissues but the 
first step of hormone synthesis is always the transport of the membrane lipid cholesterol 
into the mitochondria. This step is mediated by the steroidogenic acute regulatory protein 
(StAR) which has to be constitutively synthesized due to its instability.  
 
Figure 1.1 Steroidogenesis with steroids and steroidogenic enzymes (CYP11A1 = cholesterol side 
chain cleavage enzyme; CYP11B1 = steroid 11β-hydroxylase; CYP11B2 = aldosterone synthase; CYP17 
= steroid 17α-monooxygenase; CYP19 = aromatase; CYP21 = steroid 21-hydroxylase; 3β-HSD = 3β-
hydroxysteroid-dehydrogenase; 17β-HSD = 17β-hydroxysteroid-dehydrogenase; SRD5A1 = steroid 
5α-reductase) (Hanukoglu 1992). 
17ß-HSD
CYP11A1
17ß-HSD
CYP17
CYP17
17ß-HSD
CYP17
CYP17
SRD5A1
Smooth 
endoplasmic
reticulum
Mitochondrium
Enzymes located in the:
CYP11B1
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In the initial step of the steroidogenesis cholesterol is converted to pregnenolone by the 
cholesterol side-chain cleavage enzyme (P450scc or CYP11A1). The cytochromes P450 
(CYPs) are the major class of steroidogenic enzymes. Furthermore, 3β- and 17β-
hydroxysteroid-dehydrogenases as well as the 5α-reductases are involved (Arukwe 2008, 
Kleine & Rossmanith 2010). Cholesterol is mainly synthesized in the liver and transported 
via lipoproteins to the endocrine glands. The adrenal cortex is the main location for 
synthesis of steroids. It is divided in three zones where different classes of steroids are 
synthesized: Zona glomerulosa (mineral corticosteroids), Zona fasciculata (gluco 
corticosteroids) and Zona reticularis (gestagenes, androgens and estrogens). Further sites 
for the synthesis of estrogens are the ovary, the placenta and the testis, for gestagenes the 
Corpus luteum, the follicles and the placenta and for androgens the testis and the ovary. 
Central control of the steroidogenesis takes part in the hypothalamus and the pituitary. 
Releasing-Hormones (RH) and Release-Inhibiting-Hormones (IH) from the hypothalamus 
are signals for inhibition or induction of the pituitary hormones release which control the 
peripheral endocrine glands. Due to the presence of Pregnenolone in almost all steroids 
producing glands synthesis of the diverse steroids is depending on the presence of specific 
receptors and the involved enzymes. In the adrenal cortex 17-, 21- and 11-hydroxylases are 
present. Therefore, all paths of the steroidogenesis are possible in this part of the adrenal 
gland (Hanukoglu 1992, Payne & Hales 2004, Silbernagl 2012).  
Excursus: Vertebrate steroids in prosobranch mollusks 
Prosobranch mollusks are able to produce vertebrate-type steroids like estrogens and 
androgens. To date, almost all necessary enzymes for steroidogenesis have been detected in 
mollusks wherefore an endogenous production is suggested. Furthermore, it could be proofed 
that steroids are crucial for the regulation of sexual differentiation and reproduction. Recently, 
Stange et al. (2012) found an estrogen-receptor transcript in the mudsnail Potamopyrgus 
antipodarum and could prove that it is regulated under estrogenic and androgenic influence. 
Taken together, due to their ecological relevance and widespread distribution as well as the 
homologues to the vertebrate endocrine system prosobranch mollusks like P. antipodarum are 
promising test species for EDCs in the aquatic environment. Of course, it has to be taken in mind 
that the extrapolation of effects on steroid metabolic pathways from one phylum to the other is 
difficult. 
(Janer & Porte 2007, Lafont & Mathieu 2007, Oehlmann et al. 2007) 
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Targets of steroids in the cells are highly specific nuclear receptors in the cytoplasm and / 
or the nucleus. Due to their lipophilic properties steroids enter the cell over passive 
membrane transport. After binding to the receptor, the receptor-ligand complex mostly 
forms a dimer with a second one and the resulting homo- or heterodimer binds to 
hormone responsive elements (HREs) on the DNA. Thus, expression of the related genes is 
activated (Krauss 2006). In the present study the main focus lies on estrogen receptor (ER) 
binding capacity of EDCs. Therefore, the next paragraph exemplary explains normal 
activation and possible disruption ways of the ER pathway.  
 
1.2.2 ER signaling 
To date, two intracellular isoforms of the human ER are known, ER alpha (hERα) and ER 
beta (hERβ). Both DNA- and ligand-binding domains of the two receptors are highly 
homologous, wherefore they bind to the same response elements on the DNA and show 
analogical binding affinities to several estrogens. Nevertheless, some substances show 
different binding affinities to the ERs. For example, phytoestrogens show a significantly 
higher affinity to the ERβ. Furthermore, some compounds can act as agonists as well as 
antagonists depending on the affected tissues. While E2 is a pure agonist in all effected 
tissues, the breast cancer drug Tamoxifen acts as antagonist in the breast but as agonist in 
bone, cardiovasculature and uterus. As expression of the two receptors occurs in different 
tissues their physiological functions within the body are thought to be quite distinct. The 
classical mechanism of estrogen activity is ligand-dependent. Binding of a ligand to the 
receptor leads to a conformational change and subsequently to the formation of homo- or 
heterodimers as well as the binding to estrogen response element (ERE) consensus 
sequences (5′-GGTCANNNTGACC-3′ (Driscoll et al. 1998)) in the target genes. In some cases 
ligand-depending estrogen action is even possible in genes without EREs for example over 
binding to the transcription factor activation protein-1 (AP-1). Another way of ER-signaling 
is ligand-independent. In those cases the ER is activated by polypeptide growth factors (GF) 
like the epidermal GF (EGF) in the female reproduction tract. At last, also nongenomic 
transactivating ways of estrogen activity are known. In those cases, fast responses of 
tissues like breast and bones to estrogens are mediated through membrane-coupled ERs 
(Hall et al. 2001, Singleton & Khan 2003). 
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1.3 Endocrine disruptive compounds 
Endocrine disruption has been a blazing theme in eco(toxico)logical sciences since the early 
90th of the 20th century (Colborn et al. 1993). Mainly initiated by the publication “Our 
stolen future: are we threatening our fertility, intelligence and survival?: a scientific 
detective story” of Theo Colborn and colleges (Colborn et al. 1996) the topic now is also 
heavy discussed in public. Already in the 1940s observations over the ecological impacts of 
the insecticide dichlorodiphenyltrichloroethane (DDT) on bald eagles were made. But it took 
over 30 years of research and heavy debates until the ban of DDT in western countries in the 
1970s (Grier 1982, Patisaul & Adewale 2009). Another prominent case of endocrine 
disruptive effects of manmade chemicals was the investigation of imposex (growth of male 
sex organs) in female marine snails exposed to the antifouling agent tributyl tin (TBT) (Bryan 
et al. 1987). Even impacts on humans were observed in conjunction with Diethylstilbestrol 
(DES; 4,4'-(3E)-hex-3-ene-3,4-diyldiphenol) (Giusti et al. 1995) and polychlorinated biphenyls 
(PCBs) (Kuratsune et al. 1972). 
In the last years more and more (potential) EDCs have been detected in the environment as 
well as organic tissues of humans and wildlife (Amaral Mendes 2002). Beside the natural and 
synthetic steroids a large number of substances and metabolites have been recognized as 
steroid receptor binders. Subsequently, several substances have the potential to disrupt the 
natural steroidogenesis independent from receptor binding (Tab. 2.2). And the number of 
actual and potential EDCs is still rising (Hotchkiss et al. 2008). 
The Worlds Health Organisation (WHO) defines an EDC as “an exogenous substance or 
mixture that alters function(s) of the endocrine system and consequently causes adverse 
health effects in an intact organism, or its progeny, or (sub)populations. In case of 
substances that seem to have characteristics to cause adverse effects but no proof is given 
the term potential EDC was created (WHO 2002). Furthermore, the Organisation for 
Economic Co-operation and Development (OECD) extended the definition to the term of 
possible EDCs. A possible EDC has been tested for endocrine disruption in in vitro bioassays 
but no proof in in vivo assays or the environment has been given so far (Kortenkamp et al. 
2011). 
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Table 1.2 Outline of anthropogenic endocrine disruptive compounds 
Substance Structure1 ER agonist2 Steroidogenic 
active2 
Atrazine 
(herbicide) 
 
- + 
Bisphenol A  
(starting substance 
for polymer plastics) 
 
+++ + 
Diclofenac 
(nonsteroidal anti-
inflammatory drug) 
 
- 
(++) 
- 
2,4-Dichlorophenol 
(metabolite of 
pesticides) 
 
+ + 
Perfluorooctane 
sulfonate (PFOS) 
(fluorosurfactant) 
 
- + 
1ChemBioDraw Ultra (Perkin Elmer, Waltham, USA; free trial version); 2OECD QSAR Toolbox 
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1.4 Detection of EDCs 
1.4.1 QSAR 
To predict an endocrine activity of a substance a first screening with QSAR tools (e.g. OECD 
QSAR Toolbox, VirtualToxLab) is useful (Tab. 1.3).  
 
Table 1.3 Example for OECD QSAR Toolbox data of a screening for acridine 
Acridine 
* 
Carcinogenicity Structural alert for genotoxic carcinogenicity 
(heterocyclic polycyclic aromatic hydrocarbons) 
Toxic Hazard Classification High 
Estrogen Receptor Binder Non binder, without OH or NH2 group 
Simulated Rat Liver Metabolism (S9)  
Metabolites 8 (1 Epoxide, 4 Phenols, 3 not categorized) 
Estrogen Receptor Binder 2 moderate binder, 2 strong binder, 4 non binder 
*ChemBioDraw Ultra (Perkin Elmer, Waltham, USA; free trial version) 
 
In case of receptor binding and / or as long as the chemical structure is known, predictions 
on potential activities are quite good. But with respect to alteration of the whole 
steroidogenesis and substances with unknown modes of action models are mostly 
overextended (Kase et al. 2009, Seifert et al. 1999). These results from the various targets 
for disruption in the chain of steroid genesis like inhibition or activation of enzyme kinetics, 
building and secretion of basic and intermediate products and feedback (Cronin & Worth 
2008). 
 
1.4.2 Extraction and sample preparation 
Due to the complexity of the matrices and the often very low concentrations (ng∙L-1) of the 
analytes, extraction as well as clean-up steps prior to chemical analysis of environmental 
water samples are mandatory (Sosa-Ferrera et al. 2013). In case of in vitro bioassays it 
strongly depends on the sample structure and the test system used. While the 
investigation of native water samples is sometimes possible, sediments have always to be 
extracted. Binding assays such as enzyme linked receptor assays (ELRA) are suitable for 
crude water samples (Seifert et al. 1999). Cell based assays are partly suitable for testing of 
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native water samples. For example, the Yeast estrogenic screen (YES) has shown to be 
suitable in several studies using native samples (Wagner & Oehlmann 2009) (see also 
Chapter 6). In case of assays with mammalian cell lines problems with bacterial and fungal 
contaminations as well as general toxicity often occur. In a recent investigation spiked 
crude sewage samples were successfully applied to the ERα CALUX® (data not published). 
Investigation of native samples in in vivo test systems is possible in most cases (Tuikka et al. 
2011). 
 
1.4.2.1 Water (liquid) samples 
Preparation of water samples for investigation reaches from mere filtration steps to 
exhaustive extraction with subsequent clean up steps and fractionation. The first step is 
mostly a filtration of the native sample with glass fiber filters (±0.45 µm) to remove 
particles and microorganisms and adding of preservatives like acids (HCl, H2SO4) or 
solvents (formaldehyde, methanol) to prevent biodegradation (Li et al. 2013, Matějíček 
2012, Samaras et al. 2011, Stasinakis et al. 2012, Wang et al. 2012a, Wang et al. 2012b, 
Zhang et al. 2011). To date, the most commonly used method for extraction of EDCs from 
water samples is solid phase extraction (SPE). The advantages of this technique are the 
relatively small amount of solvent needed as well as the broad range of available sorbents 
for different analytes (López de Alda & Barceló 2001, Pavlović et al. 2007). The most 
commonly used sorbents are the non-polar alkyl-bonded silica sorbent C-18, the 
polymeric sorbents Oasis HLB (Waters, Germany) and Lichrolut ENV+ (Merck Millipore, 
Germany) as well as the mixed polymeric and cation-exchange sorbent Oasis MCX 
(Waters, Germany) (Comerton et al. 2009). Additional methods for extraction of water 
samples are solid phase micro extraction (SPME), liquid-liquid extraction (LLE) and passive 
samplers (Camilleri et al. 2012, Sosa-Ferrera et al. 2013). Advantages as well as 
disadvantages of the different extraction methods for liquid samples are summarized in 
table 1.4. 
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Table 1.4 Extraction methods for EDCs in water samples 
Method Principle Advantages Disadvantages References 
Solid phase 
extraction 
(SPE) 
Substances in 
sample (mobile 
phase) are adsorbed 
to a sorbent (e.g. C-
18; stationary 
phase) in a cartridge 
+ Low amount of 
solvent 
+ Off-line or on-line 
- plugging of 
cartridges 
- risk of channeling 
- low sample 
processing rates 
- small cross-
sectional area 
1, 2, 3 
Solid phase 
micro 
extraction 
(SPME) 
Substances in 
sample are 
adsorbed to a thin 
layer of a polymeric 
phase (stationary 
phase) e.g. on a stir 
bar 
+ Very low amount 
of solvent 
+ Small sample 
volume 
+ Fast 
+ high-enrichment 
factors 
- limited choice of 
sorbent coating 
- reduced sorption 
capacity 
1, 2 
Liquid liquid 
extraction 
(LLE) 
Substances in 
sample migrate into 
the solvent (mobile 
phase) 
 - high amount of 
solvent 
- relatively low 
selectivity, 
specificity and 
reproducibility 
1 
Passive 
samplers 
 
Substances in 
surface water are 
adsorbed to a 
polymeric sorbent 
(e.g. POCIS; 
stationary phase) 
+ time weighted 
average 
concentration of the 
substances 
+ more realistic 
overview of 
environmental 
concentrations 
- calibration is 
difficult 
- unsteady 
environmental 
conditions  
- biofouling 
4, 5 
1(Sosa-Ferrera et al. 2013), 2(Comerton et al. 2009), 3(Sosa Ferrera et al. 2004), 4(Camilleri et al. 
2012), 5(Vrana et al. 2005) 
 
1.4.2.2 Sediment (solid) samples 
Due to the hydrophobic capacities of many EDCs, for example synthetic estrogens, 
sediments and suspended particular matter are important sinks and thus even sources for 
EDCs in the aquatic environment. Therefore, partially high loads of EDCs in the aquatic 
ecosystems are adsorbed to particles and not direct available in the water phase (Lai et al. 
2000, Westrich 1986).  
Subsequent to sampling sediments are often homogenized, sieved and finally dried (air, 
heat or freeze drying) to prevent the substances from further biodegradation during 
storage. Previously, the most common extraction method for organic pollutants in solid 
matrices was the Soxhlet extraction (Liu et al. 2004, Seiler et al. 2008). But mainly due to 
its high consumption of organic solvents as well as the long duration of the extraction 
Soxhlet is more and more replaced by other techniques (Luque de Castro & Garcıá-Ayuso 
1998). Methods replacing Soxhlet currently are ultrasonic extraction (USE), microwave-
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assisted extraction (MAE) and pressurized liquid extraction (PLE) (Pavlović et al. 2007, 
Sosa-Ferrera et al. 2013). Advantages as well as disadvantages of the different extraction 
methods for solid samples are summarized in table 1.5. 
 
Table 1.5 Extraction methods for EDCs in sediment samples 
Method Principle Advantages Disadvantages References 
Soxhlet 
extraction 
Substances 
adsorbed to a solid 
matrix are 
transferred to a 
organic solvent for 
several cycles under 
high temperature  
+ extraction of high 
amounts of sample 
is possible 
+ no further 
cleaning steps are 
necessary 
+ relatively cheap 
+ easy to handle 
- large amount of 
solvent  
- long duration 
- possible thermal 
decomposition of 
substances 
- concentration step 
is necessary 
1 
Ultrasonic 
extraction 
(USE) 
Substances are 
transferred to a 
organic solvent 
through a low-
frequency sound 
wave 
+ relatively fast 
+ relatively cheap 
+ easy to handle 
- poor 
reproducibility 
- further clean-up 
and / or enrichment 
necessary 
 
2 
Microwave-
assisted 
extraction 
(MAE) 
Substances are 
transferred to a 
organic solvent 
through heating and 
accelerated pressure 
+ fast 
+ low amount of 
solvents 
+ increased sample 
throughput 
- only for polar and 
thermally stable 
substances 
2, 3 
Pressurized 
liquid 
extraction 
(PLE) 
Substances are 
transferred to a 
organic solvent 
under high pressure 
(and temperature) 
in a closed flow-
through system 
+ high 
reproducibility 
+ low amount of 
solvents 
+ fast 
+ high extraction 
rates 
 
- high acquisition 
costs 
2, 3 
1(Luque de Castro & Garcıá-Ayuso 1998), 2(Pavlović et al. 2007), 3(Sosa-Ferrera et al. 2013) 
 
1.4.3 Analytical methods 
1.4.3.1 Chemical analysis 
To screen samples for known EDCs, chemical analysis is a fast and sensitive approach. 
Nevertheless, chemical analysis of complex environmental samples requires extensive 
extraction as well as clean-up procedures and sometimes even derivatization to make the 
detection of EDCs in very low concentrations (ng·L-1) possible (Sosa-Ferrera et al. 2013, 
Streck 2009). Because of the diversity of substance classes detection of multiple EDCs 
should be performed with both gas (GC) and liquid (LC) chromatography coupled with 
mass spectrometry (MS). While LC-MS2 is suitable for polar and less volatile or 
thermodegradable compounds such as antibiotics and betablockers, GC-MS2 is to be 
preferred for non-polar and / or volatile compounds like PAHs. In general, GC-MS has 
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lower limits of detection (LOD) than LC-MS and is less affected by matrix effects but 
requires a more complicated sample preparation (Comerton et al. 2009, Sosa-Ferrera et 
al. 2013, Streck 2009). For example, according to Vulliet et al. (2008), to date it is possible 
to detect estrogens in the low ng∙L-1 range (e.g. 0.3 ng∙L-1 17ß-Estradiol) in groundwater 
samples with a LC system coupled to a triple-stage quadrupole mass spectrometer with 
electrospray ion source (LC-ESI-MS2). 
 
1.4.3.2 Bioassays 
To detect an unknown endocrine active potential of a substance or to screen an 
environmental sample with unknown composition, in vitro and where appropriate in vivo 
bioassays are the methods of choice (Hecker & Hollert 2009, Kunz et al. 2014). However, 
with this methods no qualitative or quantitative detection of a substance is possible (Kase 
et al. 2009). While the majority of the in vitro assays focus on receptor binding and / or 
activation as well as proliferation, only a small number covers the pathways of 
steroidogenic activity (Hecker & Giesy 2008). The applicability of several bioassays to 
detect estrogenic and androgenic activity in water samples was recently assessed (Kase et 
al. 2009, Leusch 2008, Leusch et al. 2010). Unfortunately, there are a vast number of 
different in vitro and in vivo test systems and therefore, investigators of EDCs are spoiled 
for choice. To give a short and admittedly subjective overview an outline of suitable 
bioassays (Bars et al. 2011, Duft et al. 2007, Hecker & Hollert 2011, Kase et al. 2009, 
Knacker et al. 2010, Leusch 2008) is presented in table 1.6. 
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Table 1.6 Outline of bioassays for the detection of EDCs 
Mechanism Name Cell line / Test species References 
Enzyme-linked binding    
 Enzyme Linked Receptor Assay 
(ELRA) 
None / Diverse 1  
 Enzyme Linked Immunosorbent 
Assay (ELISA) 
Non / Diverse 2  
Cell Proliferation    
 E / A-Screen MCF-7 / Human 3, 4, 5 
Recombinant receptor-
reporter 
   
 (L)Yeast Estrogen / Androgen Screen 
(YES / YAS) 
Saccharomyces cervisiae / 
Yeast 
6, 7 
 Estrogen / Androgen Receptor 
mediated Chemical Activated 
LUciferase gene eXpression (ER / AR-
CALUX®) 
T47D and U2OS / Human 8, 9 
 T47D-KBluc T47D / Human 10 
 MVLN; MELN MCF-7 / Human 11, 12 
 HELN HeLA / Human 12 
Steroidogenesis    
 H295R Steroidogenesis assay 
(H295R; OECD 456) 
NCI-H295R / Human 13, 14 
 
Reproduction    
 Fish Short Term Reproduction Assay 
(OECD 229) 
Pimephales promelas 15 
 
 P. antipodarum Reproduction Test 
(Pa-Repro) 
Potamopyrgus 
antipodarum 
16 
1(Seifert et al. 1999), 2(Nunes et al. 1998), 3(Sonnenschein & Soto 1998), 4(Soto et al. 1995), 5(Szelei et 
al. 1997), 6(Purvis et al. 1991), 7(Routledge & Sumpter 1996), 8(Legler et al. 1999), 9(Sonneveld et al. 
2005), 10(Wilson et al. 2004) 11(Demirpence et al. 1993), 12(Balaguer et al. 2001), 13(Hecker et al. 
2011), 14(OECD 2011), 15(OECD 2012c); 16(Duft et al. 2007) 
 
In vitro 
Binding assays like the enzyme-linked receptor assay (ELRA) or the enzyme linked 
immunosorbent assay (ELISA) are fast and relatively cheap methods to detect single 
substances (ELISA) and substances as well as mixtures with the ability of receptor-
binding (ELRA). Compared to cell-based assays, binding assays are not affected by 
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cytotoxic substances in unprocessed complex environmental samples but are suitable 
for screening of biochemical binding. ELISAs are highly sensitive (ng∙L-1 range) as well as 
simple and are available for a great number of synthetic and natural substances. 
Additionally, they can be produced in accordingly equipped laboratories. Disadvantages 
of the method are its vulnerability to cross reactions (e.g. specificity) and the limitation 
to one analyte. ELRAs share the advantages of the ELISA technique but are also able to 
detect e.g. the whole estrogenic activity of complex samples and less vulnerable to cross 
reactions (Caron et al. 2010, Huang & Sedlak 2001, Nunes et al. 1998, Seifert et al. 
1999). 
Cell proliferation assays like the E-(A-)Screen measure the estrogenic (androgenic) 
activity of single substances and mixtures containing substances with similar modes of 
action (e.g. ER-binding). They are robust, relatively cheap and easy to apply and have a 
low method quantification limit (0.2 ng∙L-1; MQL) (Leusch 2008). The induction of cell 
proliferation was thought to be one major characteristic of a substance to classify it as a 
(xeno)estrogen (Sonnenschein & Soto 1998), but to date it is proven that it can also be 
mediated through other pathways (OECD 2012b). Another major drawback of this 
method is the use of (human) breast-cancer cells (MCF-7) which express several steroid 
receptors. Therefore, the investigation of complex mixtures is partly limited due to 
antagonistic effects. Furthermore, this method is relatively slow as cell proliferation 
occurs only after several days (Connolly et al. 2011).  
There are several recombinant receptor-reporter or reporter-gene assays (RGAs) with 
the main focus on mammalian (vertebrate) cell lines but also some widely used yeast 
systems. The Yeast Estrogenic Screen (YES) developed by Routledge & Sumpter (1996) is 
one of the first RGAs and is still performed in many studies regarding estrogen activity in 
environmental samples (Bovee & Pikkemaat 2009, OECD 2012a). The yeasts were 
transformed with a constitutively expressed human ERα as well as an inducible ß-
Galactosidase reporter gene expression cassette and are suitable to measure the 
estrogenic effect of inducible substances that bind to the receptor either in an agonistic 
or antagonistic way. Because it is cheap and relatively fast, the YES is useful as a first 
screening of many samples and of highly polluted samples. Compared to some 
mammalian (vertebrate) cell lines the yeasts lack the ability to transform substances 
into (more) active metabolites. Additionally, the yeast cell wall acts as a barrier for 
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certain substances. As a result the MQL is relatively high (±4 ng∙L-1) (Leusch 2008). One 
of the first developed RGAs with mammalian cells is the MVLN assay (Bovee & 
Pikkemaat 2009). It is based on the human MCF-7 breast-cancer cell line which includes 
endogenous steroid receptors (e.g. ERα) and was transfected with a plasmid containing 
the estrogen-responsive luciferase reporter gene pVit-tk-Luc (Demirpence et al. 1993). 
Another RGA based on the MCF-7 cell line is the MELN assay. In this case, cells have 
been stably transfected with a plasmid containing the estrogen-responsive luciferase 
reporter gene pERE-βGlob-Luc-SVNeo (Balaguer et al. 2001). The MELN assay has a MQL 
of 0.27 ng∙L-1 and seems to be sensitive towards anti-estrogenic substances in complex 
mixtures (Leusch 2008). To overcome the potential interactions of endogenous steroid 
receptors in the used cell lines a further assay for the detection of estrogenic activity in 
mammalian cell lines was developed by Balaguer et al. (2001), the HELN. For this assay 
the human HeLa cervical cancer cell line was stably transfected with pERE-βGlob-Luc-
SVNeo as well as an ERα expression cassette. The commercially available “estrogen 
receptor mediated chemical activated luciferase gene expression” assay (ER CALUX®) 
and the free available KBluc assay initially both based on the human T47D breast-cancer 
cell line. This cell line includes endogenous ERα as well as ERβ and is transfected with 
plasmids containing different estrogen-responsive luciferase reporter gene expression 
cassettes (T47Dluc: pEREtata-Luc; T47D-KBluc: pGL2.TATA.Inr.luc). Subsequent 
established versions of the ER and AR CALUX® work with the human U2OS 
osteosarcoma cancer cell line which does not express endogenous estrogen or androgen 
receptors. Therefore, the human ERα (ERα CALUX®) or ERβ (ERβ CALUX®) in 
combination with the estrogen-responsive luciferase reporter gene vector pEREtata-Luc 
were transfected into the cells resulting in more selective responses towards ER ligands 
(Sonneveld et al. 2005). Both assay systems are highly sensitive with MQL between 
0.1 ng∙L-1 (ER CALUX®) and 0.2 ng∙L-1 (KBluc) (Leusch 2008). One of the advantages of all 
RGAs is the possibility to detect both agonists and antagonists of the relevant receptors. 
They are fast and reliable as well as sensitive systems to detect hormonal effects 
whereas the mammalian systems are more sensitive than the yeast based systems 
(Connolly et al. 2011). 
While the proliferation assays and RGAs exclusively concentrate on receptor-based 
mechanisms there are few in vitro bioassays which deal with the effect of substances on 
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the steroidogenesis as a major part of the reproductive system. The H295R 
Steroidogenesis Assay is based on the human H295R-NCI adrenocortical carcinoma cell 
line. This cell line expresses all key enzymes of the steroidogenesis and produces all 
steroids of the adrenal cortex (Hecker et al. 2011, Staels et al. 1993). Therefore, effects 
on steroid production, enzymatic activities and gene expression are detectable 
(Hilscherova et al. 2004, Sanderson et al. 2000).  
 
In vivo 
With the Fish Short Term Reproduction Assay (OECD 229) it is possible to measure the 
impact of chemicals on the egg production (e.g. fecundity) and the biomarker endpoints 
vitellogenin production as well as secondary sexual characteristics. Therefore, this 
screening method provides information on several endocrine disrupting mechanisms. It 
is regularly accomplished with the fathead minnow (Pimephales promelas) and takes 21 
days (Knacker et al. 2010, OECD 2012c). As the use of vertebrates for screening 
purposes should be avoided alternative methods should be preferred if possible. 
Therefore, great efforts for alternative methods are undertaken. In this context, the 
reproduction test with the mud snail Potamopyrgus antipodarum is a promising 
candidate. It sensitively detects endocrine disruption via the impact on the fecundity 
(e.g. produced eggs per female) of exposed individuals (Duft et al. 2007, Kase et al. 
2009).  
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1.5 Selected test systems 
In the present study, the two recombinant receptor-reporter assays lyticase assisted YES 
(LYES) and ER CALUX® assay as well as the H295R, that allows the detection of effects on the 
whole steroid synthesis pathway, were applied. Previous studies reported the applicability of 
these assays for the evaluation of endocrine activity in water samples (Gracia et al. 2008, 
Hecker & Hollert 2009, Kase et al. 2009, Leusch 2008, Leusch et al. 2010). Additionally, the in 
vivo reproduction test with the New Zealand mud snail Potamopyrgus antipodarum (Pa-
Repro) has been used.  
 
1.5.1 LYES  
Yeasts of the strain Saccharomyces cervisiae have been stably transformed with an 
expression cassette for the human estrogen receptor α (hER α). Additionally, the cells 
contain an expression plasmid carrying the reporter gene lacZ, which is encoding β-
galactosidase and the enhancer sequences for an estrogen responsive element (ERE) within 
the promoter region ensuring inducibility by hER activation.  
 
Figure 1.2 Mechanism of action in transformed yeasts of the Yeast Estrogen Screen (YES). The gene 
encoding the human estrogen receptor (hER) is integrated into the main genome. An expression 
plasmid is carrying estrogen responsive elements (ERE), the reporter gene encoding β-
Galactosidase (LacZ) and the human phosphoglycerate kinase 1 (PGK) promoter. Redrawn and 
adapted from Routledge & Sumpter (1996). 
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Through binding of a ligand, expression of β-galactosidase is induced and the enzyme partly 
secreted into the culture medium. The ß-galactosidase converts the yellow chromogenic 
substrate chlorophenol red-β-D-galactopyranoside (CPRG) to its product chlorophenol red 
with a detection wavelength at 540 nm (Fig. 1.2). Conversion of CPRG is therefore directly 
proportional to the presence of receptor-mediated endocrine active substances (Routledge 
& Sumpter 1996). In the present study the lyticase assisted YES system according to 
Schultis & Metzger (Schultis & Metzger 2004) has been applied. It includes a lyticase 
assisted digestion step to shorten the test and increase the sensitivity. 
 
1.5.2 ER CALUX®  
Human T47D breast adenocarcinoma cells expressing endogenous estrogen receptors α 
and β have been stably transfected with a plasmid bearing the estrogen-responsive 
luciferase reporter gene (pEREtata-Luc).  
 
Figure 1.3 Mechanism of action in transfected T47D cells (T47Dluc) for the estrogen-responsive 
chemically-activated luciferase gene expression (ER CALUX®). The cells contain endogenous human 
estrogen receptors (hER) and the estrogen-responsive luciferase reporter gene pEREtata-Luc is 
stably transfected into the genome. Redrawn and adapted from Legler et al. (1999). 
 
In case of binding of an estrogen active agent to the receptor the expression of the enzyme 
luciferase is induced and the enzyme is partly secreted into the culture medium. Luciferase 
activity can easily be measured through light emission after addition of the substrate 
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luciferin. This modified cell line (T47Dluc) is sensitive and highly responsible to 
(anti)estrogenic compounds (Legler et al. 1999).  
 
1.5.3 H295R  
This assay is a cell-based in vitro assay for the detection of chemicals with the potential to 
disrupt steroid production over various pathways (e.g. enzyme inhibition or gene 
expression) (Fig. 1.4). The H295R cell line expresses all the genes that encode all key 
proteins of steroid genesis downstream of cholesterol (Fig. 1.1). Production of steroid 
hormones can be measured with radioimmunoassays (RIA) and enzyme-linked 
immunosorbent assays (ELISA) as well as LC-MS (Hecker et al. 2011, Hecker et al. 2006).  
 
Figure 1.4 Possible mechanisms of steroidogenic disruption pathways in the H295R Steroidogenesis 
assay. Endocrine disruptive compounds (EDCs) can act over altering of gene expression (a) and 
inhibition of enzyme activities (b).  
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1.5.4 Pa-Repro 
The reproduction test with the New Zeeland mud snail Potamopyrgus antipodarum is a 
sensitive in vivo test system for the detection of EDCs (Fig. 1.5). Under laboratory 
conditions the female adults reproduce mainly over parthenogenesis. Therefore, 
determination of the exact reproduction outcome for every single animal as well as for the 
whole population is possible. It is suitable for native samples as well as extracts and is able 
to express inhibition as well as promotion of reproduction (Duft et al. 2007, Fomin et al. 
2009). 
 
Figure 1.5 Reproduction of Potamopyrgus antipodarum (Pa-Repro) after exposure to endocrine 
active substances. An estrogen (e.g. ethinyl estradiol (EE2) causes a significant increase in embryo 
production; substances like aromatase inhibitors (e.g. fadrozole) cause a significant decrease in 
embryo production. 
 
This bioassay arrangement allows a fast and simple screening of potential endocrine active 
native as well as processed samples from the aquatic environment. All test systems are 
applicable for extracted samples while native samples can be investigated by the LYES as 
well as the Pa-Repro and with some limitations (mostly regarding the possible contamination 
of samples with bacteria or fungi) even with the ER CALUX®. They cover the range of 
receptor-mediated activities as well as activities on the process of steroid genesis and 
impacts on whole organisms as well as populations.  
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1.6 Aims and objectives 
This study aims to give insights into the application as well as the development and 
establishment of in vitro and in vivo bioassays for the detection of (possible) EDCs in the 
aquatic environment. The main objective was the establishment of a suitable bioassay 
battery to detect (possible) EDCs in different compartments of the aquatic environment as 
well as different sample matrices at the laboratories of the Institute for Environmental 
Research, RWTH Aachen University, Germany. With the application of the selected battery 
on different kinds of samples the suitability to detect a set of relevant endpoints should be 
verified. The selected endpoints and according bioassays were: 
(1) Estrogen-receptor binding and activation (LYES and ER CALUX®); 
(2) Alteration of the steroidogenesis (H295R); 
(3) Alteration of the reproductive outcome (Pa-Repro). 
For the successful establishment of the bioassay battery the present study aimed to 
positively respond to the following questions: 
(A) Were the selected bioassays suitable to detect potential endocrine disrupting 
effects? Were there differences in between the investigated sample matrices? 
(B) How was the performance of the selected bioassays within this study? Were the data 
comparable to other studies?  
(C) Which kind of data analysis should be applied? 
(D) How could the selected bioassays be further developed? 
(E) Did the data revealed with the in vivo test system correlate with data revealed from 
the in vitro test systems? 
 
In the first part of this study, the development of a new in vitro test system, the H295R 
Steroidogenesis assay (H295R), was scientifically attended. The properties of the H295R cell 
line to express all the necessary genes for the production of vertebrate steroids make it a 
unique base for the detection of substances that potentially disrupt the steroidogenesis. The 
H295R was developed and validated to become an OECD guideline by Hecker et al. (2011, 
2007, 2006). In the present study, the outcomes of the inter-laboratory validation study are 
summarized. The test protocol was validated by the screening of 28 chemicals that were 
selected based on their known or suspected endocrine activity, or lack thereof. It could be 
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demonstrated that the H295R protocol successfully identified the majority of chemicals with 
known and unknown modes of interaction with the production of T and E2. 
In the second part of the study the two recombinant receptor-reporter assays LYES and ER 
CALUX® were applied to the investigation of heterocyclic aromatic hydrocarbons (hetero-
PAHs), a substance class that is frequently detected in groundwater wells and therefore 
could threaten the safety of drinking water. While there was no detectable estrogenic 
activity in the LYES the nine hetero-PAHS acridine, xanthene, indole, 2-methylbenzofuran, 
2,3-dimethylbenzofuran, dibenzofuran, dibenzothiophene, quinoline and 6-methylquinoline 
showed estrogenic activity in the ER CALUX®. Estradiol equivalent factors (EEFs) between 
2.85·10-7 and 3.18·10-5 were detected which is in the range of other known non-steroidal 
xenoestrogens (e.g. alkylphenols or bisphenol A) that are found in surface water. Chemical 
analyses revealed the metabolic capacity of the T47D cell line. Among the detected 
metabolites were hydroxides and their keto tautomers, sulfates, sulfoxides, and N-oxides. 
Because of their high concentrations measured in ground water, the metabolized hetero-
PAHs could cause a potential risk for human health and should be the subject of further 
research. Furthermore, it could be shown that test systems without the ability for 
biotransformation, such as the LYES, are susceptible to underestimate the estrogenic 
potential of complex water samples. Consequently, when using such test systems a 
metabolic activation step (e.g. S9 liver fraction) should be included in the bioanalytical 
identification of potential EDCs. 
A secondary objective of the present study was the comprehensive assessment of the 
endocrine disruptive effects of the biological mosquito larvicide Bacillus thuringiensis 
israelensis (Bti), which is regularly applied to large surface water areas in sensitive habitats 
of the aquatic ecosystem. The third part of this study, therefore, includes two chapters 
dealing with the evaluation of Bti. At first the potential endocrine disruptive effects were 
investigated with all three in vitro bioassays of the established battery. The already revealed 
estrogenic activity in the LYES was proofed for three commercially available Bti formulations 
as well as for the active substance VectoBac® TP (TP). In contrast, the investigated liquid 
formula as well as the formulation VectoBac® WDG were tested negative. With the ER 
CALUX® the estrogenic potential of TP again could be confirmed. In the H295R, significant 
but weak effects with no dose-response-relationship on the production of E2, and 21-
hydroxyprogesterone (WDG) as well as T (TP) by H295R cells could be observed. The 
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investigated field samples as well as the samples from the artificial pond showed no 
significant increase of estrogenic activity after application of TP or WDG in the ER CALUX®. 
To investigate potential changes in the composition and abundance of algae and 
zooplankton populations after exposure to TP an aquatic microcosm study was conducted. In 
addition, the indicator-species Potamopyrgus antipodarum was integrated into the system 
to deliver information on a possible endocrine disruption of higher organisms. After 
exposure to a high concentration (20 mg∙L-1) of TP a shift from green algae (Chlorophyta) to 
blue algae (Cyanobacteria) occurred. In contrast, the application of TP showed no impact on 
zooplankton communities. Clear effects on the reproduction of P. antipodarum could not be 
observed. Nevertheless, differences between the treatment-groups seemed to be associated 
with quantity and quality of the available food, which might be indirectly related to the 
application of TP (e.g. community shifts in phytoplankton and periphyton). Overall, a shift in 
the ecosystem structure in routinely treated areas seems unlikely, since maximum 
concentrations of TP utilized for mosquito control up to 50 times lower than the 
concentrations used in this study. 
In the fourth part of the present study sewages from a medium sized country hospital with 
an advanced sewage treatment system (membrane bioreactor (MBR) and ozonation (O3)) 
were investigated with all three in vitro bioassays of the established battery. A first screening 
with the LYES revealed high estrogenic activity of the raw sewage (up to 35.8±8.7 ng∙L-1 EEQ) 
which was significantly decreased after MBR and ozone treatment (up to 2.3±0.3 ng∙L-1 EEQ). 
Results were confirmed by use of the CALUX® which detected activities of up to 
0.2±0.11 ng∙L-1 EEQs. Additionally, substance-specific analyses demonstrated efficient 
removal of most of the measured estrogenic compounds by ozonation. In contrast, 
treatment with ozone resulted in higher estradiol production and aromatase activity in 
H295R cells. It was hypothesized that this could partly be due to formation of by-products 
during ozonation. Overall, results obtained in this study demonstrated applicability of the 
used in vitro assays for monitoring of endocrine-modulating potency of treated sewage. 
 
 
 
27 
Chapter 2 
 
 
Frequently applied methods 
 
 
 
 
28 
Chapter 2 – Sample preparation 
 
29 
2.1 Sample preparation 
All chemicals were purchased from Sigma Aldrich (Munich, Germany). 
 
2.1.1 Solid phase extraction (SPE) 
Parts of the liquid samples (see chapters 5 and 7) were extracted by use of solid phase 
extraction (SPE) with Oasis HLB cartridges (Waters) according to previously described 
methods by Bratkowska et al. (2010) and Cahill et al. (2004). Cartridges were conditioned 
with 4 ml hexane, followed by 4 ml acetone, 4 ml methanol and finally 4 ml demineralized 
water (pH 3). The pH of the samples was set to 3 by adding hydrochloric acid. Extraction 
was performed at a flow rate of 15-20 ml·min-1. For treated sewage and surface water 
2000 ml, for untreated sewage a volume of 500 ml were concentrated. After drying under a 
gentle stream of nitrogen, cartridges were eluted with three times 4 ml acetone and 4 ml 
methanol. Extracts were again dried under a gentle stream of nitrogen and redissolved in 
ethanol or dimethylsulfoxide (DMSO) for dosing in bioassays and in methanol for chemical 
analyses (Pinnekamp et al. 2009). Prior to use in assays samples were stored in 1-4 ml 
amber glass vials with Teflon lids at ≤ -20°C.  
 
2.1.2 Lyophilisation 
Another set of liquid samples (see chapter 5) was processed through freeze drying 
(lyophilisation). Prior to lyophilisation turbid samples were centrifuged to remove particles 
from the solution. Centrifuged solutions as well as water samples were dried for 
approximately 96 hours in a manifold freeze-dryer (Christ, Germany) at 0.22 bar. The dried 
samples were reconstituted with 2x100 ml dichloromethane (DCM) in an ultrasonic bath. 
DCM was subsequently evaporated using a rotary evaporator until only 1-3 ml remained. 
The remaining solvent was removed under a low stream of nitrogen. Dry extracts were 
reconstituted in ethanol or DMSO and stored at ≤ -20°C in 1 ml amber glass vials with 
Teflon lids.  
 
2.1.3 Liquid-liquid extraction (LLE) 
Steroids as well as metabolites in assay medium were extracted by use of liquid-liquid 
extraction according to Hecker et al. (2006). For the H295R (see chapter 3 and 7), 450 µl of 
the assay medium were mixed with 550 µl nanopure water in a glass test tube. 2.5 ml 
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diethyl ether (chapter 7) or a 1:1 mixture of hexane and ethylacetate (chapter 3) were 
added and the test tube was vortexed for 1 minute (min) for the actually extraction step. 
Afterwards, test tubes were centrifuged for 10 min at 2,000 rounds per minute (rpm). The 
solvent fraction was collected in a second test tube and the process was repeated once. For 
the LC-DAD analysis (see chapter 4), 2 ml of the assay medium were extracted in the same 
manner but using 4 ml ethyl acetate instead. Extracts were dried under a gentle nitrogen 
stream and stored at -80°C until further analysis (H295R) or reconstituted in HPLC-grade 
acetonitrile (chapter 4) or methanol (chapter 3), respectively.  
 
2.1.4 Pressurized liquid extraction (PLE) 
Parts of the solid samples were extracted according to Beck et al. (2008) with acetone p.a. 
using a SpeedExtractor® (Büchi, Switzerland). Extraction columns were loaded with 10 g of 
each sample mixed with 10 g of quartz. The extraction was performed twice, at 30°C and 
60°C (using separate loaded columns for each run). The device was operated under the 
following conditions: two extraction cycles, extraction pressure 120 bar. Each run 
contained an additional column loaded with 20 g of quartz sand only as the process 
control. Extracts were reduced in volume to about 2 ml with a rotary evaporator (Heidolph, 
Germany) and transferred to 4 ml amber glass vials. Subsequently, 500 µl DMSO were 
added as a keeper and the remaining acetone was removed under a gentle nitrogen 
stream. Upon removal of acetone, an additional 500 µl of DMSO were added (resulting in 
1 ml DMSO). 
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2.2 Bioassays 
2.2.1 Lyticase Yeast Estrogen Screen (LYES) 
The Lyticase Yeast Estrogen Screen (LYES) was conducted as described by Routledge & 
Sumpter (1996) with modifications according to Schultis & Metzger (2004) and Wagner & 
Oehlmann (2009).  
 
2.2.1.1 Cell culture 
Recipes for media and nutrient agar plates are given in table 2.1. As long as not stated 
otherwise all chemicals were purchased from Sigma Aldrich (Munich, Germany). 
 
Table 2.1 Recipes for cell culture of the yeasts 
Amino acid solution (DO) with adenine 100 mg adenine, 100 mg arginine, 500 mg asparagic acid, 
500 mg glutamic acid, 100 mg histidine, 150 mg 
isoleucine, 500 mg leucine, 150 mg lysine, 100 mg 
methionine, 250 mg phenylalanine, 2000 mg serine, 
1000 mg threonine, 150 mg tyrosine and 750 mg valine in 
500 ml ultrapure water (Millipore, Merck, Darmstadt, 
Germany); sterile filtered 
Nutrient solution (SD) 13.4 g Yeast Nitrogen Base w / o Amino Acids (Difco, 
Becton Dickinson, Heidelberg, Germany) and 40 g D-
glucose in 200 ml ultrapure water, sterile filtered 
Growth medium  1 ml DO and 1 ml SD in 8 ml ultrapure water (sterile) 
Freeze medium Growth medium containing 40 % glycerol (sterile) 
Nutrient agar plates 5 g Agar-agar in 200 ml ultrapure water; autoclaved 
Completion with 25 ml DO and 25 ml SD 
 
For long time storage, yeasts were kept as cryo cultures in freeze medium in 2 ml reaction 
tubes (Eppendorf, Hamburg, Germany) at ≤ -70°C. Prior to testing, cryo cultures were 
plated on nutrient agar at 30°C for approximately 30 h to obtain single colonies with a 
diameter of 1 mm. Plates were stored at 2-8°C for a maximum of four weeks. For test 
purposes, yeasts had to be transferred to a liquid culture. Therefore, one colony was 
transferred to 10 ml growth medium in a 45 ml reaction tube (Falcon®, Corning, 
Amsterdam, The Netherlands) and incubated at 30°C and 750 rpm for 24 h. The liquid 
culture was stored at 2-8°C for a maximum of one week. 
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2.2.1.2 Test procedure 
Recipes for test medium, buffer and reaction solutions are given in table 2.2. As long as 
not stated otherwise all chemicals were purchased from Sigma Aldrich (Munich, 
Germany). 
 
Table 2.2 Recipes for test procedure of the LYES 
Copper sulfate solution (CSS; 10mM) 2.5 g CuSO4·5H2O in 1 liter ultrapure water; 
autoclaved 
Assay medium (1 plate) 10 mg ampicillin, 10 mg streptomycin, 7.5 ml DO, 
7.5 ml SD and 148 µl CSS 
lacZ buffer 8.52 g Na2HPO4, 0.75 g KCl and 0.25 g MgSO4·7H2O in 
950 ml ultrapure water; pH 7; autoclaved 
Completion with 1 g sodium dodecyl sulfate (SDS) and 
ultrapure water up to a final volume of 1 liter 
lacZ solution (1 plate) 2 mg Chlorophenol Red-β-D-galactopyranoside 
(CPRG), 0.4 mg lyticase (from Arthrobacter luteus, 
250 U·mg
-1
) and 25 µl 2-Mercaptoethanol in 10 ml 
lacZ buffer 
 
Generally, each well of a 96-well microtiter plate was filled with 75 µl reference water 
(tap water) or 75 µl of the liquid samples. Estrogenic potency was assessed relative to a 
17ß-Estradiol (E2) standard curve (7 concentrations beginning at 1 pM and ending at 
100 pM) running in parallel on a separate plate. E2 standards in ethanol were diluted in 
test medium and 25 µl of the corresponding E2 concentration were added to the 
reference water. Extracted samples or single substances were solved in ethanol and 
diluted in test medium as well. The solvent control contained test medium with ethanol 
and the blank only test medium. Yeasts from the liquid culture were diluted five times in 
test medium and 20 µl of the yeast solution was added to all wells except for the blanks. 
Plates were covered with breathable sealing membranes (Breathe-Easy®, Sigma Aldrich, 
Munich, Germany) to allow oxygen exchange. After incubation at 30°C and 750 rpm for 
24 h cell density estimation was determined by optical density at 595 nm. Exposure was 
terminated by addition of 100 µl lacZ solution per well. The amount of converted CPRG 
was measured at 540 nm. Samples were at least tested in independent duplicates.  
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2.2.1.3 Data analysis 
Data analysis was performed with Excel (Microsoft Corporation, Redmond, USA) and 
GraphPad Prism 5 (GraphPad Software, La Jolla, USA). At first, absorbance of each well 
was corrected for the blank (Eq. 2.1) and the cell density at 595 nm (Eq. 2.2).  
 
𝐶𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 𝑐𝑒𝑙𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 = 𝑂𝐷595 − 𝑚𝑒𝑎𝑛 𝑏𝑙𝑎𝑛𝑘595𝑛𝑚  Equation 2.1 
 
C𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 𝑂𝐷540 =
𝑂𝐷540−𝑚𝑒𝑎𝑛 𝑏𝑙𝑎𝑛𝑘540𝑛𝑚
𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 𝑐𝑒𝑙𝑙 𝑛𝑢𝑚𝑏𝑒𝑟
  Equation 2.2 
 
 
Estradiol equivalents (EEQs) were calculated as described by Wagner & Oehlmann (2009). 
Corrected optical densities were inserted in an inversion of the four parameter logistic 
function (Eq. 2.4) which was fitted to the curve parameters obtained from the standard 
curve (Eq. 2.3).  
 
𝑦 =
𝐵𝑜𝑡𝑡𝑜𝑚+(𝑇𝑜𝑝−𝐵𝑜𝑡𝑡𝑜𝑚)
1+10((𝑙𝑜𝑔𝐸𝐶50−𝐸2 𝑐𝑜𝑛𝑐.)∙𝑆𝑙𝑜𝑝𝑒))
  Equation 2.3 
 
𝐸𝐸𝑄 (𝑀) = 10
(𝑙𝑜𝑔𝐸𝐶50𝐸2 – 
log(
𝑇𝑂𝑃𝐸2 – 𝐵𝑂𝑇𝑇𝑂𝑀𝐸2
𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 𝑂𝐷540𝑆𝑎𝑚𝑝𝑙𝑒 – 𝐵𝑂𝑇𝑇𝑂𝑀𝐸2
 − 1)
𝑆𝐿𝑂𝑃𝐸𝐸2
)
  Equation 2.4 
 
EEQs were then corrected by the mean EEQ of the negative control of each replicate to 
exclude activities caused by the solvent as well as the used tap water. 
To determine the performance of the test system (Armbruster & Pry 2008) the limit of 
detection (LOD; Eq. 2.5) and the limit of quantification (LOQ; Eq. 2.6) were calculated as 
EEQs by implementing the traditional applied formulas (Eq. 2.7) into the standard curve.  
 
𝐿𝑂𝐷 (𝑀) = 𝐸𝐶50 ∙ ((
𝑀𝑎𝑥𝐸2
(𝑆𝐷𝑐𝑜𝑛𝑡𝑟𝑜𝑙∙3)−1
)
1
𝑆𝑙𝑜𝑝𝑒
)  Equation 2.5 
 
𝐿𝑂𝑄 (𝑀) = 𝐸𝐶50 ∙ ((
𝑀𝑎𝑥𝐸2
(𝑆𝐷𝑐𝑜𝑛𝑡𝑟𝑜𝑙∙10)−1
)
1
𝑆𝑙𝑜𝑝𝑒
)  Equation 2.6 
 
𝐿𝑂𝐷 / 𝐿𝑂𝑄 = 𝑚𝑒𝑎𝑛𝑐𝑜𝑛𝑡𝑟𝑜𝑙 + 𝑥 ∙ 𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛𝑐𝑜𝑛𝑡𝑟𝑜𝑙  
 
As the mean of the control always is subtracted from the data it is not implemented into the 
adapted formulas. 
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2.2.2 ER CALUX® Assay 
The ER CALUX® was performed according to the method of Legler et al. (1999) with minor 
modifications according to the standard operation procedure (SOP) of BDS (2007).  
 
2.2.2.1 Cell culture 
Recipes for media, buffer and trypsine solution are given in table 2.3. As long as not 
stated otherwise all chemicals were purchased from Sigma Aldrich (Munich, Germany). 
 
Table 2.3 Recipes for cell culture of the T47D cell line 
Growth medium 500 ml Dulbecco's Modified Eagle Medium / Nutrient 
Mixture F-12 (DMEM / F12; Gibco®, Life Technologies, 
Darmstadt, Germany) containing phenol red and 
GlutaMAX™, 41 ml fetal calf serum (FCS; Biowest, Nuaillé, 
France), 0.68 g NaHCO3, 5 ml 100x non-essential amino 
acids solution (MEM; Gibco®, Life Technologies, 
Darmstadt, Germany) and 1 ml penicillin-streptomycin 
solution (5,000 U·ml
-1
; Gibco®, Life Technologies, 
Darmstadt, Germany; sterile filtered 
Phosphate buffered saline (PBS) 0.2 g of potassium chloride (KCl), 0.2 g of potassium 
phosphate (KH2PO4), 1.15 g of sodium phosphate 
(Na2PO4) and 8 g of sodium chlorid (NaCl) in 1 liter 
ultrapure water, pH 7.2, sterile filtered 
Trypsine solution 0.05 % trypsine in PBS; sterile filtered 
Freeze medium 7 ml growth medium, 1 ml DMSO and 2 ml FCS 
 
For long time storage, cells were kept in freeze medium in 2 ml cryo tubes (Greiner Bio-
One, Frickenhausen, Germany) at -196°C in the gas phase over liquid nitrogen. For regular 
cell culture, cells were transferred to 10 ml growth medium in 75 cm2 tissue culture (TC) 
flasks and incubated at 37°C and 7.5 % CO2 until they reached 85-95 % confluence. 
Subsequently, cells were rinsed with PBS twice and trypsinated. Detached cells were 
transferred to new TC flasks and diluted 1:3 with fresh growth medium. T47Dluc cells can 
be subcultured a maximum of 40 passages. 
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2.2.2.2 Test procedure 
The recipe for assay medium is given in table 2.4. As long as not stated otherwise, all 
chemicals were purchased from Sigma Aldrich (Munich, Germany). 
 
Table 2.4 Recipes for test procedure of the ER CALUX® 
Assay medium 480 ml DMEM / F12 (Gibco®, Life Technologies, 
Darmstadt, Germany) without phenol red, 25 ml 
charcoal stripped FCS, 0.63 g NaHCO3 and 5 ml MEM; 
sterile filtered 
 
T47Dluc cells were diluted in assay medium until a density of 1·105 cells was achieved. 
The outer wells of a 96-well microtiter plate were filled with 200 µl PBS. 100 µl cell 
solution was seeded into the remaining inner wells. After 24 h incubation at 37°C and 
7.5 % CO2 medium was renewed. After another 24 h medium again was removed and cells 
were exposed to a dilution series of the single substances or extracted samples (solved in 
DMSO) in assay medium for 24 h. In addition, an E2 standard dilution series 
(7 concentrations beginning at 0.3 pM and ending at 30 pM) was included on each plate. 
Exposure medium was removed and luciferase activity was measured after adding 50 µl 
of PBS and 50 µl of SteadyLite® (Perkin Elmer, USA) with a luminescence counter 
(Infinite® M 200, Tecan, Switzerland). Samples were at least tested in independent 
duplicates.  
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2.2.2.3 Data analysis 
Data analysis was performed with Excel (Microsoft Corporation, Redmond, USA). At first, 
mean values (given as relative luminescence units (RLU)) of the standard and samples 
were subtracted by the mean value of the DMSO control. Concentrations of EEQs were 
calculated as described by Legler et al. (1999) and BDS (2007). The corrected E2 
concentrations were used for the construction of a calibration curve (sigmoidal fit, four 
parameter logistic function) (Eq. 2.8). 
 
𝑦 =
𝑀𝑎𝑥𝐸2
1+(
𝐸2 𝑐𝑜𝑛𝑐.
𝐸𝐶50
)
𝑆𝑙𝑜𝑝𝑒  Equation 2.8 
 
Corrected luciferase responses of the samples were then interpolated in the linear range 
of the E2 standard curve (Eq. 2.9). 
 
𝐸𝐸𝑄 (𝑝𝑀) = 𝐸𝐶50𝐸2 (((
𝑀𝑎𝑥𝐸2
𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 𝑅𝐿𝑈𝑆𝑎𝑚𝑝𝑙𝑒
) − 1)
1
𝑆𝑙𝑜𝑝𝑒𝐸2
)  Equation 2.9 
 
LOD (Eq. 2.10) and LOQ (Eq. 2.11) again were calculated as EEQs (see chapter 2.2.1.3). 
 
𝐿𝑂𝐷 (𝑝𝑀) = 𝐸𝐶50 ∙ ((
𝑀𝑎𝑥𝐸2
(𝑆𝐷𝑐𝑜𝑛𝑡𝑟𝑜𝑙∙3)−1
)
1
𝑆𝑙𝑜𝑝𝑒
) Equation 2.10 
 
𝐿𝑂𝑄 (𝑝𝑀) = 𝐸𝐶50 ∙ ((
𝑀𝑎𝑥𝐸2
(𝑆𝐷𝑐𝑜𝑛𝑡𝑟𝑜𝑙∙10)−1
)
1
𝑆𝑙𝑜𝑝𝑒
)  Equation 2.11 
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2.2.3 H295R Steroidogenesis Assay 
The H295R Steroidogenesis assay was conducted according to the methods of Hecker et al. 
(2011, 2007).  
 
2.2.3.1 Cell culture 
Recipes for media, buffer and trypsine solution are given in table 2.5. As long as not 
stated otherwise all chemicals were purchased from Sigma Aldrich (Munich, Germany). 
 
Table 2.5 Recipes for cell culture of the H295R cell line 
Stock medium 15.6 g Dulbecco's Modified Eagle's Medium / Nutrient 
Mixture F-12 Ham containing L-glutamine and 15mM 
Hepes and 1.2 g sodium bicarbonate(Na2CO3) in 1 liter 
ultrapure water; sterile filtered 
Supplemented medium 12.5 ml Nu-Serum™ (Corning Life Sciences, Amsterdam, 
The Netherlands) and 5 ml ITS + Premix (Corning Life 
Sciences, Amsterdam, The Netherlands) in 482.5 ml stock 
medium, sterile filtered 
Phosphate buffered saline (PBS) 0.2 g KCl, 0.2 g KH2PO4, 1.15 g Na2PO4 and 8 g NaCl in 
1 liter ultrapure water, pH 7.4, sterile filtered 
Trypsine solution 0.05 % trypsine in PBS; sterile filtered 
Freeze medium 7.5 ml Nu-Serum and 5.26 ml DMSO in 92.5 ml stock 
medium 
 
H295R cells were purchased from ATCC (LGC Standards, Wesel, Germany). For long time 
storage cells were kept in freeze medium in 2 ml cryo tubes (Greiner Bio-One, 
Frickenhausen, Germany) at -196°C in the gas phase over liquid nitrogen. For regular cell 
culture, cells were transferred to 10 ml supplemented medium, resuspended and 
centrifuged at 125·g for 5 min. Medium was discarded and the pellet was resuspended in 
10 ml fresh supplemented medium in 75 cm2 tissue culture (TC) flasks and incubated at 
37°C and 5 % CO2 until they reached 85-95 % confluence. Subsequently, cells were rinsed 
with PBS twice and trypsinated. Detached cells were transferred to new TC flasks and 
diluted 1:3 with fresh supplemented medium. H295R cells can be subcultured a maximum 
of 15 passages (derived from ATCC stock). 
 
2.2.3.2 Test procedure 
After a minimum of four passages H295R cells were seeded in a 24-well microtiter plate 
at a density of 3x105 cells per ml. After 24 h the medium was discarded and 1 ml fresh 
supplemeted medium was added to each well. Cells were then exposed with 1 µl of a 
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dilution series (in DMSO) of the extracted samples or single substances as well as the two 
reference substances forskolin and prochloraz (quality control plate; QC) for 48 h. 
Subsequently, the medium was removed and extracted using liquid-liquid extraction with 
diethyl ether or a 1:1 mixture of hexane and ethylacetate (see 2.1.3). The amount of 
steroids was either determined in an enzyme-linked immunosorbent assay (ELISA) 
according to the manufacturers’ recommendations (Cayman Chemicals Europe, Tallinn, 
Estonia) as well as Grund et al. (2011) and / or by use of liquid chromatography tandem 
mass spectrometry (LC-MS2). The LC-MS2 consisted of an Agilent 1200 series HPLC system 
(Santa Clara, CA, USA) connected to an API 3000 triplequadrupole MS2 system (PE Sciex, 
Concord, ON, Canada). Both LC and MS were controlled by AB Sciex Analysts 1.4.1 
software (Applied Bioscience, Foster City, CA, USA). Chromatographic separation was 
done on a Betasil C18 column (Thermo Scientific, Waltham, MA, USA) using a mixture of 
ACN and 0.1 % formic acid in water as the mobile phase. The device was operated 
according to Chang et al. (2010). Furthermore, aromatase enzyme activity was measured 
(chapter 7) using a tritiated water release assay (3H Release Aromatase Assay) as 
described by Lephart & Simpson (1991) with minor modifications according to Sanderson 
et al. (2001a). After removal of the assay medium (see above) cells were washed with PBS 
twice and exposed to a solution of 54 nM 3H-androstenedione in stock medium at 37oC 
under a 5 % CO2 in air atmosphere for 1.5 h. The reaction was stopped reaction by putting 
the microtiter plates on ice for 5 min. Subsequently 200 µl of the solution from each well 
were transferred to 1.5 ml reaction vials containing 500 µl chloroform. After short 
vortexing the vials were centrifuged and 100 µl of the supernatant were transferred to 
reaction vials containing dextran coated charcoal. After short vortexing and a lag phase of 
5 min the vials were centrifuged and 125 µl of the supernatant were transferred to 
scintillation vials (Research Products International Corp., Mount Prospect, USA) 
containing 4 ml scintillation cocktail Bio-Safe II (Research Products International Corp., 
Mount Prospect, USA). The release of tritiated water, e.g. aromatase activity, was 
counted for 10 min in a scintillation counter (LS6500 Multi-Purpose Scintillation Counter, 
Beckman Coulter, Brea, USA). 
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2.2.3.3 Data analysis 
For determining the steroid concentrations in the ELISA measured absorption was first 
corrected for the mean of the non-specific binding (NSB) through the tracer. 
Concentrations were then calculated by inserting the corrected values in a polynomial 
cubic function based on the estradiol standard (Eq. 2.7). 
 
𝑦 = 𝑎𝑥3 +  𝑏𝑥2 + 𝑐𝑥 + 𝑑  Equation 2.7 
 
Concentrations of the steroids measured by means of LC-MS were calculated by 
comparison to the deuterium-labeled internal standards 21-HPT-d8, 17-HPT-d8, ASD-d7, 
progestrone-d9, testosterone-d5 (100 μg·L
-1) and cortosol-d4 (1 mg·L
-1) (C / D / N Isotopes 
Inc., Pointe-Claire, Canada). 
For all data fold inductions (changes) compared to the SC were calculated whereas the SC 
was set to one.  
 
2.2.4 MTT Assay 
The MTT assay was conducted according to Sanderson et al. (2001b) with some 
modifications according to Blaha et al. (2004).  
 
2.2.4.1 Test procedure 
In case of the H295R assay the MTT was applied during the main test procedure directly 
after removal of the medium. For the ER CALUX® the MTT was performed separately prior 
to the main test. In both cases cells were treated in the same way as for the main assays 
(see chapter 2.2.2.2 and 2.2.3.2). After exposure cells were rinsed with PBS and 
subsequently exposed to a 0.5 mg∙ml-1 solution of 3-(4,5-Dimethyl-2-thiazolyl)-2,5-
diphenyl-2H-tetrazolium bromide (MTT) in unsupplemented assay medium for 30 min at 
37°C and 5 % (H295R) or 7.5 % (ER CALUX®) CO2 in air atmosphere. MTT solution was 
removed and lysis of the cells was implemented through addition of DMSO. After 
homogenization on an orbital shaker for 15 min absorbance at 492 nm was measured. 
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2.2.4.2 Data analysis 
Viability of the cells was expressed as relative changes to the NC in percent, whereas the 
NC was set to 100 %.  
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3.1 Abstract  
Due to increasing concerns regarding the potential of chemicals to interact with the 
endocrine system of humans and wildlife, various national and international programs have 
been initiated with the aim to develop new guidelines for the screening and testing of these 
chemicals in vertebrates. In the current study, the validation of the H295R steroidogenesis 
assay is documented. With this test system, it is possible to detect inhibition or induction of 
sex steroid hormone production as well as alteration of enzyme activity or gene regulation. 
The aim of the inter-laboratory study was the development of an Organization for Economic 
Cooperation and Development (OECD) test guideline.  
A previously optimized and pre-validated protocol was used to assess the potential of 28 
chemicals of diverse structures and properties to validate the H295R steroidogenesis assay. 
These chemicals are comprised of known endocrine-active chemicals and chemicals that 
were not expected to have effects on the targeted endpoints, as well as a number of 
chemicals with unknown modes of action at the level of the steroidogenic pathway. A total 
of seven laboratories from seven countries participated in this effort. In addition to effects 
on hormone production, confounding factors, such as cell viability and possible direct 
interference of test substances with antibody-based hormone detection assays, were 
assessed. Each participating laboratory had to demonstrate that they were able to conduct 
the assay within the margin of predefined performance criteria.  
With a few exceptions, all laboratories met the key quality performance parameters, while 
only 2 % (testosterone) and 7 % (17ß-estradiol) of all experiments were excluded due to non-
compliance of these parameters. Of the 28 chemicals analyzed, 13 and 14 affected 
production of testosterone (T) and 17ß-estradiol (E2), respectively, while 11 and 8 did not 
result in significant effects on T and E2 production, respectively. Four and six chemicals 
produced ambiguous results for effects on T and E2 production, respectively. Significant 
interference of test chemicals with some of the antibody-based hormone detection systems 
occurred for four chemicals. Only one of these chemicals, however, significantly affected the 
ability of the detection system to categorize the chemical as affecting E2 or T production. 
With one exception, the H295R steroidogenesis assay protocol successfully identified the 
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majority of chemicals with known and unknown modes of interaction as inducers or 
inhibitors of T and E2 production. Thus it can be considered a reliable screen for chemicals 
that can alter the production of sex steroid hormones. Based on the results obtained during 
this validation study and the accordingly revised test protocols an OECD draft test guideline 
was developed (OECD 456). 
Additionally, in the present study further improvements on the usability of the test system 
were developed. These included an adaption of the H295R cell line to suspension culture as 
well as the development of a highly sensitive but cost reducing enzyme linked 
immunosorbent assay (ELISA) for the detection of steroids in the exposure medium directly. 
 
 
Keywords: endocrine disruption, estradiol, H295R, hormone production, transferability, sex 
steroid, steroidogenesis, testosterone, validation, OECD
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3.2 Introduction  
Due to increasing concerns regarding the potential of chemicals to interact with the 
endocrine system of humans and wildlife, various national and international programs have 
been initiated with the aim of developing new guidelines for screening and testing of these 
chemicals in vertebrates (Endocrine Disruptor Screening and Testing Advisory Committee 
1998, OECD 1998, 2012). One of the leading and first nationally, legally binding programs 
was the endocrine disruptor screening program (EDSP) of the US Environmental Protection 
Agency (EPA), which employs a battery of in vitro and in vivo screening assays to assess the 
endocrine disrupting potential of chemicals. Specifically, the US Congress included a 
provision in the Food Quality Protection Act of 1996 that requires EPA to “… develop a 
screening program, using appropriate validated test systems and other scientifically relevant 
information, to determine whether certain substances may have an effect in humans that is 
similar to an effect produced by a naturally occurring estrogen…” (21 U.S. Code §346a (p)). 
Subsequent to passage of the act, EPA formed the Endocrine Disruptor Screening and 
Testing Advisory Committee (EDSTAC), a committee of scientists and stakeholders that was 
charged with the duty to provide EPA with recommendations on how to implement its EDSP. 
Upon recommendations from EDSTAC, the EDSP was expanded to include the androgen and 
thyroid hormone systems and wildlife effects as well as the originally mandated effects 
relating to estrogen. In addition to the US EPA activities, the Organisation for Economic 
Cooperation and Development (OECD) initiated a high-priority activity in 1998 to revise 
existing, and to develop new, test guidelines for the screening and testing of potential 
endocrine disrupting compounds (EDCs). The OECD conceptual framework for testing and 
assessment of potential EDCs comprises five levels, each level corresponding to a different 
level of biological complexity (OECD 2012). 
The objective of the steroidogenic screening assay is to detect substances that would disrupt 
estradiol and testosterone production. It is intended to identify substances that interact with 
the biochemical pathway of steroidogenesis beginning with the sequence of reactions 
occurring after the gonadotropin-releasing hormone receptors (GnRHR) up through the 
production of the terminal sex steroid hormones testosterone and estradiol / estrone. The 
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steroidogenic assay is not intended to identify substances that affect steroidogenesis due to 
effects on the hypothalamus or pituitary gland or on storage or release of sex steroid 
hormones.  
One of the assays recommended by EDSTAC as a Tier 1 screen was an in vitro rodent minced 
testis assay to detect chemicals with the potential to disrupt steroid hormone production 
(Endocrine Disruptor Screening and Testing Advisory Committee 1998). Despite its long 
history of use, the rodent minced testis assay had not been optimized at the time that it was 
recommended by EDSTAC. EPA conducted a series of studies to optimize the assay and 
evaluate its suitability to serve a function in the EDSP testing battery. Preliminary inter-
laboratory studies exhibited large variability within and among laboratories (Johnson & 
Feder 2005). However, the seemingly insurmountable problem of assessing cytotoxicity 
specific to Leydig cells led EPA’s advisory committee to recommend that EPA abandon 
further work on the minced testis assay. As a consequence, there was a need for a less 
variable and more reliable in vitro test system as an alternative to the minced testis assay. 
One assay that offered promise with regard to the characterization of inducers and / or 
inhibitors of sex steroid production was the H295R steroidogenesis assay (Hecker & Giesy 
2008, Hecker et al. 2006).  
Development and standardization of the H295R steroidogenesis assay as a screen for the 
evaluation of the effects of chemicals on the synthesis of sex steroids has been conducted in 
a multistep process. The results of the assay optimization process and the pre-validation 
efforts undertaken to date have been reported previously (Hecker et al. 2007, Hecker et al. 
2006). After initial development of the assay, US EPA presented a progress report on the 
development of the H295R assay to an OECD committee and invited member countries to 
join the USA in its further standardization and validation. This invitation was accepted by 
laboratories in Japan, Denmark, Germany, Hong Kong, and Korea.  
In the present study, the results of an inter-laboratory study that was part of the final 
validation of a H295R protocol in accordance with the OECD guidelines for validation (OECD 
1996) are presented. Using three model chemicals tested by five independent laboratories, 
an inter-laboratory pre-validation study was conducted to develop the H295R 
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steroidogenesis assay protocol (Hecker et al. 2007). These studies indicated that the H295R 
test protocol was capable of characterizing the effect of chemicals on the production of 
testosterone (T) and 17ß-estradiol (E2). The goal of the present project was to further 
validate the H295R steroidogenesis assay by assessing the transferability, flexibility, and 
applicability of an improved and revised protocol across several laboratories using an 
extended test set of 28 chemicals selected and approved by the OECD Validation and 
Management Group for Non-Animal Testing (VMG NA).  
Subsequently to validation, further developments to enhance cell performance as well as to 
cheapen the test system were conducted. The adherent H295R cell line was adapted to 
chemical defined medium (CDM5) and brought into suspension culture which led to a 
prolonged growth period and therefore, fewer passages were needed. Additionally, a new 
ELISA protocol was developed which significantly lowered costs as well as duration of the 
H295R steroidogenesis assay. 
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3.3 Material & Methods  
3.3.1 Study protocol 
Based on the results obtained during the initial pre-validation studies (Hecker et al. 2006), a 
standardized H295R steroidogenesis assay protocol was developed (OECD 2011) (see 
chapter 2.2.4). To ensure sufficient basal E2 production cells were to be cultured under 
standard cell culture conditions for a minimum of four to five passages (cell age was not to 
exceed ten passages). For the inter-laboratory study cells were exposed to seven 
concentrations between 0.0001 and 100 μM of the test chemical in triplicate. At the end of 
the exposure period hormones were extracted using ethyl ether (see chapter 2.1.3). One 
laboratory (Lab 3) did not conduct extraction because the medium was directly used in a 
radio immunoassay (RIA). Cell viability in each well was analyzed immediately after removal 
of medium by means of the MTT assay (see chapter 2.2.1) (Mosmann 1983). All 
concentrations, where cell viability was less than or equal to 80 %, were excluded from the 
data analysis. Concentrations of hormones in medium were measured using commercially 
available hormone detection kits, namely enzyme linked immunoassays (ELISA; Lab 1, 2, 4 
and 6) and radio immunoassays (RIA; Lab 3). Responses measured by means of antibody-
based assays in the QC plate experiments were confirmed by instrumental techniques 
(liquid chromatography mass spectroscopy (LC-MS)) at Lab 1 following the method 
described by Chang et al. (2010) (data not shown). Each experiment was repeated three 
times with exception of Labs 1 and 3, where one and two replicate experiments were 
conducted per chemical, respectively.  
Laboratories were required to demonstrate competence in performing all of the 
procedures that are part of the H295R steroidogenesis assay prior to testing chemicals 
(Tab. 3.1). The QC also served as a benchmark for determining laboratory competence 
prior to the initiation of chemical testing. 
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Table 3.1 Performance criteria to be met by each laboratory during experiments 
System Parameter Comparison to / Between T E2 
Hormone detection 
system 
Sensitivity Detectable fold decrease relative to 
SC 
≥2-fold ≥2-fold 
 Precision CV among replicate measures 
(absolute concentrations) of the 
same well for SCs 
≤25 % ≤25 % 
Cell assay Basal hormone 
production (SCs) 
Fold greater than LOQ of hormone 
detection system 
≥5-fold ≥2.5-fold 
 Precision (SCs) CV among absolute concentrations 
of replicate wells 
≤30 % ≤30 % 
 Sensitivity 
(induction at 10 µM 
forskolin) 
Fold greater than SC ≥2-fold  ≥7.5-fold 
 Sensitivity 
(inhibition at 3 µM 
prochloraz) 
Fold less than SC ≥0.5-fold  ≥0.5-fold 
Induction and inhibition refer to the relative change in hormone production after exposure to 
10 μM forskolin or 3 μM prochloraz, respectively, in the QC plates 
CV = Coefficient of variation (%), LOQ = limit of quantification, SC = solvent control 
 
Prior to initiation of the actual exposure experiments, each chemical was tested for 
potential interference with the hormone detection system used. This was of particular 
relevance for antibody-based assays such as ELISAs and RIAs because it has been previously 
shown that some chemicals can interfere with these tests (Puddefoot et al. 2002, Shapiro & 
Page 1976).  
 
3.3.2 Participating laboratories  
Seven laboratories from the USA, Denmark, Germany, Japan, Hong Kong, and Canada, each 
with different levels of experience in conducting the H295R steroidogenesis assay, were 
invited to participate in this validation study. Inclusion of laboratories with different levels 
of proficiency in conducting the assay was essential to evaluate the completeness of the 
test protocols and their transferability. Each laboratory was assigned a random code 
number (1–7) as part of the study. However, part way through the study, two of the seven 
laboratories decided to cease their participation in the validation studies. Thus, with the 
exception of the QC exposure data, only the data for the remaining five laboratories that 
completed the validation studies is presented (Labs 1, 2, 3, 4, and 6).  
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3.3.3 Selection and testing of chemicals  
A total of 28 chemicals were selected in this study to validate the H295R steroidogenesis 
assay as a screen for potential effects of endocrine-disrupting chemicals on the production 
of T and E2. These chemicals were selected based on their known or suspected endocrine 
activity, or lack thereof, and included inhibitors and inducers of different potencies as well 
as positive and negative controls. Where possible, the test set of chemicals was 
harmonized with those used in other steroidogenesis assays currently under development 
or in validation (e.g., the Registration, Evaluation, Authorization and Restriction of 
Chemical substances (REACH) program).  
Prior to the start of the validation studies, all chemicals were pre-analyzed by the lead 
laboratory (Lab 1). To reduce the workload for individual laboratories, each of the other 
groups tested only 17 to 18 chemicals. Each chemical set consisted of a “core group” of 12 
chemicals that were tested in parallel by all laboratories. In addition, three laboratories 
plus the lead laboratory conducted assays on a different set of five or six chemicals 
selected from the 16 chemicals that did not comprise the core chemicals. The 16 non-core 
chemicals were divided into three subgroups of five to six chemicals, and each chemical 
subgroup was tested by one of the three laboratories as well as the lead laboratory.  
 
3.3.4 Further improvement of the H295R 
For effective adaption of the H295R cell line to suspension culture different approaches 
were applied including epigenetic resetting by DNA demethylation. Successively, H295R 
cells were cultured within three different kinds of media: (1) DMEM F12 / Ham's (Sigma 
Aldrich, Munich, Germany) including standard H295R supplements and containing 5 µM 5-
Aza-2′-deoxycytidine (5-Aza-dc), (2) ProVero™1 (Lonza, Cologne, Germany) and (3) “CDM5” 
(working title). 5-Aza-dc is a demethylating agent that inhibits DNA methyltransferase 
activity which presumably reactivates silenced genes (Ferguson et al. 1997). The serum-
free medium ProVero™1 is a non-animal origin, protein-free medium for the culture of 
MDCK and Vero cell lines containing low levels of human recombinant insulin. The chemical 
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defined medium “CDM5” (working title) is designed for biopharmaceutical production and 
contains neither proteins nor steroids.  
To replace the cost extensive, error prone as well as time consuming steroid extraction as 
well as the detection step with commercially available ELISA kits (Cayman Chemicals 
Europe, Tallinn, Estonia) a new ELISA method was developed. Therefore, 96-well-plates 
with high sorption capacities were coated with monoclonal antibodies for estradiol (E2), 
testosterone (T) or progesterone (Pro) (Tab. 3.2) at 100 µl per well. Plates were incubated 
for 12 hours (up to one week) at 2-8°C. Afterwards remaining plate surface was covered 
with skimmed milk powder (in PBS) at 200 µl per well for 1 hour at 37°C. Plates were 
washed three times with PBS-T and one time with PBS only. In a low-binding plate (TPP, 
Trasadingen, Switzerland) 60 µl per well of samples, standards and controls in cell culture 
medium were mixed with 60 µl of tracer in PBS (Tab. 3.2).  
 
Table 3.2 Reagents and solutions for the alternative ELISA 
Solution Formula Dilution 
Antibodies Monoclonal antibodies (α-estradiol-6 mAB, α-
testosterone-3 mAB, α-progesterone-3 mAB; 
Antibodies-online, Aachen, Germany) in PBS 
(Sigma-Aldrich, Munich, Germany) 
E2 1:4000 
T   1:3000 
P   1:1000 
Blocking 5 % skim milk powder (Sigma-Aldrich, Munich, 
Germany) in PBS 
 
Washing 0.5 % Tween-20 (Roth, Karlsruhe, Germany) in 
PBS 
 
Tracer 17ß-estradiol(6)-short linker-HRP conjugate 
(Randox Laboratories, Wülfrath, Germany) in PBS 
17ß-testosterone-3-HRP conjugate (Randox 
Laboratories, Wülfrath, Germany) in PBS 
Progesterone-3-HRP conjugate (Antibodies-
online, Aachen, Germany) in PBS 
1:2000 
Substrate Mix 10 ml 0.1 M KPO4 / citrate (pH 6.0; Sigma-
Aldrich, Munich, Germany) with 500 µl MeOH 
containing 5 µl of 5 mM 3,3',5,5'-
tetramethylbenzidine (TMB; Sigma-Aldrich, 
Munich, Germany) in DMSO. Prior to incubation 
add 5 µl H2O2 (30 %) 
 
 
100 µl per well of this mixture were transferred to the ELISA plates and incubated at room 
temperature for one to two hours. Plates were washed three times with PBS-T and one 
time with PBS only. Per well 100 µl of the substrate solution were added and plates were 
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incubated for 20 to 45 minutes until Signal / Blank ratio at A640nm reached >2.0. Reaction 
was stopped by adding of 3 M HCl (50 µl per well) and the absorption at 455 nm was 
measured immediately.  
 
3.3.5 Statistical analysis  
All data were expressed as mean±standard error of the mean (SEM). To examine the 
relative changes in hormone production, results were normalized to the mean solvent 
control (SC) value for each assay, and results were expressed as percent change relative to 
the SC. Prior to conducting statistical analyses, the assumptions of data normality and 
variance of homogeneity were evaluated. Normality was evaluated using standard 
probability plots or the Shapiro-Wilk’s test. If the data were normally distributed or 
approximated a normal distribution, differences between chemical treatments and SCs 
were analyzed using one-way analysis of variance (ANOVA) followed by a two-sided 
Dunnett’s test. If data were not normally distributed, the Kruskal-Wallis test followed by 
the Mann-Whitney U test was used. Data analysis was conducted using pooled replicate 
experiments. All statistical analyses were conducted using SYSTAT 11 (SYSTAT Software, 
Point Richmond, CA). Differences were considered significant at p<0.05.  
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3.4 Results & Discussion  
3.4.1 Laboratory performance assessment  
With a few exceptions, all of the laboratories met the key quality performance parameters 
for conducting the H295R assay protocol (Tab. 3.1; Fig. 3.1).  
 
Figure 3.1 Comparison of changes in the concentrations of testosterone (T) and 17ß-estradiol (E2) 
relative to the solvent controls (SC = 1) in the quality plates (QC) among laboratories (Lab). 
For1 = 1 μM Forskolin; For10 = 10 μM Forskolin; Pro0.3 = 0.3 μM Prochloraz; Pro3 = 3 μM 
Prochloraz. Error bars = 1×standard deviation. Bars represent means of four independent 
experiments. (Lab 5: only T data from two experiments.) 
 
However, at Lab 2, there was a greater increase (forskolin) and a lesser decrease 
(prochloraz) in T concentrations when compared to the other laboratories. Furthermore, at 
one laboratory, there were instances when decreases in E2 or T production could not be 
measured due to low basal hormone production (Tab. 3.3). In addition, in rare occasions, 
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there was an increase in variation among replicate wells such that the data could not be 
used. However, this only occurred at one laboratory during a single experiment (Lab 4; 
chemicals: letrozole, paraben, molinate, ethylene dimethanesulfonate (EDS); experiment 
1), where the average coefficient of variation (CV) of the SCs was 48 %, which is almost 
20 % greater than the QC criterion of 30 % for this parameter. None of the results obtained 
during these experiments was used for the data evaluation. However, it should be 
emphasized that these were rare events that did not impact the overall validity and utility 
of data produced during these studies. Overall, only 2 % or 7 % of all experiments for T and 
E2, respectively, were excluded due to exceedance of permitted variation. Relative changes 
in the production of T and E2 after exposure to forskolin and prochloraz in the QC plates 
were comparable both within and among laboratories (Fig. 3.1), indicating that the H295R 
steroidogenesis assay functioned similarly at all laboratories. Coefficients of variation for 
relative changes measured after exposure to forskolin and prochloraz were between 12 % 
and 13 % and between 44 % and 77 %, respectively, for T, and between 62 % and 73 % and 
31 % and 55 %, respectively, for E2. There were no significant decreases in cell viability 
between any of the different treatment groups (results not shown). 
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Table 3.3 Lowest observed effect concentrations (LOECs) and strength and direction of change for 
testosterone (T) and estradiol (E2) after exposure to the 12 core chemicals. 
 Lab 1
a Lab 2 Lab 3 Lab 4 Lab 6 
 LOEC 
(µM) 
Max 
change 
LOEC 
(µM) 
Max 
change 
LOEC 
(µM) 
Max 
change 
LOEC 
(µM) 
Max 
change 
LOEC 
(µM) 
Max 
change 
 Testosterone 
Prochloraz 0.0001  0.1  0.0001  0.01  0.01 
Aminoglutethimid
e 
100
b
  100
b
  10  100
b
  100
b 

Letrozole 100b  100b  100a, b  100b  100b 
Nonoxynol-9 10b, c  10b, c  n.d.d  10b, c  10b, c  
Molinate n.d.  n.d.  100  n.d.  n.d.  
Benomyl n.d.  n.d.  n.d.  n.d.mu  n.d.  
EDS n.d.  n.d.  n.d.  n.d.  n.d.  
HCG n.d.  n.d.  n.d.  n.d.  n.d.  
Paraben 10  n.d.  1  n.d.  n.d.  
Atrazine 100b  1  100b  n.d.  n.d.  
Forskolin 10  1  1  1  1 
Trilostane* 0.1mu  0.01mu  1mu  1mu  0.01mu 
 17ß-Estradiol 
Letrozole 0.001  0.001  0.0001mu  0.01  0.01 
Prochloraz 0.1  1  0.1  1  0.1 
Aminoglutethimid
e 
100
b
  10
mu
  10  100
b, e
  100
b
 
Benomyl n.d.  n.d.  n.d.a  n.d.a  n.d. 
EDS n.d.  n.d.  n.d.  n.d.  n.d. 
Nonoxynol-9 n.d.  n.d.  n.d.  n.d.  n.d. 
HCG n.d.  n.d.  n.d.a  n.d.a  n.d. 
Paraben n.d.mu  10  10mu  n.d.  n.d. 
Molinate 100b 
mu
 100b  100mu b  100mu b  100b 
Atrazine 10  1mu  1mu  10mu  0.1 
Forskolin 0.01mu  0.1mu  0.1mu  0.1mu  0.01mu 
Trilostane* 1mu  100  0.1mu  1mu  1mu 
LOECs measured by Dunnett’s or Mann–Whitney U test (mu); ranges refer to maximum values measured 
in repeated experiments 
 = >0.5-fold;  = 0.5-fold to >0.25-fold;  = 0.25-fold to >0.1-fold;  = ≤0.1-fold;  
 = <2-fold;  = 2-fold to <4-fold;  = 4-fold to <20-fold;  = ≥20-fold 
n.d. = not detectable, * = uncertainty due to cross-reactivity; aOnly one experiment was conducted or 
considered for data evaluation; bEffects occurred at greatest non-cytotoxic concentration; no dose–
response; cGreatest concentration cytotoxic; dCytotoxicity observed at concentration at which effects 
occurred at other laboratories = 10; eNot statistically significant; p=0.051 
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3.4.2 Core chemical exposure experiments  
There were chemical-specific differences in the response of prochloraz T production after 
exposure of H295R cells to the 12 core chemicals (Tab. 3.3). With a few exceptions, the 
observed chemical-specific responses of T production were comparable among 
laboratories and could be grouped into three different types of effects: inducers, inhibitors, 
and negative reference chemicals. Among the inducers, exposure to trilostane resulted in 
the greatest fold changes (>10-fold induction) in T concentration when compared to SCs. 
The least fold changes were observed for the atrazine exposures where induction of T 
production was less than 1.5-fold with the exception of Lab 2, at which maximum induction 
was 2.4-fold. No effect on T production was observed after exposure to atrazine at Lab 6. 
Exposure to prochloraz resulted in a greater than 15-fold reduction of T production at the 
greatest concentration tested (100 μM) at all laboratories with the exception of Lab 4 
where an up to 4.5-fold reduction was observed. The greater LOEC reported for Lab 2 is 
likely a function of the relatively great variation among replicate experiments at 0.01 M 
(CV=35 %). It is unclear why T production by cells was more sensitive to exposure with 
prochloraz at Labs 1 and 3. However, a concentration-dependent response was observed 
starting at 0.01 M, which is similar to the response patterns at the other labs. Therefore, it 
cannot be excluded that the significant reduction at 0.0001 and 0.001 M represents an 
artifact. Exposure to the other inhibitors resulted in less than 4-fold changes in T 
production. When chemicals exhibited a less than 1.5-fold change in T production, they 
were categorized as negatives. This threshold was defined based on the average variation 
observed across all laboratories among replicate experiments. Some of these negative 
chemicals could have been categorized as inhibitors in individual cases (molinate: Lab 4; 
benomyl: Lab 1). However, even in situations where inhibition was observed at an 
individual laboratory, changes were always less than 2-fold and typically were not 
concentration-dependent. For instance, exposure to nonoxynol-9 resulted in a decrease in 
T concentrations at non-cytotoxic concentrations at two of five laboratories for which data 
was available. Relative to the SCs, inhibition of T production at Lab 1 was 29 % (1 μM), 
while at Lab2, it was 47 % (10 μM). However, it should be noted that exposure to 10 μM 
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nonoxynol-9 resulted in an average increase in cell viability at Lab 2 (138 % viable cells 
relative to the SCs), and thus the observed reduction in T production may be an artifact due 
to the correction for cell viability, especially as no such increase was observed by any of the 
other groups. The greatest letrozole concentration resulted in a significant decrease in T at 
all laboratories.  
Significant differences in E2 production were observed for H295R cells exposed to the 12 
core chemicals. The direction of the effect for each chemical was comparable among 
laboratories (Tab. 3.3). Three chemicals inhibited E2 concentrations (letrozole, prochloraz, 
and aminoglutethimide), while human chorionic gonadotrophin (HCG), EDS, benomyl, and 
nonoxynol-9 did not elicit any clear (>1.5-fold) effects at non-cytotoxic concentrations. For 
inducers of E2 production, the magnitude of the response ranged between 20-fold or 
greater (forskolin) to <3-fold (paraben) than SCs. The most potent inducer of E2 production 
was forskolin. Exposure to forskolin resulted in increases in E2 production at 
concentrations greater or equal to 0.1 μM, while exposure to other inducers typically did 
not reveal effects at concentrations less than 1 μM. While responses for E2 after exposure 
to atrazine appeared to be greater or equal to two orders of magnitude more sensitive 
than at the majority of the other labs no concentration-dependent response pattern 
occurred up to 1 μM. In fact, increases in E2 concentrations did not follow a concentration 
response at lesser concentrations and were very small (1.16-fold greater than SCs). The 
most potent inhibitors were letrozole and prochloraz, exposure to which resulted in 
marked reductions of E2 at concentrations greater 0.001 and 0.1 μM, respectively. The 
exception to this pattern was exposure to letrozole at Lab 6, for which significant 
reductions occurred at concentrations greater than 0.01 μM. In contrast, exposure to 
aminoglutethimide only caused a clear reduction in E2 concentrations at the greatest 
concentration tested. Variation between laboratories did not exceed 2-fold for a given 
concentration with the exception of trilostane.  
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3.4.3 Supplemental chemical exposure experiments  
For the additional 16 chemicals, the H295R steroidogenesis assay was able to categorize 
inducers and inhibitors of T and E2 (Tab. 3.4). One exception was dinitrophenol, which was 
identified as a significant inhibitor of T at all concentrations tested at the 1st lab. However, 
changes in T were not concentration-dependent and the magnitude of the effect was weak 
(inhibition did not exceed 0.67-fold relative to the SC at any given exposure concentration). 
Therefore, it is possible that this response represents an artifact. Some of the chemicals 
identified as inhibitors of T showed a biphasic response where slight increases in hormone 
production were observed at concentrations of up to 1 μM. However, with the exception of 
genistein, none of these changes exceeded 1.5-fold. Compared to the 12 core chemicals, 
there was greater variation among the responses observed at different laboratories for the 
16 supplemental chemicals. 
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Table 3.4 Lowest observed effect concentrations (LOECs; detected by Dunnett’s test) and strength and direction of change observed for 
the 16 test chemicals 
 Testosterone 17ß-Estradiol 
 LOEC [µM] Max change LOEC [µM] Max change 
 1st Laba 2nd Labb 1st Lab 2nd Lab 1st Laba 2nd Labb 1st Lab 2nd Lab 
Ketoconalzole 1 1   10 10  
Genistein 10 10   10 10  
Finasteride 10 100
c
   n.d. 100
c
 n.d. 
Bisphenol A 10 10   10 1  
Dinitrophenol 0.0001 100
c
   n.d. n.d. n.d. n.d. 
Piperonyl butoxide 10 10   n.d. n.d. n.d. n.d. 
Spironolactone 1 1   n.d. n.d. n.d. n.d. 
Fenarimol n.d. 10 n.d.  n.d. 1 n.d. 
Danazol n.d. n.d. n.d. n.d. 1 10  
DEHP n.d. n.d. n.d. n.d. 1
d
 1  
Dimethoate n.d. n.d. n.d. n.d. 10 n.d.  n.d. 
Flutamide n.d. n.d. n.d. n.d. 10 n.d.  n.d. 
Glyphosate n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Prometon n.d. n.d. n.d. n.d. 100
c
 100
c
  
Tricrecyl phosphate 10 n.d.  n.d. 10 n.d.  n.d. 
Mifepristone 0.1 n.d.  n.d. 0.1 1  
Chemicals tested at the second laboratories (2nd Lab) were as follows: Lab 2: Piperonyl butoxide, ketoconazole, prometon, DEHP, 
flutamide, and danazol; Lab 3: Bisphenol A, fenarimol, genistein, finasteride, and dinitrophenol; and Lab 4: Spironolactone, mifepristone, 
tricrecyl phosphate, dimethoate, and glyphosate. 
 = >0.5-fold;  = 0.5-fold to >0.25-fold;  = 0.25-fold to >0.1-fold;  = <2-fold;  = 2-fold to<fold;  = 4-fold to <20-fold; 
 = ≥20-fold 
n.d. = not detectable; aLead laboratory (Lab 1); bParticipating laboratory (Labs 2, 3, and 4); cEffects occurred at greatest non-cytotoxic 
concentration; no dose–response; dConsidered because there was a clear concentration–response at all but the greatest concentration 
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Approximately 19 % and 31 % of the chemicals showed a significant response for T and E2, 
respectively, at only one of the two laboratories where they were tested (Tab. 3.4). These 
were fenarimol, finasteride, dimethoate, flutamide, and tricrescyl phosphate for E2, and 
fenarimol, mifepristone, and tricrescyl phosphate for T. It is unclear what the bases for 
these differences are, but it should be noted that in four out of the eight cases where such 
incongruencies were observed (E2: dimethoate, tricrescyl phosphate; T: mifepristone, 
tricrescyl phosphate), they were associated with Lab 4. In all four cases, these chemicals 
were identified as inducers by Lab 1, while no statistically significant effects were reported 
by the other testing group. Also, at the same laboratory, some of the cell viability data 
revealed no effects where significant decreases were observed at Lab 1 (tricrescyl 
phosphate and spironolactone). These results indicate that there might have been some 
issues related to dosing or supply of the chemicals. Finally, basal E2 production measured 
by Lab 4 was approximately three-to-four times greater than that measured by Lab 1 (~200 
vs. ~50 pg·ml-1), indicating that cells were at a later passage when used for the experiment. 
This supports the need for stringent conditions regarding the age of the cells as well as the 
need for further optimizing of the cell line (see also chapter 3.4.6). Nevertheless, QC 
criteria were met by Lab 4 in all experiments conducted. 
 
3.4.4 Confounding factors—interference with hormone detection assays  
The analysis of cross-reactivity of each chemical with the antibodies of the immunoassays 
used at most of the laboratories revealed interaction with a few chemicals at the greatest 
concentrations tested. A large interaction of the E2 immunoassay with trilostane (up to 
100 % of the overall response measured at the greatest test concentration) was observed 
at all laboratories with the exception of Lab 2. Similarly, a less pronounced cross-reactivity 
of trilostane was also reported for the T antibodies (up to 60 % of overall response at the 
greatest concentration tested). However, since at most of the laboratories only the 
greatest chemical concentration was evaluated, an adjustment of the concentration–
response curves could not be performed. However, an attempt to correct for the 
interaction with the antibodies at this greatest concentration (greatest three 
concentrations for Lab 1) indicated that while the induction of E2 after exposure to 
trilostane is likely to be solely due to this cross-reactivity, the induction of T could not be 
explained alone by this factor (Fig. 3.2).  
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Figure 3.2 Changes in the concentrations of testosterone (T) and estradiol (E2) relative to the 
solvent controls (SC=1) after exposure to trilostane with (a) and without (b) adjustment of final 
hormone concentration for interference with the antibody-based hormone detection system. Bars 
represent average responses of one (Lab 1), two (Lab 3), and three (Lab 2) independent 
experiments. 
 
Similar interactions of trilostane with hormone detection systems have been also observed 
by other authors (Puddefoot et al. 2002, Shapiro & Page 1976). In addition, nonoxynol-9, 
paraben, and prochloraz also interacted with the E2 immunoassays. However, since the 
cross-reactivity of prochloraz, paraben, and nonoxynol-9 at the greatest concentrations 
tested were either low or these concentrations were excluded due to marked cytotoxicity, 
this factor had no effect on the interpretation of the results. Significant interactions of the 
chemicals with the hormone detection assays that occurred at non-cytotoxic 
concentrations were only observed for T after exposure to spironolactone, finasteride, and 
danazol at Lab 1 and for E2 after exposure to genistein at Labs 1 and 3. When uncorrected 
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data (Fig. 3.2 b) for spironolactone, finasteride, and danazol were compared to the data 
corrected (Fig. 3.2 a) for this interference, significant impacts on the overall trend / 
response were not observed (data not shown). Similarly, while genistein interference with 
the E2 ELISA antibodies reduced the magnitude of the response by approximately 30 %, it 
did not change the overall trend of the response. However, further analyses are required to 
address possible uncertainties resulting from the interference of a test chemical with the 
hormone detection system utilized.  
 
3.4.5 Predictive power and accuracy of H295R steroidogenesis assay  
In addition to the ability of an assay to produce reliable and transferable results, the 
potential of data obtained with an in vitro test to be predictive of effects at higher 
organizational levels is one of the key parameters relevant to its use as a screening tool. 
Comparisons of the in vivo and in vitro effects of prochloraz, ketoconazole, fenarimol, 
prometon, and aminoglutethimide have been made previously (Hecker et al. 2006, 
Villeneuve et al. 2007), and the findings reported in this study were similar to those 
reported by these authors. Comparing with results from in vivo studies the potential of a 
cell line to metabolize xenobiotics is crucial. In principle, to a certain extent, H295R cells are 
capable of xenobiotic biotransformation. For example, both CYP1A1 and CYP1B1 are 
expressed in this cell line (Sanderson et al. 2001). Through oxygenation CYP1A1 catalyzes 
the initial step of the conversion of several chemicals to more polar metabolites and 
subsequently increased excretion. On the other hand, it catalyzes the metabolic activation 
of e.g. polycyclic aromatic hydrocarbons (PAHs) to their carcinogenic metabolites. 
Therefore, it plays a critical role in chemical carcinogenesis and toxicity (Ma & Lu 2007). 
A comparison of the effects of E2 inducers observed in the H295R validation studies and 
the findings of in vivo studies showed that the results were comparable for six out of ten 
chemicals tested: atrazine (Spanò et al. 2004, Wetzel et al. 1994), mifepristone (Fassett et 
al. 2008, Wang et al. 1994), danazol (Peters et al. 1980), tricresyl phosphate (Latendresse et 
al. 1995), flutamide (Andrews et al. 2001), and genistein (Harrison et al. 1999) (Tab. 3.5). 
The results obtained with H295R cells for inhibitors of E2 production corresponded to the 
findings of in vivo studies for five out of six chemicals studied: letrozole (Kumru et al. 2007), 
aminoglutethimide (Berman & Laskey 1993, Rocha Monteiro et al. 2000), prochloraz 
(Brande‐Lavridsen et al. 2008, Vinggaard et al. 2005), ketoconazole (Rocha Monteiro et al. 
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2000), and fenarimol (Ankley et al. 2005). In only three cases opposite trends among 
results for E2 production obtained with the H295R steroidogenesis assay and in vivo tests 
were observed. Exposure to DEHP, prometon, and bisphenol A (BPA) in vivo resulted in an 
inhibition (Davis et al. 1994) and no effect (Villeneuve et al. 2006, Yamasaki et al. 2002) on 
E2 concentrations, respectively, while all three chemicals caused a significant increase in E2 
in the present study. However, the increase of E2 concentrations observed with the H295R 
cells for prometon may have been an indicator for the decrease in the expression of 
secondary sex characteristics observed in male fish (Villeneuve et al. 2007). In case of BPA, 
the lack of response in the in vivo studies is likely due to the administration route, which 
was via gavage. Previous studies have reported that orally administered BPA has very low 
bioavailability and is rapidly excreted (Pottenger et al. 2000).  
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Table 3.5 Comparison of data obtained with the H295R steroidogenesis assay (this study) with in vivo data  
Chemical 
Testosterone Estradiol 
Species Reference 
H295R in vivo H295R in vivo 
Aminoglutethimide     Fish; Rat Bergman and Laskey 1993; Monteiro et al. 2000 
Atrazine  / - -   Fish; Rat Spano et al. 2004; Wetzel et al. 1994 
Benomyl - - - - Rat Carter and Laskey 1982; Spencer et al. 1998 
Bisphenol A  n.d.  n.d. - - 
Butyl paraben - -  n.d. Rat Taxvig et al. 2008 
Danazol - n.d.   Human Murakami et al. 1993; Peters et al. 1980 
DEHP - -   Rat Davis et al. 1994; Noriega et al. 2009 
Dimethoate - n.d. - - Sheep Rawlings et al. 1998 
Dinitrophenol - n.d. - n.d. - - 
EDS - n.d. - n.d. - - 
Fenarimol     Fish Ankley et al. 2005 
Finasteride - - - n.d. Amphibian Canosa and Ceballos 2001 
Flutamide - -  n.d. Rat Adamson et al. 2008; Mikkilä et al. 2006 
Forskolin  n.d.  n.d. - - 
Genistein     Monkey; Rat Harrison et al. 1999; Ohno et al. 2003 
Glyophosate - - - - Fish Soso et al. 2006 
HCG - -
a 
- -
a
 -
a
 -a 
Ketoconazole     Fish; Rat Monteiro et al. 2000; O’Connor et al. 2002 
Letrozole     Rat Kumru et al. 2007 
Mifepristone     Human Fassett et al. 2008; Wang et al. 1994 
Molinate  n.d.b - - Rat Ellis et al. 1998 
Nonoxynol-9 - n.d. - n.d. - - 
Piperonyl butoxide  n.d. - n.d. - - 
Prochloraz     Amphibian; Rat Vinggaard et al. 2005; Brande-Lavritsen et al. 2008 
Prometon - -  -c Fish Villeneuve et al. 2006 
Spironolactone   - n.d.c Amphibian; Rat Canosa and Ceballos 2001; Yamasaki et al. 2004 
Tricrescyl phosphate  / - n.d.   Rat Latendresse et al. 1995 
Trilostane d  / - -d - Fish; Human; Rat Jungmann et al. 1983; Villeneuve et al. 2006 
 = Increase;  = Decrease; - = No effect; n.d. = no data / study available; aH295R Assay only captures effects downstream of LH / FSH; 
bData not considered because of inconclusive results; cIdentified as a reproductive toxicant in vivo; dCorrected for cross-reactivity
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Three chemicals that tested negative for E2 effects in the H295R, namely, benomyl, 
dimethoate, and glyphosate, also did not cause any changes in serum E2 concentrations in 
vivo (Soso et al. 2007, Spencer et al. 1996, Waldbillig et al. 1998). No studies describing in 
vivo effects on the production of E2 were found for the other chemicals tested. However, 
given the general toxic properties of chemicals, such as nonoxynol-9 (spermaticide), EDS 
(cytotoxicant to Leydig cells (Cooper & Jackson 1970, Kerr et al. 1985)), and dinitrophenol 
(metabolic poison uncoupling oxidative phosphorylation), no specific interactions with the 
steroidogenic pathway at non-cytotoxic concentrations would be expected. 
In general, effects on T production were less consistent when the results obtained with 
H295R cells were compared to those of in vivo studies (Tab. 3.5). Out of the five chemicals 
found to be inducers of T production in the cells only mifepristone showed a similar trend 
in vivo (Wang et al. 1994), while three of the seven inhibitors (prochloraz: Vinggaard et al. 
(2005), Brande-Lavridsen et al. (2008); ketoconazole: O’Connor et al. (2002), Monteiro et 
al. (2000); genistein: Ohno et al. (2003)) revealed comparable trends between the results 
of the validation studies and previously reported in vivo data. However, five of the test 
chemicals demonstrated conflicting trends between the results obtained with the H295R 
cells and those from in vivo studies: the inducers atrazine (Spanò et al. 2004, Wetzel et al. 
1994) and trilostane (Jungmann et al. 1982), the inhibitors letrozole (Kumru et al. 2007) 
and aminoglutethimide (Berman & Laskey 1993, Rocha Monteiro et al. 2000), and the 
negative chemical BPA (Yamasaki et al. 2002). As previously discussed for E2, the lack of 
response reported for BPA in vivo was likely a function of low bioavailability and rapid 
excretion due to the form of administration (oral; Pottenger et al. (2000)). With the 
exception of flutamide, 5 of the 11 chemicals that tested negative for changes in T 
production in the H295R steroidogenesis assay were also reported as causing no significant 
alterations in T concentrations in vivo: flutamide (Mikkilä et al. 2006), glyphosate (Soso et 
al. 2007), DEHP (Noriega et al. 2009), benomyl (Carter & Laskey 1982), and molinate (Ellis 
et al. 1998). For flutamide, a significant induction in T production was reported in rats in 
vivo (Andrews et al. 2001). Information on the effects of the other chemicals on production 
of T in vivo could not be found. The reason for the increased number of chemicals showing 
discrepancies between in vivo studies and the current work in the production of T as 
opposed to that of E2 is likely due to the intermediate role of T in the steroidogenesis 
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pathway, which makes it possible that changes in T can be better compensated by the cells 
than those in E2.  
Overall, no chemical was falsely characterized as having no effect by the H295R 
steroidogenesis assay based on its known mechanism of action with the exception of T 
production after exposure to flutamide. However, this chemical would have been flagged 
due to a comparable in vivo / in vitro effect on E2. There were no studies describing the 
effects of the model inducer forskolin on hormone homeostasis in vivo. However, 
considering the rapid metabolism of forskolin by an organism no marked effects would be 
expected. Overall, these results indicate that, while not necessarily always directly 
predictive of a specific type of response in an organism, the H295R assay system always 
flagged a chemical as a potential disruptor of steroidogenic processes. Furthermore, there 
were only two chemicals for which both in vivo and in vitro data were available that would 
have been wrongly characterized as either inducers or inhibitors of each hormone tested 
by the H295R steroidogenesis assay (atrazine (Wetzel et al. 1994) and BPA (Yamasaki et al. 
2002) for T induction and prometon (Villeneuve et al. 2006) and BPA (Yamasaki et al. 2002) 
for E2 inhibition). In case of BPA recent studies of Zhang et al. (2011) detected leakage of 
the substance from the standard laboratory material used for the H295R steroidogenesis 
assay into the test medium. The measured background contamination (0.38 ng·ml-1) after 
24 h was not in a range near the LOEC of BPA (10 µm) in the current study but it has to be 
kept in mind that laboratory material can have an effect on the actual concentration in in 
vitro test systems. Furthermore, the authors detected metabolization of BPA in H295R 
cells. After approximately 48 h over 50 % of the substance was metabolized. Overall, 
investigation of BPA, as well as most other substances, should be accompanied by chemical 
analysis to verify the actual concentrations tested. 
 
3.4.6 Further improvements of the H295R 
Exposure to 5-Aza-dc lead to a suspension cell rate of 20 % but after a few passages 
insufficient proliferation and finally complete cell death were discovered. Therefore, this 
approach was skipped. The observed growth arrest may be caused by the reactivation of 
tumor suppressor genes like CDKN2A and SCGB3A1 (Fonseca et al. 2012). In contrast, 
replacement of the standard cell culture medium (DMEM F12 / Ham's) containing fetal 
bovine serum (FBS) by the serum-free medium ProVero™1 (Lonza, Cologne, Germany) 
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showed sufficient cell growth as well as a suspension rate of about 20 %. Unfortunately, 
there were issues regarding the quality between different batches, most likely due to the 
use of plant derived protein hydrolysates, wherefore an alternative medium was needed. 
In contrast, the replacement of the standard medium by a chemical defined medium for 
biopharmaceutical production without proteins and steroids (working title: CDM5) was 
overall successful. The H295R cells grew in suspension (H295R-S) with a stable cell viability 
of ≥95 % over 12 days without passage. Cell density increased in a linear manner from 
0.5·106 cells·ml-1 to 2.5·106 cells·ml-1, a reaction that was already described by Logie et al. 
(1999). Hence, the total cell density was higher than achieved in adherent cultures in tissue 
culture flasks. With this modification it is now possible to study the effect of a substance 
(or a mixture as well as environmental sample) on the steroidogenesis over a time period 
of up to 10 days. Within this period, medium samples can be taken and analyzed at a daily 
rate without changing the exposure medium. Additionally, the basal testosterone (T) 
production was higher compared to the adherent cells (Logie et al. 1999) but basal 
production of E2 was much lower (approximately 30 ng·L-1 after 19 passages from ATCC 
stock; data not shown). The quality criteria of the OECD guideline (OECD 456), however, 
were met by the suspension cells. The high level of T and at the same time low level of E2 
could be explained by the lack of growth factors such as the epidermal growth factor (EGF). 
In the presence of the EGF, expression of aromatase is upregulated in H295R cells 
(Watanabe et al. 2006) which leads to an increased transformation of T to E2. In addition, 
the fast increase of steroid production over time could be decelerated (data not shown). 
Another advantage of chemical defined media is the total absence of FBS. There are several 
drawbacks related to the usage of FBS in cell culture. First, there is the issue of animal 
welfare and the claim to save the lives of laboratory animals by use of alternative in vitro 
methods. FBS is a common supplement of cell culture media and includes several essential 
components for growth, homeostasis and survival of the cells (Barnes & Sato 1980, Even et 
al. 2006). The amounts of FBS that are used for in vitro methods are increasing mostly due 
to large scale manufacturing of cell therapy processes and biotechnology (Brindley et al. 
2012) and to a certain extent even to the increasing number of in vitro test systems that 
are used for toxicity testing (e.g. for REACH purposes) (Hecker & Hollert 2011). While in 
vitro methods are a sufficient way to reduce suffering of laboratory animals the collection 
of FBS from fetal calves after slaughtering of the pregnant cow may cause severe suffering 
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of the fetuses. This seems to be contradictory to the 3R (replace, reduce, refine) principle 
(Russell et al. 1959) and is more than ethical questionable. Beside the ethical problems 
regarding to the use of FBS, there are also scientifically issues. On the one hand, FBS is a 
mixture of unknown composition which could lead to reduced reproducibility of different 
experimental approaches. For bioassays on endocrine disruption, for example, strongly 
varying steroid concentrations in the used FBS could influence the steroidogenesis within 
the cells. Therefore, in most cases stripping of FBS prior to use in the exposure medium is 
necessary. On the other hand, there is the risk of disease transmission because FBS could 
be contaminated with fungi, viruses, bacteria, mycoplasmas and prions. To overcome the 
problems related to the use of FBS as well as for the manufacture of biological products for 
human use, several serum free and chemical defined media have already been developed. 
Nevertheless, in contrast to media supplemented with FBS the alternative media are more 
cell type specific. Therefore, a special medium has to be used for most cell types (Even et 
al. 2006, Van der Valk et al. 2004). Additionally, culture medium without FBS leads to 
suspension cell cultures in most cases (Barnes & Sato 1980), though this was a desired side 
effect in the present study. 
Performance of the newly developed ELISA method using monoclonal antibodies and 
tetramethyl benzidine / H2O2 as substrate (Nara et al. 2008) was good. For both the E2 and 
T standard clear dose-respond curves could be shown (Fig. 3.3).  
According to the booklet (https://www.caymanchem.com/pdfs/582251.pdf) of the so far 
used ELISA kit the LOD of the assay is around 19 pg·ml-1 for E2. Estimated by the same 
calculation method (80 % Bound / Maximum bound) the LOD of the here established 
method is lower than 8 pg·ml-1 and the test system, therefore, more sensitive. The 
detected LOD is also in the same range as other recently developed sensitive ELISA 
methods (10 pg·ml-1) (Cha et al. 2010). For the Testosterone (T) ELISA the LOD of the 
former used method is 6 pg·ml-1 according to the booklet 
(https://www.caymanchem.com/pdfs/582701.pdf). In this case, the LOD of the new 
established ELISA method is higher (up to 30 pg·ml-1, in 100 % culture medium). But due to 
the high testosterone production in H295R-S cell cultures (µg·L-1 range), the obtained LOD 
is suitable for the detection of testosterone in the H295R-S culture medium. The detected 
LOD is also in the same range as other recently developed ELISA methods (50 pg·ml-1) 
(Uraipong et al. 2013).  
Chapter 3 – Results & Discussion 
 
69 
 
Figure 3.3 17ß-Estradiol (E2) and Testosterone (T) standards for the new developed ELISA protocols 
for the H295R Steroidogenesis Assay. LOD = limit of detection. 
 
Overall, it could be shown that the developed ELISA method is highly sensitive and reliable 
for measurement of steroids in different cell culture mediums. 
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3.5 Conclusion  
It was demonstrated that, with one exception, the H295R steroidogenesis assay protocol 
successfully identified the majority of chemicals with known and unknown modes of 
interaction with the production of T and E2. The results obtained in the current study 
confirm the findings reported for H295R cells by Hecker et al. (2006) as well as effects 
described in other in vitro and in vivo studies (discussed in Hecker et al. (2006) and this 
manuscript) for a broad range of chemicals. Major remaining limitations associated with the 
H295R steroidogenesis assay protocol are the relatively low basal production of E2 and its 
effect on quantifying the decreased production of this hormone with regard to the 
identification of weak inhibitors and at the same time the fast increase of basal hormone 
production within the passages which strongly reduces their useful life. To address this 
uncertainties, there should be further efforts aimed at increasing basal E2 production, e.g., 
by altering the cells or test protocols without affecting the potential of the cells to detect 
inducers of E2 production. In addition, several approaches to increase the useful life of the 
cell line as well as enhance the applicability of the whole test system already have been 
made. Furthermore, most of the variation observed among laboratories was likely due to 
changes in test practices during the course of this validation study. To address similar issues 
in the future, a number of additional performance criteria were included into the test 
protocols. These include the addition of a proficiency test that is required of each laboratory 
that plans to start using the assay or that has undergone changes in personnel, and the 
flexible protocols for refinement of the spacing of test chemical concentrations to enable the 
description of more precise concentration-response relationships. An initial comparison of 
H295R data from this study to in vivo studies from the literature demonstrated the potential 
of the H295R steroidogenesis assay to identify chemicals affecting hormone homeostasis in 
whole organisms. Particularly promising was the lack of any false negatives during the 
validation. Furthermore, the very low number of chemicals giving false positives represents 
an important aspect of this bioassay since it confirms the specificity of the test and will help 
avoid unnecessary additional testing. Future studies, including a larger number of chemicals 
with different structures and properties as well as comparison to parallel studies with whole 
organisms, should be conducted to confirm the predictive power of the H295R 
steroidogenesis assay for in vivo scenarios.  
Chapter 3 - Acknowledgement 
 
71 
Acknowledgement 
We thank the OECD VMG NA as well as the OECD secretariat for their support, 
encouragement, and guidance. Furthermore, we acknowledge many helpful discussions and 
manuscript review by Dr. Jerome Goldman, Endocrinology Branch, NHEERL, US EPA, 
Research Triangle Park, NC. Funding for this project was provided by US EPA, ORD Service 
Center / NHEERL (contract # GS-10F-0041L), a grant from the Western Economic 
Diversification Canada (project #s 6971 and 6807), and the Nordic Chemical Group (project # 
2008-06-05). Conclusions drawn in this manuscript neither constitute nor necessarily reflect 
US EPA policy regarding the test chemicals and methods. 
 72 
 73 
Chapter 4 
 
 
Estrogenic activity of heterocyclic aromatic 
hydrocarbons 
 
Markus Brinkmann1 & Sibylle Maletz1, Martin Krauss2, Kerstin Bluhm1, Sabrina 
Schiwy1, Jochen Kuckelkorn1, Andreas Thiem3, Werner Brack2 & Henner Hollert1 
 
1 Institute for Environmental Research, Department of Ecosystem Analysis, RWTH Aachen 
University, Worringerweg 1, 52074 Aachen, Germany 
2 Department Effect-Directed Analysis, Helmholtz Centre for Environmental Research – UFZ, 
Permoserstraße 15, 04318 Leipzig, Germany 
3 Water Technology Center, Department of Environmental Biotechnology, Karlsruher Strasse 
84, 76139 Karlsruhe, Germany 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter has been published in Environmental Science & Technology 
 
 74 
Chapter 4 – Abstract 
 
75 
4.1 Abstract 
High concentrations of heterocyclic aromatic hydrocarbons (hetero-PAHs) are increasingly 
detected in groundwater plumes at former industrial facilities where coal tar-oil was 
handled, e.g. wood treatment plants. Previous studies have shown that fractions of ground 
water with high estrogenic activity contained hetero-PAHs and their hydroxylated 
metabolites. To evaluate this preliminary evidence, twelve selected hetero-PAHs were 
screened for their estrogenic activity in the LYES and the ER CALUX® assay. All tested 
substances were inactive in the LYES assay. In contrast, nine hetero-PAHs (acridine, 
xanthene, indole, 2-methylbenzofuran, 2,3-dimethylbenzofuran, dibenzofuran, 
dibenzothiophene, quinoline and 6-methylquinoline) showed estrogenic activity in the ER 
CALUX®, with estradiol equivalence factors (EEFs) from 2.85 10-7 to 3.18 10-5. The EEF values 
of the investigated substances were comparable to those of other non-steroidal 
xenoestrogens (e.g. alkylphenols, bisphenol A or phthalates) that are found in surface water. 
Chemical analyses revealed that T47Dluc cells were able to metabolize most of the 
substances. Among the metabolites (tentatively) identified were hydroxides and their keto 
tautomers, sulfates, sulfoxides, and N-oxides. Because of their high concentrations 
measured in ground water, we conclude that the detected estrogenicity of metabolized 
hetero-PAHs causes a potential risk for human health and should be the subject of further 
research. 
 
 
Keywords: ER CALUX®, Heterocyclic aromatic compounds, hetero-PAH, NSO-HET, LYES  
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4.2 Introduction 
A large number of synthetic heterocyclic aromatic compounds are produced by chemical 
industry to manufacture for example solvents, dyes or pesticides, respectively. In addition, 
they occur as contaminations in waste material from the mining industry, coal tar-oil 
processing operations, wood preservation facilities and the chemical industry (Kaiser et al. 
1996). Therefore, heterocyclic aromatic hydrocarbons (hetero-PAHs) containing nitrogen, 
sulphur or oxygen heteroatoms represent pollutants increasingly studied at contaminated 
(former) industrial sites. During technical processes large amounts have been emitted into 
the environment since the 19th century (Alinsafi et al. 2006, Becker et al. 2001, Dyreborg et 
al. 1997, Thomas et al. 1995). Due to their heterocyclic structure (Fig. 4.1) hetero-PAHs are 
easily soluble in water and therefore transported to the ground water. As a consequence, 
long contaminated ground water plumes have been observed – a fact that also implies an 
elevated risk for human health since ground water is an important drinking water resource 
(Reineke et al. 2007, Tiehm et al. 2008). At former industrial sites even the soil can still 
contain high concentrations of heterocyclic PAHs (Meyer & Steinhart 2000, 2001). 
 
Figure 4.1 Chemical structure (ChemBioDraw Ultra (Perkin Elmer, Waltham, USA; free trial version) of 
the heterocyclic aromatic hydrocarbon acridine.  
 
While extensive knowledge exists concerning environmental fate, as well as toxicological and 
ecotoxicological effects of PAHs (Douben 2003), such knowledge is still limited for their 
heterocyclic analogs. Just recently, the scientific community began to comparatively 
investigate a range of heterocyclic PAHs in different in vitro bioassays: e.g. acute toxicity to 
Daphnia and growth inhibition of green algae (Eisentraeger et al. 2008), mutagenicity (Ames 
assay) and embryotoxicity in the zebrafish (Peddinghaus et al. 2012) or aryl hydrocarbon 
(Hinger et al. 2011, Sovadinová et al. 2006) as well as retinoid receptor (Benisek et al. 2011) 
mediated effects. In most assays, hetero-PAHs caused similar or even higher toxicity 
compared to their homocyclic analogs. However, there are still data gaps, especially with 
regard to potential endocrine disrupting effects of hetero-PAHs. 
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For homocyclic PAHs, it was already demonstrated that vertebrates can transform the 
parent molecules into hydroxylated metabolites (e.g. Varanasi et al. 1989). In the organisms, 
this reaction of phase I biotransformation has the purpose to increase the water solubility of 
the molecule and to make it more susceptible to phase II biotransformation reactions – both 
processes ultimately facilitating the excretion of a compound. In permanent cell lines, which 
have been developed for bioanalytical determination of chemicals with mechanism-specific, 
e.g. dioxin-like or estrogenic effects, these biotransformation reactions could also lead to 
formation of active metabolites. Consequently, not only direct effects of the parent 
compounds but also indirect effects of metabolites have to be considered. For PAHs, e.g. 
benzo[a]pyrene and chrysene, it has been shown that indirect effects can occur in 
bioanalytical assays for detection of estrogenic substances (Santodonato 1997, van Lipzig et 
al. 2005). Furthermore, previous bioanalytical studies on the contamination of ground water 
with estrogenic substances have shown that fractions with high estrogenic activity 
contained, among others, hetero-PAHs and their hydroxylated metabolites (Kuch et al. 
2010). In another study on endocrine activity of river sediments, a correlation between 
endocrine activity and fractions containing PAHs could be identified (Higley et al. 2012). To 
investigate whether heterocyclic PAHs also have the potential to act as indirect estrogenic 
compounds, we report on a study on the effects of selected substances in the lyticase 
assisted yeast estrogen screen (LYES) as well as the “estrogen receptor mediated chemical 
activated luciferase gene expression” assay (ER CALUX®). Most compounds tested here were 
suggested earlier as being representative for tar-oil contaminated sites by the project 
framework BMBF KORA (retention and degradation processes to reduce contaminations in 
groundwater and soil, cf. Blotevogel et al. 2008, Eisentraeger et al. 2008) and comprised the 
individual compounds indole, 1-benzothiophene, benzofuran, 2-methylbenzofuran, 2,3-
dimethylbenzofuran, quinoline, 6-methylquinoline, carbazole, dibenzothiophene, 
dibenzofuran, acridine, and xanthene. To assess the loss of parent substance and the 
formation of metabolites during incubation with T47Dluc cells, supernatants were analyzed 
by means of liquid chromatography with diode array detection (LC-DAD) and high resolution 
tandem mass spectrometry (LC-HRMS2). 
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4.3 Material & Methods 
4.3.1 Chemicals 
Indole (> 99 %), quinoline (> 98 %), carbazole (approx. 95 %), 6-methylquinoline (> 98 %), 
benzothiophene (> 98 %), dibenzothiophene (> 98 %) were obtained from abcr (Karlsruhe, 
Germany). Acridine (> 98 %) was supplied by Merck (Darmstadt, Germany). Xanthene 
(99 %), benzofuran (> 99 %), 2-methylbenzofuran (≥ 96 %), 2,3-dimethylbenzofuran 
(≥ 97 %) and dibenzofuran (approx. 98 %) were purchased from Sigma-Aldrich 
(Deisenhofen, Germany). Stock solutions of the investigated hetero-PAHs were prepared in 
dimethyl sulfoxide (DMSO). Generalized structures of the investigated compounds are 
given in Figure 3. 
 
4.3.2 LYES 
For principle and general implementation of LYES see also chapter 1.4.3.2 and 1.5.1 as well 
as chapter 2.2.2. In the present investigation, yeast cells were exposed to a 1:2 dilution 
series of the heterocyclic PAHs in quadruplicate wells for 24 h. The maximum 
concentration of the tested chemicals was chosen according to concentrations used in the 
work of Hinger & Brinkmann et al. (2011).  
 
4.3.3 ER CALUX® 
For principle and general implementation of the ER CALUX® see also chapter 1.4.3.2 and 
1.5.2 as well as chapter 2.2.3. In the present investigation, the cells were exposed to a 1:2 
dilution series of each of the heterocyclic PAHs in triplicates. The maximum concentration 
of the tested chemicals was chosen according to concentrations used in the work of Hinger 
& Brinkmann et al. (2011).  
 
4.3.4 MTT assay 
An MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) cell viability assay 
(see chapter 2.2.1) was conducted to assure that the test items did not cause non-specific 
cytotoxic effects in the T47Dluc cell line.  
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4.3.5 Data analysis 
Data analysis of both ER CALUX® and LYES were conducted following the recommendations 
of Villeneuve at al. (2000). Mean luminescence and absorbance values, respectively, of test 
items and E2 standards were corrected for the response of the solvent controls. Resulting 
values were then divided by the maximum induction of the E2 standard (E2-max.) to scale 
all values from 0 (solvent control) to 1 (E2-max.). Scaled values from triplicate experiments 
were plotted using the software GraphPad Prism 5 (GraphPad, San Diego, USA) and fitted 
using four-parameter logistic regression with variable slope where top and bottom of the 
curve were set to 0 and 1, respectively (Figure 2 and 3). EEF20-80 ranges, i.e. multiple 
estradiol equivalence estimates (EEFs, Equation 4.1) along the concentration-response 
curves based on a ratio of EC20s, EC50s and EC80s, were calculated in order to both test the 
assumptions of parallelism and equal efficacy and give a measure of uncertainty for mass-
balance analyses. 
 
𝐸𝐸𝐹𝑋 =
𝐸𝐶𝑋𝐸2
𝐸𝐶𝑋𝑠𝑎𝑚𝑝𝑙𝑒
  Equation 4.1 
 
4.3.6 Prediction of estrogen receptor binding affinities 
Estrogen receptor (ER) binding affinities were simulated using the (Q)SAR Toolbox 2.3 
provided by the Organization for Economic Cooperation and Development (OECD). 
Simulations were performed for parent compounds, as well as for measured metabolites 
and metabolites predicted by the liver metabolism simulator of the toolbox. Results of the 
model were qualitatively compared with experimental data from both bioassays. 
 
4.3.7 Determination of total metabolism by means of LC-DAD 
T47Dluc cells were seeded in 6-well microtiter plates and incubated in duplicates with the 
highest concentration and under the same conditions as in the ER CALUX®. A control 
without cells was incubated under the same conditions as the cells to determine substance 
losses due to, e.g., sorption, precipitation or volatilization. After liquid-liquid extraction 
(see chapter 1.4.2.1 as well as 2.1.3) heterocyclic PAHs and respective metabolites were 
analyzed according to Mundt & Hollender (2005), with slight modifications. Liquid 
chromatography was performed using a 1200 Series LC chromatograph (Agilent, 
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Waldbronn, Germany) equipped with an UV-diode array detector at 1.0 ml·min-1 flow. 
Briefly, 40 µl of the reconstituted extracts were separated on a Nucleosil C18 pre-packed 
column (250 mm × 4 mm, 5 µm particle size; Macherey-Nagel, Düren, Germany) by 
gradient elution with acetonitrile (solvent A) and 5 mM potassium phosphate buffer at 
pH 7 (solvent B) using the following program: held 10 / 90 % (v / v) for 2 min, in 2 min up to 
50 / 50 % (v / v), up to 60 / 40 % (v / v) in 8 min, up to 75 / 25 % (v / v) in 10 min, to 100 / 
0 % (v / v) in 5 min, back to 10 / 90 % (v / v) in 12 min and held 6 min for equilibration. The 
diode array detector signals at 210 and 254 nm, as well as the spectra from 190 to 400 nm 
were recorded. Acridine was quantified at 254 nm, all other hetero-PAHs at 210 nm. 
Substance losses during incubation with and without cells were compared. 
 
4.3.8 Identification of metabolites by LC-high resolution tandem mass spectrometry (LC-
HRMS2) 
To assess the formation of potentially estrogenic transformation products, T47Dluc cells 
were exposed to 10 mg·L-1 of each heterocyclic PAH as for the determination of total 
metabolism. Instead of using 6-well microtiter plates, cells were seeded in 75 cm2 tissue 
culture flasks to obtain a higher volume of cell culture supernatant (15 ml). To assure full 
compatibility with the LC-HRMS2 method, stock solutions (10 mg·ml-1) of the substances 
were prepared in ethyl acetate instead of DMSO. The final concentration of ethyl acetate in 
the exposure medium was 0.1 %. A solvent control was treated as the dilutions without 
addition of substance. Following 24 h incubation at 37°C, cells were detached with a cell 
scraper and homogenized with the cell culture supernatant using an automatic disperser. 
The suspension was then centrifuged at 25°C (4000 × g) and the supernatant stored at -
80°C until analysis. 
The samples were analyzed by LC-high resolution mass spectrometry using an Agilent 1200 
LC system coupled to a LTQ Orbitrap XL (Thermo Scientific). The LC method is described in 
(Hug et al. 2014). Full scan chromatograms (m / z 100-1000) were acquired after 
electrospray ionization in positive and negative ion mode at a nominal resolving power of 
100,000 referenced to m / z 400. HRMS product ion spectra were recorded in data-
dependent mode using collision-induced fragmentation (CID) and higher-energy collisional 
dissociation (HCD) at different collision energies. Full scan spectra were manually searched 
for the masses of human and mammalian metabolites of the studied compounds reported 
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in the literature as well as possible phase I metabolites based on common pathways (e.g., 
the ion mass of an M+O molecule, corresponding to N-oxides, sulfoxides, hydroxylated 
metabolites or their corresponding keto tautomers, M+O-2H molecule corresponding to an 
epoxide, etc.). For detection of unknown and unexpected metabolites the software 
MZmine 2.10 (Pluskal et al. 2010) was used. Processing of full scan chromatograms was 
carried out using the settings described in (Hug et al. 2014). The obtained peak lists were 
searched for peaks newly formed solely by the incubation of each heterocyclic PAH that 
were absent in all other samples. For these peaks, molecular formulas were determined 
based on accurate masses and isotope patterns using the Xcalibur software 
(ThermoScientific) and MS2 spectra were visually evaluated. Tentatively identified 
metabolites were confirmed by reference standards if these were commercially available.  
Chapter 4 – Results & Discussion 
 
82 
4.4 Results & Discussion 
4.4.1 LYES 
None of the tested compounds was active in the LYES, i.e. reached 20 % induction of the E2 
standard (Fig. 4.2).  
 
Figure 4.2 Dose-response curves and corresponding 95 % confidence bands in the LYES for all 
investigated heterocyclic compounds (closed circles) and the E2 standard curves (open circles) were 
measured in n=3 independent assay repetitions. Concentration values on the x-axis refer to nominal 
medium concentrations of the substances. Dots represent mean values from technical replicates of 
one respective experiment. All substances were inactive in the LYES assay, i.e. did not reach 20 % 
induction of the E2 standard. 
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The EC50 of the E2 standard was 57.7 ± 0.7 pM (mean ± standard error, n=3) throughout the 
whole study. Other publications including studies from our own lab report lower values in 
the range of 30 – 50 pM (Maletz et al. 2013, Schultis & Metzger 2004). These studies 
commonly used ethanol as solvent for dosing of the test items. In the present study, 
however, it was necessary to use another solvent, i.e. DMSO, since the substances did not 
readily dissolve in ethanol. Furthermore, data calculation was different. In the present 
study data were normalized to values between zero and one and the scaled data was used 
to create the dose-response curve. Bottom and top of the curve were therefore set to zero 
and one, respectively, which caused a shift of the EC50 in comparison to the data analysis in 
the other publications mentioned above.  
 
4.4.2 ER CALUX® 
The EC50 of the E2 standard was 8.1 ± 0.9 pM (mean ± standard error, n=12) throughout the 
whole study, which is within the range reported in other studies (Legler et al. 2002b, Legler 
et al. 1999, Maletz et al. 2013).  
 
Figure 4.3 Estradiol equivalence factor (EEF) ranges of the investigated heterocyclic compounds 
relative to E2 as measured in the ER CALUX®. Bars refer to EEF50s (i.e. the EEFs based on 50 % E2-
max.), error bars represent the EEF20-80 ranges. Benzofuran, benzothiophene and carbazole were 
inactive in the ER CALUX®, i.e. did not reach 20 % induction of the E2 standard. 
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Benzofuran, benzothiophene and carbazole did not reach 20 % induction of the E2 
standard of the ER CALUX®. The substances 2-methylbenzofuran, quinoline and 
6-methylquinoline, did not reach 80 % induction of the E2 standard, making slight 
extrapolation beyond the measured range of response necessary to establish the EEF20-80 
ranges as described by Villeneuve at al. (2000). Because acridine and 
2,3-dimethylbenzofuran exhibited higher maximum induction compared to the standard, 
data was normalized to the maximum induction of these substances (Fig. 4.3 and 4.4).  
 
Figure 4.4 Dose-response curves and corresponding 95 % confidence bands in the ER CALUX® for all 
investigated heterocyclic compounds (closed circles) and the E2 standard curves (open circles) were 
measured in n=3 independent assay repetitions. Concentration values on the x-axis refer to 
nominal medium concentrations of the substances. Dots represent mean values from triplicate 
measurements in one respective experiment. 
 
-1 0 1 2 3 4 5 6 7 8
0.0
0.2
0.4
0.6
0.8
1.0
Benzofuran
R
e
la
ti
ve
 L
u
m
in
e
s
c
e
n
c
e
-1 0 1 2 3 4 5 6 7 8
0.0
0.2
0.4
0.6
0.8
1.0
2,3-Dimethylbenzofuran
-1 0 1 2 3 4 5 6 7 8
0.0
0.2
0.4
0.6
0.8
1.0
Dibenzofuran
R
e
la
ti
ve
 L
u
m
in
e
s
c
e
n
c
e
-1 0 1 2 3 4 5 6 7 8
0.0
0.2
0.4
0.6
0.8
1.0
Benzothiophene
-1 0 1 2 3 4 5 6 7 8
0.0
0.2
0.4
0.6
0.8
1.0
Dibenzothiophene
-1 0 1 2 3 4 5 6 7 8
0.0
0.2
0.4
0.6
0.8
1.0
Acridine
R
e
la
ti
ve
 L
u
m
in
e
s
c
e
n
c
e
-1 0 1 2 3 4 5 6 7 8
0.0
0.2
0.4
0.6
0.8
1.0
Carbazole
-1 0 1 2 3 4 5 6 7 8
0.0
0.2
0.4
0.6
0.8
1.0
Xanthene
-1 0 1 2 3 4 5 6 7 8
0.0
0.2
0.4
0.6
0.8
1.0
Indole
Log pM
R
e
la
ti
ve
 L
u
m
in
e
s
c
e
n
c
e
-1 0 1 2 3 4 5 6 7 8
0.0
0.2
0.4
0.6
0.8
1.0
Quinoline
Log pM
-1 0 1 2 3 4 5 6 7 8
0.0
0.2
0.4
0.6
0.8
1.0
2-Methylquinoline
Log pM
0 1 2 3 4 5 6 7 8
0.0
0.2
0.4
0.6
0.8
1.0
2-Methylbenzofuran
Chapter 4 – Results & Discussion  
 
85 
In contrast to the LYES that utilizes yeast cells, Piao et al. (1997), Kuil et al. (Kuil et al. 1998) 
and Spink et al. (1998) have shown that the T47Dluc cells express a number of Cytochrome 
P450 (CYP) isoforms as well as 17β-HSD and thus are readily capable of biotransformation 
and conversion of steroids. It has been demonstrated by van Lipzig et al. (2005) that the 
homocyclic PAHs benzo[a]pyrene (BaP) and chrysene were transformed into several 
hydroxylated metabolites during incubation with β-naphtoflavone-induced rat-liver S9. 
Furthermore, BaP itself caused a significant induction of luciferase in the ER CALUX® that 
was completely inhibited by the CYP inhibitor 3’-,4’-dimethoxyflavone. Similar results have 
been shown previously in a transfected human breast cancer cell-line, MCF-7 (Charles et al. 
2000, Fertuck et al. 2001). By use of a gastrointestinal simulator, Van de Wiele et al. (2005) 
have demonstrated that ingested PAHs can be transformed into estrogenic metabolites by 
colon microbiota and may thus pose a higher risk to human health after absorption via 
food or drinking water than would be expected from the parent substances. We 
hypothesize that heterocyclic PAHs are, comparable with their homocyclic analogues, a 
class of indirect estrogenic compounds that are transformed into the active form 
(hydroxylated and other) by (mammalian) biotransformation enzymes. The observed EEFs 
were relatively high and within the range of other non-steroidal EDCs of high concern 
commonly found in surface water, e.g. alkylphenols (Preuss et al. 2006), bisphenol A, 
phthalates or pesticides (Houtman et al. 2006, Legler et al. 2002a). 
 
4.4.3 Identification of metabolites 
No estrogen receptor (ER) binding affinity was predicted from the structural properties of 
the parent substances by using the OECD (Q)SAR Toolbox (Tab. 4.1).  
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Table 4.1 Comparison of measured data with predicted ER binding for parent compounds and simulated metabolites (OECD QSAR toolbox liver 
metabolism simulator).  
Substance 
Maximum 
concentration1 
Measured effects in the ER 
CALUX® 
Predicted ER binding 
of parent substance2 
Metabolism 
(LC-DAD) 
Predicted ER binding of 
simulated metabolites2 
mg L-1 EEF50 (EEF20-80)   %  
Benzofuran 120.9 - - - n.d. - 
2-Methylbenzofuran 210.0 2.85 (1.49-5.45) 10
-7
 + - n.d. + 
2,3-Dimethylbenzofuran 110.0 1.38 (1.12-1.69) 10
-5
 ++ - n.d. + 
Dibenzofuran 56.9 1.82 (1.74-1.92) 10
-6
 + - 3.3 ++ 
Benzothiophene 136.1 - - - 46.1 + 
Dibenzothiophene 40.8 5.53 (5.27-5.80) 10
-6
 + - 86.7 ++ 
Acridine 40.9 3.18 (2.20-4.61) 10
-5
 ++ - 17.0 ++ 
Xanthene 75.5 3.94 (3.94-3.94) 10
-6
 + - 71.9 ++ 
Carbazole 25.6 - - - 24.7 ++ 
Indole 162.7 5.53 (5.27-5.80) 10
-6
 + - 90.0 - 
Quinoline 226.0 1.25 (1.12-1.40) 10
-7
 + - 18.5 - 
6-Methylquinoline 528.0 5.21 (4.45-6.09) 10
-7
 + - 49.3 + 
EEF50 and EEF20-80 ranges are given for use in mass-balance calculations. n.d. – not determinable due to complete loss during incubation without 
cells; 1according to the concentration range earlier used by Hinger et al. (2011); 2predicted ER binding ( OECD QSAR toolbox) 
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This is, most likely, due to the absence of hydroxy-substituted aromatic rings, which is a 
prerequisite for binding to the ER (Blair et al. 2000). For Saccharomyces cerevisiae, which is 
used for the LYES assay, it is generally assumed that it lacks capability of biotransformation 
(Connolly et al. 2011), and thus, no hydroxylation of the heterocyclic PAHs by the yeast 
would be expected. Thus, results from the present study confirmed the expectation that no 
direct estrogenic effects are caused by heterocyclic PAHs and that the used yeast strain is 
not capable of biotransformation. 
To test the hypothesis that heterocyclic PAHs are transformed into more reactive 
metabolites, we first investigated the losses of parent substances from the incubation 
medium by means of LC-DAD. It was shown that T47Dluc cells were able to metabolize 
most of the substances to a significant extent (Tab. 4.1). In a next step, metabolites were 
detected and (tentatively) identified using LC-HRMS2. We were able to detect one to four 
individual metabolites for each of the investigated parent substances (Tab. 4.2). For six of 
these compounds the identity could be confirmed by authentic reference standards 
(acridone, 2-hydroxyquinoline, quinoline N-oxide, oxindole, xanthone, and 2-
hydroxyphenylacetic acid formed from both, benzofuran and benzothiophen). In four cases 
a tentative structure assignment was possible based on MS2 fragmentation behavior and 
analogy to reference standards of other compounds (Tab. 4.2). For the other detected 
metabolites an assignment based on MS2 spectra, retention times and ionization behavior 
was considered too speculative. Among the identified metabolites, only for 2-
hydroxyphenylacetic acid an estrogenic activity was predicted by the OECD QSAR toolbox. 
However, MS2 spectra showing neutral losses of H2O in many cases suggest that a range of 
hydroxylated and thus phenolic compounds are formed, of which at least some isomers 
show an estrogenic activity as predicted by the QSAR. 
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Table 4.2 Metabolites of heterocyclic PAHs detected and (tentatively) identified in the incubation medium by high resolution tandem mass 
spectrometry (LC-HRMS2). 
Parent compound  
(RT in min) 
Metabolite  
(bold: identified) 
RT (min) Molec.  
Formula 
Confirmed 
by ref. std. 
Predicted  
ER binding1 
Ref. 
Acridine (RT 15.8) Acridone 21.7 C13H9NO yes -  
Acridine Acridine +O 16.9 C13H9NO no +
2
  
Acridine Acridine +2O 20.3 C13H9NO2 no ++
2
  
Acridine Acridine +2OH   9.4 C13H11NO2 no ++
2
  
Quinoline (RT 5.9) 2-Hydroxyquinoline 18.2 C9H7NO yes - (Thiebau
d et al. 
2013) 
Quinoline Quinoline +O 18.9 C9H7NO no   
Quinoline Quinoline N-oxide 14.8 C9H7NO yes - (LaVoie 
et al. 
1983) 
Quinoline Quinoline +OH2 16.9 C9H9NO no -  
6-Methylquinoline (RT 11.9) 6-Methylquinoline +O 16.0 C10H9NO no +
2
  
6-Methylquinoline 6-Methylquinoline N-oxide 18.2 C10H9NO no - (Scharpin
g et al. 
1993) 
6-Methylquinoline 6-Methylquinoline +OH2 18.0 C10H11NO no - (Scharpin
g et al. 
1993) 
Indole (RT 20.4) 2-Oxindole 17.4 C8H7NO yes - (Skordos 
et al. 
1998) 
Indole Indole +OH2 14.0 C8H9NO no +
2
  
Indole Indole +OH2 19.1 C8H9NO no +
2
  
Indole Indole -2H+O 16.6 C8H5NO no -  
Carbazole (RT 24.5) Carbazole-sulfate 21.9 C12H9SO4 no -  
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Xanthene (n.d.) Xanthone 25.3 C13H8O2 yes -  
Benzofuran (n.d) 2-Hydroxyphenylacetic acid 16.4 C8H8O3 yes + (Connelly 
et al. 
2002) 
Benzofuran Benzofuran +2OH 17.7 C8H8O3 no   
Benzofuran Benzofuran +CH4O2 17.8 C9H10O3 no (+)  
Benzofuran Benzofuran +CH4O2 19.8 C9H10O3 no (+)  
2-Methylbenzofuran (n.d.) 2-methylbenzofuran +2OH 17.7 C9H10O3 no +
2
  
2-Methylbenzofuran 2-methylbenzofuran + 2OH 18.5 C9H10O3 no +
2
  
2-Methylbenzofuran 2-methylbenzofuran -2H+O 19.1 C9H6O2 no -  
2,3-Dimethyl benzofuran (n.d.) 2,3-dimethylbenzofuran +O 16.3 C10H10O2 no +
2
  
2,3-Dimethyl benzofuran 2,3-dimethylbenzofuran -2H+O  20.2 C10H8O2 no -  
2,3-Dimethyl benzofuran 2,3-dimethylbenzofuran +2OH 16.4 C10H12O3 no ++
2
  
Dibenzofuran (n.d.) Dibenzofuran sulfate 23.1 C12H8SO5 no -  
Benzothiophen (n.d.) Benzothiophen +O 15.5 C8H6OS no -  
Benzothiophen Benzothiophen –S+CH4O3 18.1 C9H10O3 no   
Benzothiophen Benzothiophen –S+CH4O3 18.5 C9H10O3 no   
Benzothiophen 2-Hydroxyphenyl acetic acid 16.4 C8H8O3 yes +  
Dibenzothiophen (n.d.) Dibenzothiophen sulfoxide 20.9 C12H8OS no - (Vignier 
et al. 
1985) 
Identified metabolites are given by name, those not identified by their modification as compared to the parent molecule. The retention times (RT) of 
the parent compounds are given for reference. n.d. – not detected due to poor ionization. 1Predicted ER binding (OECD QSAR toolbox); 2Different 
isomers possible of which some show estrogenic activity as predicted by QSAR.  
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4.4.4 Possible contribution to estrogenic activity in water resources 
The main sources for estrogenic substances in the aquatic environment are municipal 
sewage and agriculture. The overall activity, however, is a result of complex substance 
mixtures from many different sources (Hecker & Hollert 2011, Moltmann et al. 2007). 
These include high amounts of pharmaceuticals in hospital sewage (Verlicchi et al. 2010) 
and diverse point sources such as the here investigated tar-oil contaminated sites. Most 
attempts to explain the overall estrogenic activity of water samples by mass-balance 
studies were not conclusive and detection of target analytes often underestimated the 
response in the bioassays (Di Dea Bergamasco et al. 2011, Leusch 2008). A number of 
studies confirmed that hydroxylated PAHs contributed to the estrogenicity of different 
complex samples (e.g., Kamiya et al. 2005, Machala et al. 2001, Muthumbi et al. 2003, 
Wenger et al. 2009). Previous research on contamination of ground water with estrogenic 
compounds identified polycyclic aromatic hydrocarbons, including hydroxylated and 
heterocyclic analogues, in those fractions with high estrogenic activity when applying 
effect-directed analyses using the E-Screen assay (Kuch et al. 2010). Further studies (Blum 
et al. 2011, Schlanges et al. 2008) found several heterocyclic PAHs, including quinoline, 
carbazole, acridine, benzofuran and benzothiophene, in concentrations up to 4 mg·L-1 in 
ground water samples from tar-oil contaminated sites in Germany. Acridine, which showed 
a higher induction in the ER CALUX® than 17β-estradiol, was found in concentrations up to 
3 µg·L-1. Recently, acridine, quinolone and carbazole were also detected in several surface 
water samples from German rivers in concentrations up to 20 ng·L-1 (Siemers et al. 2015). 
Regarding its high potential to activate the ER in mammalian cells, acridine should possibly 
be included in the screening battery of chemical analyses of estrogenically active water 
samples in the catchment area of former tar-oil sites. Additionally, acridine and some of its 
transformation products are among the major photodegradation as well as 
biotransformation products of the antiepileptic pharmaceutical carbamazepine (Calisto et 
al. 2011, Kaiser et al. 2014, Kosjek et al. 2009) which is regularly found in surface, as well as 
drinking water in concentrations up to 1 µg·L-1 (surface water) or 0.258 µg·L-1 (drinking 
water), respectively (Benotti et al. 2008, Heberer 2002, Stackelberg et al. 2004). In 
summary, our study demonstrates that some heterocyclic PAHs have comparable 
estrogenicity as some non-steroidal EDCs of concern and are consequently of highest 
relevance in respect to the estrogenicity of water resources as well as human health. 
Chapter 4 – Results & Discussion  
91 
Overall, this substance class has to be taken into account regarding the estimation of 
overall estrogenic activity in surface and ground water. Since ground water is an important 
drinking water resource the investigated hetero-PAHs could also imply an increased risk for 
human health (Brack et al. 2012, Grummt et al. 2013). 
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4.5 Conclusion 
In the present investigation, it was demonstrated that certain hetero-PAHs show estrogenic 
activity after transformation in mammalian cells. For some hetero-PAHs, the detected 
maximum induction of luciferase was even higher than that of 17β-estradiol in the 
concentrations tested. The observed EEFs were within the range of other non-steroidal EDCs 
of high concern commonly detected in surface water (e.g. alkylphenols, bisphenol A, 
phthalates or pesticides). Regarding its high potential to activate the ER in mammalian cells, 
at least acridine should be added to the chemical screening battery of estrogenically active 
water samples. Overall, this substance class has to be taken into account regarding the 
estimation of estrogenic activity in surface and ground water. Since ground water is an 
important drinking water resource the observed hetero-PAHs could imply an increased risk 
for human health.  
Furthermore, we could show that test systems without the ability for biotransformation, 
such as the LYES, are susceptible to underestimate the estrogenic potential of complex 
water samples. Consequently, when using such test systems a metabolic activation step 
should be included in the bioanalytical identification of potential EDCs. 
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5.1 Abstract 
Bacillus thuringiensis var. israelensis (Bti) is successfully used as a biological control agent for 
mosquito control. It has proven to be ecological friendly, and thus, is used in ecologically 
sensitive habitats. Recent investigations of the toxicological potentials of groundwater in 
Germany have detected estrogenic activity in five consecutive groundwater wells in a region 
in the Upper Rhine area (Germany) where Bti is applied. Together with initial confirmation of 
estrogenic properties of Bti in a yeast based estrogen screen, it was suspected that this 
compound can act as an environmental xenoestrogen.  
In the present study, five Bti formulations as well as the active ingredient of Bti, VectoBac® 
TP (TP), were investigated regarding their estrogenic activity using the LYES and ER CALUX® 
assays. Furthermore, their potential steroidogenesis disruption properties were studied 
using the H295R Steroidogenesis Assay. Additionally, field samples from a Bti application 
area as well as samples from an artificial pond were examined. 
Three of the Bti formulations and the active ingredient TP showed significant estrogenic 
activity in the LYES (up to 52 ng∙L-1 estradiol equivalents (EEQ) in the 18-fold concentration) 
and / or the ER CALUX® (up to 1 ng∙L-1 EEQ in the 18-fold concentration). In the H295R 
significant but weak effects with no dose-response-relationship on the production of 
estradiol, and 21-hydroxyprogesterone (WDG) as well as testosterone (TP) by H295R cells 
could be observed. The field samples as well as the samples from the artificial pond showed 
no significant increase of estrogenic activity after application of TP or WDG in the ER 
CALUX®. With the exception of the controlled laboratory experiments with direct application 
of Bti to the utilized in vitro test systems the present study did not reveal any significant 
effects of Bti on endocrine functions that would indicate that the application of Bti could 
cause adverse endocrine effects to organisms in aquatic ecosystems. Instead, our results 
support previous studies that the use of Bti products against mosquitos would be safe even 
for sensitive habitats such as conservation areas. 
 
 
Keywords: Bacillus thuringiensis israelensis, H295R, ER CALUX®, YES, endocrine disruption 
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5.2 Introduction 
As a biological alternative to synthetic insecticides, such as the organophosphates 
Fenitrothion (O,O-Dimethyl O-(3-methyl-4-nitrophenyl) phosphorothioate) and Temefos 
(O,O,O′,O′-Tetramethyl O,O′-sulfanediylbis(1,4-phenylene) diphosphorothioate), Bacillus 
thuringiensis israelensis (Bti) toxins are increasingly used for control of mosquitoes since the 
1980s (Becker 1997, Boisvert et al. 2007). The larvicidal activity is due to the δ-endotoxins, 
which are synthesized during sporulation. Based on a large number of toxicity studies with 
non-target organisms the environmental safety of Bti has been suggested (Boisvert & 
Boisvert 2000). It was therefore recommended for use in aquatic environments and drinking 
water reservoirs by the World Health Organization (WHO 1999). Nevertheless, screening for 
endocrine activity was not included in the previous studies (El-Bendary 2006, Russell & Kay 
2008, Tilquin et al. 2008). 
During a study that investigated the toxic properties of groundwater in the Upper Rhine area 
(Germany) estrogenic activities were detected for five consecutive groundwater wells in 
areas with intensive Bti application (data not published). Because no suspected or confirmed 
estrogen receptor agonists were detected in these samples, it was hypothesized that Bti 
could have contributed to these activities. Subsequently, a spiked water sample, containing a 
commercial available Bti formulation, was tested in the Yeast Estrogen Screen (YES) 
(Routledge & Sumpter 1996). The measured estrogenic activity of the spiked sample  
motivated the present study. Here, we investigated the estrogenic activity of the active 
substance of Bti, five commercial available formulations and the ingredients of one of the 
formulations.  
Attempts to explain the overall estrogenic activity of water samples by mass-balance studies 
are not conclusive in many cases and detection of known or suspected estrogenic active 
substances underestimated the response in the bioassays. Therefore, it is important to 
explore the potential contribution of other, so far unknown, compounds to the measured 
biological effects (Schulte-Oehlmann et al. 2006). In addition to natural and synthetic 
hormones, EDs include a range of other classes of chemicals such as phthalates, organotin 
compounds and hydroxylated polychlorinated biphenyls (PCBs) as well as several 
pharmaceuticals and personal care products. Due to their different physicochemical 
properties initial identification of hormonally active substances is not straightforward 
(Heberer 2002, Van der Linden et al. 2008). The concentration of most potent EDs in the 
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environment is near or below the detection limit of current chemical analysis, i.e. the lower 
ng∙L-1 range. This becomes an issue as some of these compounds – particularly hormones – 
exert their effects in this range. Additionally, chemical interactions of EDs have to be taken 
into account to estimate the potential impacts of EDs in aquatic ecosystems.  
To examine estrogenic activity of Bti two receptor mediated assays, the Lyticase Yeast 
Estrogen Screen (LYES) (Routledge & Sumpter 1996, Wagner & Oehlmann 2009) and the 
Estrogen Receptor mediated Chemical Activated LUciferase gene eXpression (ER CALUX®) 
assay (Legler et al. 1999), were applied. Furthermore, the H295R Steroidogenesis assay 
(H295R) (Hecker et al. 2011) that enables detection of effects on the steroid synthesis 
pathway was used to identify potential disruptors of sex steroid production. Previous studies 
reported the applicability of a combination of receptor-mediated and non-receptor-
mediated assays for a holistic evaluation of potential endocrine activity in complex 
(waste)water and sediment samples (Grund et al. 2011, Hecker & Hollert 2009, Kase et al. 
2009, Leusch 2008, Leusch et al. 2010, Maletz et al. 2013). As previously reviewed by Hecker 
& Hollert (2011) the combined use of receptor-mediated and non-receptor-mediated-
methods is necessary to enable objective assessment of endocrine disrupting potentials of 
complex samples.  
The aim of the present study was to investigate the potential estrogenic activity as well as 
possible impacts on steroidogenesis of Bti as well as its formulations usually applied in 
aquatic ecosystems and private water bodies. Furthermore, it should be examined if the 
detected activity was caused by the active ingredient or the adjuvants or the fermentation slurry, 
respectively. 
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5.3 Material & Methods 
5.3.1 Samples 
5.3.1.1 Bti formulations for the public market 
In an initial experiment, four different commercially available Bti formulations for the 
public market were tested regarding their estrogenic activity in the LYES: Three solid 
products (tablets) and one liquid suspension. The tablets as well as the liquid formulation 
were obtained from local stores, online stores as well as a registered association to cover the 
whole range of purchase possibilities of the public market. The tablets were homogenized 
using a porcelain mortar and weighed. A 30-fold concentration in mg∙L-1 was calculated 
depending on the dosage recommendations of the manufacturers (Tab. 5.1). This stock 
concentration resulted in a maximum concentration of 18-fold within the LYES. 
 
Table 5.1 Concentration of the investigated formulas 
 Solid 
products 
A B C Liquid 
product 
D 
One fold 
concentration 
[mg∙L-1] 7.7 6.8 23.27 [µl∙L-1] 1.5 
30-fold 
concentration 
[mg∙L-1] 231 204 698.1 [µl∙L-1] 45 
 
The homogenized tablets as well as the liquid formulation were diluted in 250 ml tap 
water and samples were stirred overnight. Samples were stored at 4°C in amber glass 
bottles with polytetrafluoroethylene (PTFE) lids.  
 
5.3.1.2 Ingredients of product B 
As one manufacturer kindly provided the composition of the tablet, screening of the 
individual substances contained in this product in the LYES was possible. The tablets 
contain the active substance as well as six adjuvants. According to the highest tested 
concentration of the investigated formulas, the main adjuvants were diluted in tap water 
and tested in an 18-fold concentration. As the composition of the screened product is 
proprietary single substances are not disclosed in this study. For further investigations the 
percentage of the active substance was set to 50 % of product B (personal 
communication with the manufacturer).  
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5.3.1.3 VectoBac® TP and WDG 
The active substance VectoBac® technical powder” (TP) and the formulation VectoBac® 
water dispersible granule” (WDG) were produced by Valent Biosciences and have been 
provided by the German Mosquito Control Association (GMCA; Speyer, Germany). The 
manufacturing process is protected by corporate secret but as stated by Valent 
Biosciences the bacteria are fermented in tanks containing slurries based on either fish or 
soy meal. In case of TP fermentation the slurry is dried and remaining spores are 
inactivated through radiation sterilization. WDG is processed in the same manner but 
then further treated (e.g. blended with adjuvants) to enhance water solubility and 
granulation. 51 mg of the powder / granule were diluted in 250 ml tap water and stirred 
overnight. Samples were stored at 4°C in brown glass bottles with PTFE lids. To examine 
the development of the strogenic activity over time, one solution of VectoBac® TP was 
stored over a period of two month and investigated at the beginning (June) as well as the 
end (August) of this period. 
 
5.3.1.4 Field samples 
Water samples (Tab. 5.2) were provided by the Heinrich-Sontheimer-Laboratory (HSL) of 
the Water Technology Centre (TZW), Karlsruhe, Germany. Each sample consisted of two 
liters and was stored in two one liter polyethylene (PE) bottles. 
 
Table 5.2 Field samples 
Sample Description Product Time [after 
application] 
WS1 Surface water none 0 
WS2 Surface water VectoBac® TP 30 min 
WS3 Surface water none 0 
WS4 Surface water VectoBac® WDG 30 min 
WS5 Ground water none 0 
WS6 Artificial pond VectoBac® TP 2 h 40 min 
WS7 Ground water VectoBac® TP 3 h 40 min 
WS8 Ground water VectoBac® TP 6 h 
WS9 Ground water VectoBac® TP 9 h 35 min 
WS10 Ground water VectoBac® TP 13 h 25 min 
VectoBac® TP = Technical Powder, WDG = Water Dispersible Granule 
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Two surface water samples (WS1 and WS2) were taken directly before and approximately 
30 min after application of a TP-sand-oil-mixture at a water depth of approximately 
10 cm. Another two samples (WS3 and WS4) were taken after application of WDG ice 
granules (out of WDG and tap water) in the same manner. The samples were stored at 
4°C and send to the RWTH Aachen University, Aachen, Germany, in 1 L PE bottles. 
A third set of samples was taken after application of VectoBac® TP (WS5 to WS10) to an 
artificial pond (W: 2.0 m, H: 2.6 m, T: 0.4 m) that was build 12 m from a ground water well 
contrary to the ground water flow direction to investigate the possible distribution of 
VectoBac® TP within the water body (Fig. 5.1). The pond was filled with ground water and 
2 Kg of a VectoBac® TP-Sand-Rapeseed Oil mixture as well as a tracer were added to the 
surface. Samples were taken as stated in table 5.2.  
 
Figure 5.1 Scheme of the artificial application setup. The artificial pond was build 12 m from a 
groundwater well contrary to the groundwater flow direction. WS = water sample. 
 
5.3.2 Sample Preparation 
5.3.2.1 Solid phase extraction (SPE) 
In the present investigation, WS1 and WS2 were extracted by use of SPE. Prior to 
extraction the water samples were filtered through 1.6 µm glass fiber filters (GE 
Healthcare Life Sciences, Solingen, Germany). For principle and general implementation 
of the SPE see chapter 1.4.2.1 as well as chapter 2.1.1. 
 
5.3.2.2 Pressurized liquid extraction (PLE) 
For testing of the samples in the H295R two different extraction methods were applied. A 
first set of TP and WDG samples was tested after extraction with a PLE device at two 
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different temperatures. For principle and general implementation of the PLE see chapter 
1.4.2.2 as well as chapter 2.1.4. 
 
5.3.2.3 Lyophilisation 
The majority of the water samples (WS3 to WS10) as well as VectoBac® TP and WDG were 
processed by freeze drying (lyophilisation). For measurement in the ER CALUX® all samples 
were initiallys centrifuged and freeze dried. To monitor possible losses of activity during 
the lyophilisation an additional sample with 30 ng 17ß-Estradiol (E2) in one liter tap water 
was processed (PC E2). Additionally, one liter tap water was processed as a process negative 
control (PC H2O). For principle and general implementation of the lyophilisation see 
chapter 2.1.2. 
 
5.3.3 LYES 
For principle and general implementation of the lyticase assisted yeast estrogen screen 
(LYES) see chapter 1.4.3.2 and 1.5.1 as well as chapter 2.2.2. In the present investigation, 
cells were exposed to a dilution series (18x, 15x, 12x, 9x, 6x, 3x, 1x and 0.5x the 
recommended application concentration) of the Bti formulations as well as the active 
substances.  
 
5.3.4 Viability Assay 
An MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) cell viability assay 
(see chapter 2.2.1) was conducted to assure that the test items did not cause non-specific 
cytotoxic effects in mammalian cell lines.  
In the present investigation, cells were seeded into 96-well (ER CALUX®) or 24-well (H295R) 
microtiter plates at a density of 1∙105 cells·ml-1 (ER CALUX®) or 3∙105 cells·ml-1 (H295R). 
After 48 h (ER CALUX®) or 24 h (H295R) the cells were exposed to a dilution series of the 
samples for 24 h (ER CALUX®) or 48 h (H295R), respectively.  
 
5.3.5 ER CALUX® 
For principle and general implementation of the ER CALUX® see chapter 1.4.3.2 and 1.5.2 
as well as chapter 2.2.3. In the present investigation, the cells were exposed to a dilution 
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series (18x, 15x, 12x, 9x, 6x, 3x, 1x and 0.5x concentration the recommended 
concentration) of the processed samples.  
 
5.3.6 H295R 
For principle and general implementation of the H295R see chapter 1.4.3.2 as well as 
chapter 2.2.4. In the present investigation, the amount of 17ß-estradiol (E2) was 
determined with an enzyme-linked immunosorbent assay (ELISA). The amount of 
testosterone (T), corticosterone (COR), androstenedione (ASD), progesterone (PRO), 17-
hydroxyprogesterone (17-OHP) and 21-hydroxyprogesterone (21-OHP) was determined by 
use of liquid chromatography tandem mass spectrometry (LC-MS2). Due to the small 
amount of some samples at least one measurement with three internal replicates was 
conducted. 
 
5.3.7 Statistical analysis 
Data were statistically analysed with SigmaStat 3.5 (Systat Software, San José, USA) and 
presented as mean ± standard deviation (SD) or standard error of the mean (SEM) if 
possible. All data were tested for normality using the Shapiro-Wilk test as well as for 
homogeneity of variance (p<0.05). For data fulfilling the parametric assumptions and 
comparison of more than two samples a one way analysis of variance (ANOVA) followed by 
Dunnett’s post hoc test (against control) or Bonferroni t-test (pairwise) was used to 
determine the treatments which differ significantly from the SC. When data did not fit the 
parametric assumptions, a non-parametric Kruskall-Wallis test followed by Dunn’s post hoc 
(against control or pairwise) was used. For comparison of two samples an unpaired t-test 
(parametric data) or a Mann-Whitney Rank Sum test (nonparametric) was conducted. 
Differences were considered significant at p<0.05.  
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5.4 Results 
5.4.1 Bti formulations for the public market 
The three examined tablet formulations showed a dose-dependent estrogenic activity in 
the LYES (Fig. 5.2 A-C). No estrogenicity could be detected for the liquid formulation (Fig. 
5.2 D). 
 
Figure 5.2 Estrogenic activity of four commercially available Bti formulations displayed as estradiol 
equivalents (EEQ) in the LYES. (A) – (C)=solid formulations; (D)=liquid formulation. [x fold] = x fold 
the recommended concentration. Bars represent mean values of three independent experiments 
with standard error (SEM). Data were statistically analyzed with one way analysis of variance 
(ANOVA) followed by Dunnett’s test or non parametric ANOVA followed by Dunn’s test (*=p<0.05). 
 
The lowest activity was detected in sample B ranging between 0.2±1.0 and 14.3±2.6 ng∙L-1 
EEQs, whereas sample C showed greatest estrogenicity between 3.2±1.6 and 
51.8±16.4 ng∙L-1 EEQs. The lowest observed effect concentrations (LOECs) were determined 
at the six fold concentration (C) and the nine fold concentration (A and B), respectively.  
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5.4.2 Ingredients of product B 
None of the examined ingredients of product B showed any estrogenic activity in the LYES. 
Therefore, they were excluded from additional investigations in the ER CALUX® or H295R, 
respectively. 
 
5.4.3 VectoBac® TP and WDG 
5.4.3.1 LYES 
VectoBac® TP showed a dose-dependent estrogenic activity in the LYES (Fig. 5.3). In 
contrast, the investigated batch of VectoBac® WDG showed no estrogenic activity. 
 
Effect of storage time on estrogenic activity of TP 
When exposing cells to samples immediately after their preparation (June) the LOEC was 
represented by the six-fold concentration (Fig. 5.3).  
 
Figure 5.3 Estrogenic activity of VectoBac® TP displayed as estradiol equivalents (EEQ) directly 
after preparation (June) and after two months at 4°C in dark (August) in the LYES. [x fold] = x fold 
the recommended concentration. Bars represent mean values of two independent experiments 
with standard error (SEM). Data were statistically analyzed with one way analysis of variance 
(ANOVA) followed by Dunnett’s test or non parametric ANOVA followed by Dunn’s test 
(*=p<0.05). TP=Technical Powder. 
 
Estrogenicity ranged between 0.7±0.8 ng∙L-1 EEQ (one-fold concentration) and 
52.3±30.0 ng∙L-1 EEQ (18-fold concentration). After storage time of two months (August) 
at ±4°C under exclusion of light no estrogenic activity was detectable up to the nine-fold 
concentration, wherefore the LOEC was represented by the 12-fold concentration. 
Detectable estrogenic activity ranged between 1.5±0.9 ng∙L-1 EEQ (nine-fold) and 
11.5±1.4 ng∙L-1 EEQ (18-fold). In the highest concentration, estrogenic activity therefore 
decreased to 22 % of the initial activity.  
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Effect of processing on samples for the ER-CALUX®  
Processed samples were tested in the LYES to show a theoretical loss of estrogenic 
activity through the processing steps. Processing of the original VectoBac® TP sample led 
to a significant decrease of estrogenic activity as measured in the LYES (Fig. 5.4).  
 
Figure 5.4 Estrogenic activity of VectoBac® TP displayed as estradiol equivalents (EEQ) after 
solving in water and the following treatment steps centrifugation and freeze drying in the LYES. [x 
fold] = x fold the recommended concentration. Bars represent mean values of three independent 
experiments with standard error (SEM). Data were statistically analyzed with one way analysis of 
variance (ANOVA) followed by Dunnett’s test or non parametric ANOVA followed by Dunn’s test 
(*=p<0.05). *=significant difference to the control; °=significant difference between each other. 
TP=Technical Powder. 
 
The decrease was mainly caused by centrifugation as the first processing step. 
Estrogenicity was detectable from the three-fold concentration on whereas significant 
differences to the SC were detectable beginning with the six-fold concentration. Before 
centrifugation estrogenic activity was between 2.5±1.3 ng∙L-1 EEQ (three-fold 
concentration) and 21.3±4.5 ng∙L-1 EEQ (18-fold concentration) and dropped to 
0.6±0.8 ng∙L-1 and 15.4±2.2 ng∙L-1 EEQ, respectively after centrifugation. The freeze drying 
step decreased estrogenicity further but not for all concentrations tested (see Fig. 5.4). 
After centrifugation losses of estrogenic activities between 74 % (three-fold 
concentration) and 25 % (12-fold concentration) were detected. After lyophilisation the 
losses compared to the activities before centrifugation were between 67 % (three-fold 
concentration) and 14 % (18-fold concentration). 
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5.4.3.2 ER CALUX® 
VectoBac® TP showed a dose-dependent increase in estrogenic activity in the ER CALUX® 
assay while VectoBac® WDG showed no significant estrogenic activity at any of the 
concentrations tested (Fig. 5.5). 
 
Figure 5.5 Estrogenic activity of VectoBac® TP displayed as estradiol equivalents (EEQ) in the ER 
CALUX®. [x fold] = x fold the recommended concentration. Bars represent mean values of three 
independent experiments with standard error (SEM). Data were statistically analyzed with one 
way analysis of variance (ANOVA) followed by Dunnett’s test or non parametric ANOVA followed 
by Dunn’s test (*=p<0.05). PC=Process Control; WDG=Water Dispersable Granules; TP=Technical 
Powder. 
 
For the process control as well as VectoBac® WDG estrogenic activity below 0.2 ng∙L-1 EEQ 
could be detected for some concentrations but with no dose-dependent correlation. 
VectoBac® TP caused estrogenicity between 0.01±0.01 ng∙L-1 EEQ (one-fold 
concentration) and 1.04±0.28 ng∙L-1 EEQ (18-fold concentration). The lowest 
concentration that was significantly greater compared to the SC was 12-fold. 
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5.4.3.3 H295R 
After extraction with a PLE device significant differences in production of E2 and 21-OHP 
(WDG) as well as T (TP) compared to the SC were detected at concentrations greater or 
equal to nine-fold (Fig. 5.6).  
 
Figure 5.6 Alteration of hormone production in H295R cells after exposure to VectoBac® TP and 
WDG displayed as induction compared to the solvent control (SC). 30°C / 60°C = extraction 
temperature. Bars represent mean values of three independent experiments with coefficient of 
variation (CV). Data were statistically analyzed with one way analysis of variance (ANOVA) 
followed by Dunnett’s test or non parametric ANOVA followed by Dunn’s test (*=p<0.05). 
TP=Technical Powder; WDG=Water Dispersable Granules. 
 
No differences could be detected for COR, ASD, PRO and 17-OHP. VectoBac® TP led to a 
slight but significant decrease of T production in the 9- and the 18-fold concentration 
after extraction at 60°C (0.7-fold induction). WDG led to a slight but significant increase of 
E2 production in the 9- and 18-fold concentrations after extraction at 30°C (induction 1.5- 
and 1.4-fold). 21-OHP production was also induced after exposure to WDG in the 9- and 
18- fold concentrations after extraction at 60°C (induction 1.4- and 1.3-fold) and for the 9-
fold concentration after extraction at 30°C (induction 1.4-fold). For samples that were 
subjected to freeze-drying and reconstitution in DCM no significant inductions could be 
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detected for the production of E2 and T when using ELISA. The other steroids were not 
tested due to the small sample size as well as a lack of an equivalent ELISA product.  
 
5.4.4 Field samples 
WS1 and WS2 showed weak but significant estrogenic activity in the ER CALUX® (Fig. 5.7 a). 
As there was no statistically significant difference between WS1 and WS2 but only between 
the surface water samples and the groundwater sample no effect of the application of TP 
could be detected. For WS3 and WS4 no significant differences between the samples and 
the tap water control could be detected (Fig. 5.7 b). Estrogenicity of the surface water 
samples (WS1 –WS4) was in the low ng∙L-1 range (below 0.3 ng∙L-1 EEQ) and did not reach 
0.1 ng∙L-1 EEQ in the groundwater sample (GW)  
 
Figure 5.7 Estrogenic activities of field samples of VectoBac® TP (a) and WDG (b) applications 
displayed as estradiol equivalents (EEQ) in the ER CALUX®. Bars represent mean values of at least 
three independent experiments with standard error (SEM). Data were statistically analyzed with 
one way analysis of variance (ANOVA) followed by Dunnett’s test or non parametric ANOVA 
followed by Dunn’s test (*=p<0.05). TP=Technical Powder; WDG=Water Dispersable Granules; 
TW=Tap Water; WS=Water Sample; GW=Ground Water; E2=17ß-Estradiol Process Control (EEQ = 
1.9±0.3 ng∙L-1). 
 
Samples from the artificial pond showed estrogenic activities (Fig. 5.8) in the low ng∙L-1 
range (0.1 to 0.2 ng∙L-1 EEQ). There was no significant difference in the estrogenicity 
calculated for the groundwater well samples before (WS5) and after (WS7 – WS10) 
application of TP. Only WS6, which was taken at the artificial pond directly after application 
of TP, showed a weak but statistically significant increase in estrogenicity relative to the 
process control with tap water. However, the measured activity of sample WS6 reached 
only 0.23±0.08 ng∙L-1EEQ.  
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Figure 5.8 Estrogenic activity of field samples of an artificial application setup of VectoBac® TP 
displayed as estradiol equivalents (EEQ) in the ER CALUX®. Bars represent mean values of at least 
three independent experiments with standard error (SEM). Data were statistically analyzed with one 
way analysis of variance (ANOVA) followed by Dunnett’s test or non parametric ANOVA followed by 
Dunn’s test (*=p<0.05). *=significant difference to the control; °=significant difference between each 
other. TP=Technical Powder; PC H2O = Tap Water Process Control; PC E2 = 17ß-Estradiol Process 
Control (EEQ = 2.3±0.4 ng∙L-1); WS=Water Sample. 
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5.5 Discussion 
In the present study the former findings on the etrogenic activity of a commercially available 
Bti formulation could be confirmed and extended by two additional formulations. 
Furthermore, the estrogenic activity could be linked to the active substance VectoBac® TP. 
The estrogenic activity of at least one batch of VectoBac® TP could be confirmed by the LYES 
and the ER CALUX® assays. Results obtained with the LYES for the active substance were in 
the same range as the Bti formulations tested. Estrogenicity for the same samples detected 
with the ER CALUX® was in a much lower range than in the LYES. Estrogenic activity caused 
by the highest tested concentration of freeze dried samples was 18-fold lower in the ER 
CLAUX than in the LYES, respectively. This could be due to the fact that yeasts show 
significant structural differences compared to mammalian cells including the cell wall and 
different metabolic capacities (Connolly et al. 2011, Dudley et al. 2000, Legler et al. 2002, 
Legler et al. 1999). Such differences between the two test systems were already detected in 
earlier studies (Legler et al. 2002, Leusch et al. 2010, Maletz et al. 2013). But as shown in the 
present study even the processing of the samples reduced the estrogenic activity. 
Centrifugation of the diluted active substance TP already reduced the estrogenic activity by 
up to 74 %. Since TP is not completely soluble and substances with octanol-water partition 
coefficients (logKOW) between 2.6 and 4.0 are easily adsorbed onto solids (Khanal et al. 
2006), most likely, this decrease is foremost a result of the adsorption of the estrogenic 
active content(s) to the remaining solids in the untreated samples. As process steps like 
extraction and clean-up have already shown to change the characteristics of samples (Seiler 
et al. 2008) the possibility to investigate unprocessed complex environmental samples is an 
important option to screen for the effective estrogenic potential. Investigation of the Bti 
formulations as well as the active substance VectoBac® TP and the adjuvants of product B 
with the LYES confirmed the applicability of the test system for non-processed samples. For 
investigation in test systems with mammalian cell lines some form of processing of the 
sample is almost always necessary to prevent the cells from contamination with 
microorganisms such as bacteria and yeasts which could falsify the mechanism specific 
results. However, to minimize the impact of this procedure on the bioassay while insuring to 
efficiently extract most of the active components it is crucial to identify the right extraction 
method for each type of samples. In case of VectoBac® TP pressurized liquid extraction with 
acetone did not efficiently extract the active estrogenic ingredients detected with the LYES in 
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the unprocessed samples. Even though further studies on the extraction of estrogenic active 
compounds from environmental samples confirmed the applicability of the method (Beck et 
al. 2008, Brix et al. 2010, Nieto et al. 2008, 2010). In contrast, freeze dried samples 
confirmed the previous observations regarding at least a fraction of the estrogenic activity of 
VectoBac® TP in native samples. The advantage of this method is the relatively low 
modification of the sample compared to extraction methods with solvents and high 
temperatures like PLE and Soxhlet (Seiler et al. 2008). Nevertheless, one observed 
disadvantage was that some viable bacteria spores of unknown origin in the active 
substances samples were able to survive the freeze drying and reconstitution process, and 
caused a bacterial contamination in the biotest. Therefore, a sterile filtration step prior to 
freeze drying (e.g. after reconstitution in DCM) could prove necessary. 
Overall, based on the estrogenic activity reported in this study for the Bti formulations and 
the active substance VectoBac® TP is unlikely to have an impact on aquatic environments in 
the area investigated in this study. Usage of VectoBac® TP is limited on private households 
and manual mosquito control in areas that are difficult to access. The yearly applied amount 
of TP in the Upper Rhine area does not exceed 32 Kg in the entire region, and the amount 
per hectare is approximately 400 g (personal communication with Norbert Becker, GMCA). A 
minimal water depth of 10 cm would cause a maximum final concentration of 0.4 mg∙L-1 
VectoBac® TP. In most cases the water depth lies in the range of 30 cm with a final estimated 
concentration of 0.13 mg∙L-1. The lowest concentration tested was 2.2 mg∙L-1 (0.5-fold 
concentration), which had not significant estrogenic activity in the LYES (0.4 ng∙L-1 EEQ) and 
the ER CALUX® (<0.1 ng∙L-1 EEQ) assays. Results obtained with samples collected from the 
field as well as the artificial pond system support this conclusion. Neither the investigated 
surface water samples (WS1 and WS2) nor the groundwater samples (WS5 and WS7-WS10) 
caused a significant increase of estrogenic activity. For comparison, the detected estrogenic 
activity of the TP treated surface water sample was 2-times lower than the recommended 
environmental quality standard for E2 (0.4 ng∙L-1) of the European Union Water Framework 
Directive (EC 2012) and 2.5 times lower than the lowest observed effect concentration (LOEC 
= 0.5 ng∙L-1) on the reproduction of the aquatic standard test organism Pimephales promelas 
(Miles-Richardson et al. 1999). It can be concluded that the dilution of VectoBac® TP in the 
treated water bodies is sufficiently great to prevent estrogenic effects on biota or a 
contamination of the groundwater. Data also showed, that even under lab storage 
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conditions (±4°C in dark) estrogenic activity of the Bti formulations is attenuated relatively 
fast. It can be assumed that under natural conditions with higher temperatures, exposure to 
UV radiation and the presence of microorganisms the decrease would occur even faster 
(Leech et al. 2009, Raman et al. 2001). Nevertheless, the confirmed estrogenic activity of the 
three solid formulations as well as the active substance VectoBac® TP needs to be 
considered when estimating risk scenarios for accidental release of high amounts of these 
compounds such as can occur during spills. Therefore, storage and transport has to be 
carried out with appropriate caution. Until now the source of estrogenic activity is not 
verified, but it is suggested that it could be linked to the fermentation slurry, which is based 
either on fish meal or soy (personal communication with the manufacturer). Soy products 
contain high concentrations of phytoestrogens such as daidzein and genistein (isoflavones) 
and have already shown to exert estrogenic activity in both yeast estrogenic screens and ER 
CALUX® (Behr et al. 2011, Dip et al. 2008, Kalita & Milligan 2010). Behr et al (2011) detected 
estrogenic activity of tofu up to 1.5 ng∙g-1 EEQ in the LYES. Kalita & Milligan (2010) calculated 
relative potencies of 0.1 % for genistein and 0.02 % for daidzein in comparison to E2, which 
was set to 100 %. Therefore, the soy based slurry could have contributed to the estrogenic 
activity of the samples. In case of the fish meal a certain amount of steroids can be expected 
as well. Concentrations of estrogens detected in whole fish seem to be relatively low 
(Hartmann et al. 1998) but studies with commercial fish meals showed high estrogen 
contents up to 1.5 µg E2 and 0.5 µg E1 in 100 g (Pelissero et al. 1989). Depending on the fish 
meals used for slurry, this component could also be accountable for the estrogenic activity of 
the samples.  
Results from the H295R Steroidogenesis Assay also indicated that the application of Bti-
based products is unlikely to cause adverse effects to aquatic ecosystem. For VectoBac® 
WDG there was a slight but significant decrease of E2 as well as 21-OHP production for the 
two greatest concentrations (9x and 18x) tested but the effect was very weak with induction 
factors not exceeding 1.5-fold. For the one-fold concentration no differences relative to the 
SC could be detected. For TP there was a slight but significant decrease of T production in 
the two high concentrations but again the inhibition was only low compared to the control. 
The one-fold concentration did not reveal significant differences to the control. 
Furthermore, those findings could not be verified with samples processed via freeze drying 
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where no significant differences could be detected at all. In case of an appropriate use of 
either WDG or TP there should be no adverse effects on steroidogenesis.  
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5.6 Conclusion 
In the present study on potential endocrine effects of Bti formulations for mosquito control 
the former findings on the estrogenic activity of a commercially available Bti formulation 
could be confirmed and extended by two additional formulations. Furthermore, the 
estrogenic activity could be linked to the active substance VectoBac® TP. Nevertheless, the 
source of estrogenic activity remains unclear but a contribution of the fermentation slurry 
based on either soy or fish meal is supposed. In contrast to the measured estrogenic activity, 
no adverse effects on steroidogenesis could be detected. 
Furthermore, data of field samples within this study did not reveal any results that the 
investigated active substances (TP and WDG) alone have the potential to cause adverse 
effects in the aquatic ecosystems concerned. Instead, our results amend the previous studies 
on the safe use of Bti products against mosquitoes even in sensitive habitats. 
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6.1 Abstract 
In this microcosm-study an approach was made to examine a possible effect of VectoBac® TP 
on an aquatic community of invertebrates including an indicator-species for estrogens 
(Potamopyrgus antipodarum). The results indicated an influence on the primary production 
of the systems, as composition of phytoplankton and periphyton-communities seemed to be 
changed. On the level of zooplankton communities no distinct effects were observed, 
however a slightly higher abundance of Daphnia magna was detected in treatments with a 
concentration of 4 mg·L-1 Bti. An endocrine activity of VectoBac® TP could not be clearly 
stated, as conditions in the microcosms seemed not to be sufficient for an unaffected 
development of P. antipodarum (probably due to quantity and quality of available nutrients). 
According to the data of this study a further observation seems reasonable as effects on the 
community level were observed, but their exact nature remains unclear. Furthermore an 
impact on the reproduction of P. antipodarum should be examined more closely as clues on 
a possible estrogenic activity were noticed due to a significantly higher reproduction at the 
beginning of the test, and the observation of a very high abundance of snails, six weeks past 
the treatment in the former 20 mg·L-1 Bti-treatments. 
 
 
Keywords: Bacillus thuringiensis israelensis, microcosm, endocrine disruption, Potamopyrgus 
antipodarum 
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6.2 Introduction 
In the need for specific and potent insecticides, the use of Bt-toxins from various strains of 
Bacillus thuringiensis became more and more popular over the last decades. One of those 
strains, Bacillus thuringiensis var. israelensis (Bti) is used since the 1980s as larvicide against 
mosquito larvae. It is considered to have a minor impact on the environment, as it is a 
biological insecticide with a narrow range of target organisms. Hence, Bti is widely 
distributed for mosquito control (Boisvert & Boisvert 2000, Kroeger et al. 1995). A routine 
examination of ground water samples from a Bti application area in South Germany 
indicated an estrogenic activity in the Yeast Estrogenic Screen (YES). A further investigation 
of different Bti products as well as the two active substances VectoBac® TP and VectoBac® 
WDG with the lyticase assisted Yeast Estrogenic Screen (LYES) substantiated the former 
detected estrogenic activity (see Chapter 5). Therefore, a further investigation to estimate 
the possible ecological impact on treated areas seemed necessary. 
Since ecotoxicology is a multidisciplinary field which combines the knowledge of chemical 
fate, single-species toxicology and organism interaction, data of different scientific 
approaches needs to be integrated to predict a potential risk of substances introduced to the 
environment. Hence, the extrapolation of observed effects from the laboratory to the 
environment is one of the biggest difficulties in this discipline. Accordingly, mesocosms and 
microcosms have been proven to be reliable tools to predict the effect of a suspicious 
substance to the environment (Taub 1989). 
The microcosm as well as the mesocosm is a system that mimics natural conditions. 
According to Taub (1997) the main features of this systems are the possibility to get 
information on direct trophic-level effects as well as the retrieval of information on: (1) 
indirect trophic-level effects, (2) compensatory shifts within trophic levels, (3) responses to 
chemicals within the context of seasonal patterns that modify water chemistry and birth- / 
death- rates of populations, (4) chemical transformations by some organisms that cause 
effects in other organisms, and persistence of parent and transformation products. 
In the present investigation the possible impact of the larvicide VectoBac® TP on aquatic 
communities has been studied. Potential changes in the composition and abundance of 
algae and zooplankton populations have been revealed by use of aquatic microcosm 
systems. In addition, an approach to integrate the indicator-species Potamopyrgus 
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antipodarum (Stange et al. 2012, Wagner & Oehlmann 2011) into this system with the goal 
to deliver information on a possible endocrine disruption of higher organisms was made. 
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6.3 Material & Methods 
6.3.1 Setup of the microcosm test systems  
The microcosm study was performed in 13 aquaria with the volume of 20 L and the size of 
0.4 x 0.25 x 0.25 m each. All aquaria were placed on isolating mats (thickness 0.5 cm) and 
filled with 1500 ml of pure silica sand as well as 17 L of dechlorinated (10 days at room 
temperature) tap water. After six days two fluorescent lamps (LIFE-GLO, T5 H0, 39 W, 
Hagen, Germany) were placed directly on each basin and two liters of sieved (mesh-width 
120 μm) mesocosm-water (provided by gaiac mesocosm facility, Aachen, Germany) and 
300 ml of a well grown (one month old) Cryptomonas obovoidae-culture in COMBO-
medium (according to Kilham et al (1998)) were added. One day later 50 ml of a 
Desmodesmus subspicatus-suspension and one microscope slide well covered with 
periphyton (from a laboratory pre-culture) were added to each aquarium. The suspension 
was made from a well grown D. subspicatus-culture in Khul-medium (Kuhl & Lorenzen 
1964) from which the algae were separated by centrifugation (4000 rpm, 10 min) and the 
resulting pellet was resuspended in tap water. One day later each aquarium was inoculated 
with a well grown Brachionus calyciorus-culture in COMBO-medium , additionally one glass 
pipette was attached to the back wall of each aquarium for aeration. The aeration results in 
a slight turbulence in the water column which should support the growth of the immobile 
algae D. subspicatus. The day after, 25 individuals of the copepod Mesocyclops leuckarti 
were introduced to each basin. Three days later, 30 individuals of the cladoceran Daphnia 
magna, all carrying eggs, were added to each aquarium. Two days after that, 20 
synchronized larvae of the chironomid Chironomus riparius were added to every basin. 
Nine days later, 75 individuals of the mud snail P. antipodarum were inserted to each test 
aquarium. Only fecund snails with an appropriate size of 3 to 5 mm shell heights were 
inserted. Then, 19 days after the introduction of the C. riparius larvae to the systems, the 
aeration was removed and all basins were covered with a thin mesh fabric to avoid 
escaping of hatched C. riparius imagines. The treatment of the microcosms was started 35 
days after the beginning of the microcosm installation (Table 6.1). 
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Tab 6.1 Timetable of the microcosm installation 
Day Operation / Addition of 
0 1500 ml silica sand and 17 L dechlorinated tap water 
1 2 L sieved (120 µm) mesocosm water (Gaiac e.V.) and 300 ml C. obovoidae-culture 
2 50 ml D. subspicatus-suspension and 1 microscope slide covered with periphyton 
3 50 ml B. calyciorus-suspension and installation of aeration 
4 25 adults of M. leuckarti 
7 30 adults of D. magna 
9 20 juveniles of C. riparius 
18 75 adults of P. antipodarum 
28 End of aeration and covering of the aquaria with mesh fabric 
35 (0) 
Start of the treatment with 4 and 20 mg∙L
-1
 VectoBac® TP (application biweekly for a duration 
of eight weeks) or 40 ng∙L
-1
 17ß-estradiol as positive control (weekly for nine weeks) 
(0) = day 0 of the treatment  
 
6.3.2 Treatment of the microcosms 
Of the 13 aquaria installed, four served as negative control (NC), eight as treatment with 
VectoBac® TP and one as a positive control (PC). Treatment was accomplished with a high 
concentration (4 aquaria containing 20 mg∙L-1 TP) and a lower concentration (4 aquaria 
containing 4 mg∙L-1 TP). While the NCs were not treated at all, 40 ng∙L-1 17ß-estradiol (E2) 
were added to the PC. The application of E2 was carried out once a week for a duration of 
nine weeks. For the Bti treatments two dispersions with VectoBac® TP (Valent BioSciences® 
Corporation, Libertyville, USA) and dechlorinated tap water were made. Hence 1520 mg 
and 304 mg of VectoBac® TP were added and the mixture was stirred at least for 90 min 
until a good dispersion was achieved. Subsequently, 150 ml of the dispersions were applied 
to each of the eight corresponding treatments. This application was carried out biweekly 
for a period of eight weeks. 19 ml of a nutrient solution (344 mg NH4Cl∙L
-1 and 66 mg 
KH2PO4∙L
-1) were added twice a week. This corresponds to a nitrogen and phosphor 
addition of 0.09 mg N∙L-1 and 0.015 mg P∙L-1. Once a week water evaporation from the 
systems was compensated by addition of dechlorinated tap water, resulting in a total 
volume change of less than 10 %. All aquaria were kept at a temperature of 16°C±4°C with 
a light / dark interval of 16 / 8 hours and a light intensity right beneath the water surface 
between 120 and 150 μE·s-1·m-2 throughout the whole experiment. 
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6.3.3 Sampling 
6.3.3.1 Water samples 
Samples for the determination of phytoplankton and zooplankton abundance and the 
determination of the abiotic parameters pH, temperature, conductivity, and oxygen 
saturation were taken weekly. The first samples were taken right before the start of the 
treatment, on day 0, and the last samples were taken ten weeks after start of the 
treatment, on day 56. The samples were taken with a sampling-tube of an approximate 
length of 40 cm and 2 cm in diameter. For sampling, the pipe was inserted vertically in the 
water column without dipping into the sediment and removed quickly out of the water 
while the top hole was closed with the thumb (in total 20 times per aquarium). The 
microcosm water collected this way was pooled in a 1.5 L beaker as a mixed sample. Each 
single sample consisted of approximately 50 ml. 30 ml of each of the mixed samples were 
taken and stored in a 30 ml glass vial. The phytoplankton samples were measured on the 
same day to determine algae classes and the correspondent amount of chlorophyll a. The 
measurement was performed with a fluorescence analytic kit (Sensor bbe FluoroProbe, 
bbe Moldaenke GmbH, Schwentinental, Germany). Afterwards temperature, pH, 
conductivity, and oxygen saturation were measured in the 1.5 L beaker. 
Subsequently, to get zooplankton samples, the water of the mixed sample was poured 
gently through a sieve (mesh-width 55 μm) right back in the microcosm it was taken from. 
The remains on the sieve were rinsed out with fixating solution (70 % ethanol with 
40 ml∙L-1 glycerol and 40 g∙L-1 saccharose) and were transferred into a 15 ml glass vial. 
Zooplankton samples were stored in dark at 16°C. For determination of the taxa and the 
correspondent abundance the samples were transferred into a counting dish and 
examined completely with an inverse microscope (CK2, Olympus, Hamburg, Germany). 
This was repeated until all zooplanktic organisms in the sample were determined and 
counted. The determination of the rotifers was performed with the determination key in 
Koste (1978). For the dominating groups of zooplankton, the cladocerans, the copepods, 
and the rotifers, abundances were calculated from the volume of the samples. 
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6.3.3.2 Documentation of the hatching of C. riparius 
The basins where checked regularly for hatched C. riparius imagines. The animals and the 
exuviae of the pupae were removed and the number of individuals and the date of 
discovery were documented. 
 
6.3.3.3 Potamopyrgus antipodarum  
To determine the reproductive activity of P. antipodarum 20 individuals were collected 
from each aquarium 14, 42, and 56 days after beginning of the treatment. The snails were 
stored in 15 ml glass vials and covered with fixating solution. According to Schmitt et al. 
(2013) snails were measured on a scale paper under a binocular (SMZ1500, Nikon, 
Chiyoda, Japan) and their length and aperture height were documented. Subsequently 
they were cracked carefully with a forceps. The shell was removed and the brood pouch 
opened gently with dissecting needles. All embryos were removed and the number of 
embryos with shell and without shell was documented. At the last day of sampling the 
number of juvenile snails sitting on the aquaria glass walls was documented. Therefore all 
individuals on one of the side walls and on the front wall were counted. 
 
6.3.3.4 Periphyton determination 
Periphyton was measured 64 days after beginning of the treatment. Therefore a 
fluorescence analytic kit was equipped with a glass fiber sonde (Sensor bbe FluoroProbe, 
BenthoFluor Kit, bbe Moldaenke GmbH, Germany). This sonde was held from the inside of 
the aquarium onto the glass wall and the corresponding area on the outside of the 
aquaria was covered with a black cardboard. For each basin two representative areas on 
the glass walls were chosen and measured. 
 
6.3.4 Statistical analysis 
All data were statistically analyzed for significant differences between the treatments and 
the NC with SigmaStat 3.5 (Systat Software, San José, USA) and presented as mean ± 
standard deviation (SD). All data were tested for normal distribution using the 
Kolmogorov-Smirnov test as well as for homogeneity of variance. Zooplankton data was 
checked by one-way analysis of variance (ANOVA) analysis followed by Dunnett's test, if 
data distribution was normal and variance was equal. In cases were a one-way ANOVA 
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could not be performed, a Kruskal-Wallis test followed by Dunn's Multiple Comparison 
test was used. The data of the fluorometric algae determination was analyzed via t-test. 
For data with unequal variance and no normal distribution a Mann-Whitney test was 
performed. The results of the P. antipodarum reproduction were analyzed by the use of 
Kruskal-Wallis test followed by Dunn's Multiple Comparison test. Differences were 
considered significant at p<0.05. 
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6.4 Results 
6.4.1 Temperature, conductivity, pH, and oxygen saturation 
The water parameters temperature, conductivity, oxygen saturation, and pH were 
measured every seven days from day 0 to day 56 of the treatment. Over the whole test 
period the temperature within a treatment group never differed for more than 3°C in a 
total range between 14.9 and 19.5°C. Throughout the test the mean conductivity measured 
for the different treatment groups was between 250 and 334 μS∙cm-1. The oxygen 
saturation found in the different basins generally increased over the time of treatment and 
never was lower than 6.9 mg∙L-1. Over the duration of the test mean pH values were 
between 7.58 and 9.95 for all treatments and steadily increased for the duration of the 
test. 
 
6.4.2 Phytoplankton 
In general the abundance of phytoplankton was very low throughout the microcosm study. 
The class of chlorophyta showed the highest abundance at the beginning of the test when 
the concentration of chlorophyll a never undercut 0.44 μg∙L-1 in all treatments for the first 
seven days (Fig. 6.1). After day seven the concentration of chlorophyll a never exceeded 
0.25 μg∙L-1 in all treatments except for the PC on day 56 with a concentration of 0.83 μg∙L-1. 
 
Figure 6.1 Mean concentration of chlorophyll a ± standard deviation related to green algae 
(Chlorophyta) and cyanobacteria for the different Bti-treatments (4 and 20 mg·L-1) and the controls 
(NC = negative control; PC = positive control with 17ß-estradiol) from day 2 to day 56. * = significant 
differences to the NC (t-test, when t-test failed Mann-Whitney test was performed).  
 
The class of cyanobacteria could not be detected after 36 hours except for the 4 mg∙L-1 
treatment with a very low concentration of 0.01 μg∙L-1 chlorophyll a. After day seven 
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cyanobacteria were found in all treatments throughout the duration of the test. While 
concentrations in the NC and 4 mg∙L-1 treatment stayed in a range between 0.01 to 
0.07 μg∙L-1 chlorophyll a and showed only one momentary peak after 14 days for the NC 
(0.21 μg∙L-1 chlorophyll a) and two momentary peaks for the 4 mg∙L-1 treatment after seven 
days (0.11 μg∙L-1 chlorophyll a) and 56 days (0.13 μg∙L-1 chlorophyll a) chlorophyll a 
concentrations from cyanobacteria in the PC and the 20 mg∙L-1 treatment were steadily 
increasing from day 14 on. Both treatments had a peak after 7 days with 0.35 μg∙L-1 
(20 mg∙L-1 Bti) and 0.8 μg∙L-1 (PC) chlorophyll a before on day 14 low peaks with 
concentrations of 0.07 μg∙L-1 (20 mg∙L-1 Bti) and 0.06 μg∙L-1 (PC) could be found. For the 
following duration of the test both treatments showed increasing cyanobacteria 
abundance with a chlorophyll a concentration of 0.59 μg∙L-1 (20 mg∙L-1 Bti) and 0.53 μg∙L-1 
(PC) on day 56 (Figure 1). A comparable development of blue algae to the PC was 
monitored for the 20 mg∙L-1 group. On day 14 a concentration of 0.35 μg∙L-1 chlorophyll a 
was measured that dropped to 0.07 μg∙L-1 on day 14 and then increased steadily to a final 
concentration of 0.59 μg∙L-1 on day 56. 
 
6.4.3 Periphyton 
At the beginning of the treatment with Bti the periphyton covered most of the fine sandy 
sediment as a very thin layer and had only started growing on the glass walls of the 
aquariums. With further proceeding of the test the periphyton covered almost all glass 
walls completely until the end of the study. In all treatment-groups, except for the PC, the 
dominating periphyton class was the green algae (Chlorophyta). Their mean chlorophyll a 
content was 1.51 μg∙cm-2 for the NC, 1.59 μg∙cm-2 for the 4 mg∙L-1 treatment, and 
1.08 μg∙cm-2 for the 20 mg∙L-1 treatment (Fig. 6.2). In the PC no chlorophyll a from green 
algae was found. 
The second dominant class was the blue algae (Cyanobacteria) which represented 
0.26 μg∙cm-2 chlorophyll a in the NCs, 0.72 μg∙cm-2 for the 4 mg∙L-1 group, 0.64 μg∙cm-2 for 
the 20 mg∙L-1 treatment, and 0.32 μg∙cm-2 chlorophyll a as the most dominant class in the 
PC. The least represented class, the Diatoms, were found in the negative controls with an 
average amount of 0.22 μg∙cm-2 chlorophyll a, 0.2 μg∙cm-2 in the 4 mg∙L-1 treatment, 
0.25 μg∙cm-2 in the 20 mg∙L-1 treatment, and 0.14 μg∙cm-2 in the PC. 
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Figure 6.2 Amount of periphyton given as mean ± standard deviation of measured chlorophyll a 
detected 67 days after start of the treatment with Bti (4 and 20 mg·L-1) and the controls (NC = 
negative control; PC = positive control with 17ß-estradiol). 
 
6.4.4 Zooplankton 
With exception of one measurement within the crustacea at day 42, the abundance of 
zooplankton organisms showed no significant differences compared to the NC (Fig. 6.3).  
In case of D. magna (crustacean) abundance was very similar for all treatments through the 
first 28 days and oscillated in a range between 16 and 60 individuals∙L-1. Only the PC had a 
higher abundance of 87 individuals∙L-1 at the first sampling (day 0) within this period. Even 
though densities did not vary very much at this time, the daphnids started to develop 
ephippia after 14 days of the treatment in the 20 mg∙L-1 treatment, and within the next 
week for all other treatments. After day 28 densities in the 4 mg∙L-1 Bti-treatment 
increased to abundances from 74 to 88 individuals∙L-1 until the end of the test whilst 
abundances in the other treatments stayed in a range between 31 to 64 individuals∙L-1. 
Abundances of M. leuckarti were relatively similar over all treatments in a range between 
41 and 516 individuals (nauplii). The number of individuals reached a peak (305 to 516 
individuals) at day 14 in all treatments and declined afterwards until day 28 (20 mg∙L-1 Bti 
and PC), day 35 (4 mg∙L-1 Bti) and day 42 (NC). For the PC a second peak was reached at day 
42 with 416 individuals whereas abundances in the higher Bti-treatment increased until 
day 49. At day 56 a slight decrease could be detected for both treatments. Both the NC as 
well as the lower Bti-treatment showed increasing abundances until day 56. 
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Figure 6.3 Mean values of abundance ± standard deviation of Daphnia magna for the Bti-
treatments (4 and 20 mg·L-1) and the controls (NC = negative control; PC = positive control with 
17ß-estradiol) over the whole study period (56 days). * = significant differences to the NC (1way 
ANOVA followed by Dunnett's test). 
 
With exception of day 7, where the number of individuals in the NC was much lower (6) 
than in the other treatments (± 30), abundances of the rotifers were in a similar range until 
day 28. For the higher Bti-treatment significant differences were detected for days 7 and 
28, but taking the standard deviations into account the difference seems not to be that 
high. From day 35 on abundances in the PC strongly increased up to 79 individuals at day 
56 with significant differences to the NC from days 35 to 49. Abundances of the Bti-
treatments both increased in a lower scale up to 29 (4 mg∙L-1) and 39 (20 mg∙L-1) 
individuals, respectively. Abundances in the NC also increased slightly until day 49 but 
showed a strong increase on day 56 with 117 individuals per liter. In case of the rotifers 
also the composition of the community shifted throughout the study. While the genus 
Cephalodella spec. could be found at all sampling times, the genus Lecane spec. was mainly 
observed for the first and the last seven days of the test. From day 42 on, the new genus 
Mytilina spec. occurred with increasing density. 
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6.4.5 Reproduction of Potamopyrgus antipodarum 
The reproduction of P. antipodarum in general showed a high variability (Fig. 6.4).  
 
Figure 6.4 Reproduction of Potamopyrgus antipodarum for the different Bti-treatments (4 mg∙L-1 
and 20 mg∙L-1) and the controls (NC = negative control; PC = positive control) after 14, 42 and 56 
days. Data are given as box plots (25 to 75 percentile), including the median (―), whiskers (5 to 95 
percentile) and outliers (·); * = significant differences to the NC (Kruskal-Wallis test followed by 
Dunn's Multiple Comparison Test). 
 
This is due to the fact that for almost all replicas, treatments and sampling times, animals 
which did not reproduce at all and animals with a relatively high offspring could be found. 
The median of the embryos in the NC increased from 5.5 over 14 to 15 at day 56 while the 
median of the PC increased from 10 to 14.5 at day 42 and remained static at day 56. In the 
lower Bti-treatment the number increased from 7 over 10.5 to 13 embryos on day 56 while 
in the higher treatment the number increased from 12 to 15 on day 42 and decreased 
afterwards to 11.5 on day 56. 
The distribution between younger embryos without a fully developed shell and older 
embryos with a shell at day 14 was 88 % to 12 % for the NC, 81 % to 19 % for both the 
4 mg∙L-1 Bti-treatment and the PC and 84 % to 16 % for the 20 mg∙L-1 Bti-treatment (Fig. 
6.5). At day 42 this ratio was 75 % to 25 % for the NC, 77 % to 23 % for the 4 mg∙L-1 Bti-
treatment and 74 % to 26 % for the 20 mg∙L-1 Bti-treatment and the PC, whilst for day 56 
this ratios changed to 69 % and 31 % for the NC and the 4 mg∙L-1 Bti-treatment, 66 % and 
34 % for the 20 mg∙L-1 Bti-treatment and 75 % and 25 % for the PC.  
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Figure 6.5 Distribution in percent between younger embryos of Potamopyrgus antipodarum 
without a fully developed shell and older embryos with a shell for the Bti-treatments (4 mg∙L-1 and 
20 mg∙L-1) and the controls (NC = negative control; PC = positive control) after 14, 42 days and 56 
days.  
 
Counting of juvenile snails at the end of the study lead to a mean of five snails for the NC, a 
mean of two snails for the 4 mg∙L-1 Bti-treatment, a mean of ten snails for the 20 mg∙L-1 Bti-
treatment and 19 snails for the PC. 
 
6.4.6 Hatching of Chironomus riparius larvae 
The development of the C. riparius larvae seemed to be very unequal in between the 
different microcosms and even within the same treatment groups. Already in the 
equilibration phase differences in the development of larvae could be observed. Some 
larvae were already in third or fourth instar, whilst other larvae seemed to be still in second 
instar. Therefore, some imagines had already hatched before the beginning of the test and 
the application of the test substance. Hatching of imagines occurred in seven of thirteen 
microcosms preliminary to the start of the study. The day after the application of Bti in 
seven of eight aquaria of the Bti treatments dead larvae were collected. The dead larvae 
were laying on the sediment surface and the color of their mid-section had changed from 
red to dark-grey while there was also no more tension in this part of their bodies. After the 
application of Bti no more larvae could be observed in the treated microcosms, and 
hatched imagines could only be found the day after and no more during the further study 
in those treatments. Only in some of the NCs and the PC a few imagines could be seen 
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throughout the following weeks. After the beginning of the test some pupae were seen, 
also in one of the 4 mg∙L-1 Bti-treatments, but most of them did not finish the 
metamorphosis and died before the imagines could hatch. 
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6.5 Discussion 
6.5.1 Phytoplankton 
The abundance of the green algae in general was very low throughout the duration of the 
study (Fig. 6.1). Except for the 20 mg∙L-1 Bti-treatments with a concentration of 1.52 μg 
chlorophyll a∙L-1 after 36 hours, all abundances were at a level that is comparable to a 
clear-water phase (Lampert et al. 1986). The decline within the first 14 days of the study in 
all treatments was probably due to grazing by zooplankton, as zooplankton densities in 
general were relatively high. 
The statistical analysis of the data showed a significant higher abundance in the 20 mg∙L-1 
Bti treatments compared to the NC after 36 hours and 56 days, while almost no green 
algae were found between day 14 and 49 in the 20 mg∙L-1 Bti-treatment. 
Since the decline in the abundance was very steep within the first two weeks and after 49 
days a sudden increase was monitored, it cannot be excluded that the 20 mg∙L-1 Bti-dosage 
affected the greenalgae respective the composition of their community. The concentration 
of chlorophyll a from cyanobacteria was below the level of detection throughout the test 
for the NC and the 4 mg∙L-1 Bti-treatment, whilst a constant increase could be seen for the 
PC and the 20 mg∙L-1 Bti-treatment from day 14 on (Fig. 6.1). Even though concentrations 
were still very low in those treatments for most of the duration of the test, a tendency 
could be seen and significant differences between the NC and the 20 mg∙L-1 Bti-group were 
detected for the final sampling on day 56. Therefore an effect on the phytoplankton 
community can be assumed. Boisvert & Boisvert (2000) suspected the application of Bti to 
have an impact on the primary production of green algae. It is thinkable that after a first 
adverse influence on the algae an adaption to the substance occurred and therefore a later 
increase in the population was possible, and / or that a change in the community structure 
to less susceptible species was performed. A comparable development could be seen in the 
PC. Also Hense et al. (2008) reported a shift in phytoplankton communities from green 
algae to cyanobacteria after the application of 17α-ethinylestradiol to freshwater 
microcosms as well. 
An examination of one of the phytoplankton samples of the 20 mg∙L-1 Bti-treatments from 
day 56 showed that some of the cyanobacteria were originating from the periphyton. This 
was probably due to grazing of the daphnids, as they were observed feeding on periphyton 
which was also demonstrated by Siehoff et al. (2009). Since green algae were almost 
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absent in the 20 mg∙L-1 Bti-treatment from day 14 to day 49 this seems very likely. But also 
"normal" grazing on phytoplankton by large grazers like D. magna thus can foster a shift to 
the class of cyanobacteria and therefore intensify the abundance of preexisting blue algae 
(Haney 1987). 
 
6.5.2 Periphyton 
The results of the periphyton indicate that in the treatments containing Bti the growth of 
periphyton from the class of the cyanobacteria might be favored. The dominant periphyton 
group found in the NC and the 4 mg∙L-1 treatment for all replicas (except for one) were 
green algae. This observation could not be confirmed for the PC and the 20 mg∙L-1 
treatment, where green algae were only dominating the periphyton community in one of 
the four replicas of the Bti-treated microcosm. Therefore, observations on a shift from 
green to blue algae through high concentrations of Bti or estrogens, respectively, could be 
confirmed. 
 
6.5.3 Zooplankton abundance 
The data of D. magna abundances illustrates that for the first four weeks of the study, 
population densities in all treatments were in the range of approximately 20 to 50 
individuals∙L-1 (Fig. 6.3). According to Carvalho & Hughes (1983) the observed development 
of ephippia occurs mainly due to three factors: a limitation in food (<0.05 mg∙individual-1), 
high abundances (300 to 400 individuals∙L-1), and a light / dark ratio of less than 12 : 12 
hours. As population densities of the daphnids were not that high between day 14 and day 
21 and the light regime was 16 hours light to 8 hours darkness, the production of ephippia 
was probably caused by a limitation of food. This explanation would go in hand with the 
fact that the abundance of green algae dropped within the first two weeks of the study for 
all treatments. Since the concentrations do not state information on the quality of the 
algae and their edible fraction is also consumed by copepods and rotifers, a limitation in 
food seems very likely. Especially as a status comparable to a clear-water phase could be 
assumed throughout the test, and population densities adjusted in a certain range. 
Nevertheless, the populations of D. magna in the treatments were bigger than those for 
the controls from day 35 on. In particular the 4 mg∙L-1 treatment showed abundances that 
were twice as high as those of the NC for day 35 to 49 (with a significant higher density at 
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day 42). This could be a hint on a possible use of the applied Bti as food source by the 
daphnids (Geller & Müller 1981). Duchet et al. (2010) reported a slightly higher fecundity 
for D. magna and thus slightly higher growth rates of the populations compared to the 
negative control in a laboratory experiment with VectoBac® 12AS, but no higher 
abundances. Therefore a favorable effect of relatively low Bti concentrations on D. magna, 
which is constrained by an additional antagonist effect in higher Bti concentrations, seems 
possible. 
Abundances of M. leuckarti and the rotifers are correlating throughout the study which is 
related to the fact that rotifers serve as food for the copepods and therefore are directly 
accountable for their reproductive outcome (Hansen & Santer 1995). On the one hand, the 
decline in the abundances of the rotifers is due to the predation pressure of M. leuckarti. 
On the other hand Gilbert (1988) could show that grub competition of daphnids has a 
negative influence on rotifers. The limitation in food therefore could also have played a 
role. Nevertheless, there was a significant increase of rotifer abundance in the PC from 
days 35 to 49. Further studies could not detect increases of density after exposure to 17ß-
estradiol (Gallardo et al. 1997, Preston et al. 2000), but they used much higher 
concentrations ranging from 10 µg·L-1 up to 50 mg·L-1. Effects in the present study could 
therefore be caused by low-dose effects of E2 (Vandenberg et al. 2012). The strong or 
rather very strong increase of abundances of the PC respectively the NC after 56 days was 
not significant due to the large standard deviation. 
 
6.5.4 Reproduction of Potamopyrgus antipodarum 
The reproduction of P. antipodarum revealed no clear tendency for the different 
treatments (Fig. 6.4). The NC, the 4 mg∙L-1 treatment, and the PC seemed to reach a 
maximum in reproduction at day 42, as embryo numbers increased between day 14 and 
42, and did only change marginally until day 56. The reproduction of the snails in the 
20 mg∙L-1 group did undergo the most severe change, since reproduction increased 
between the first two samplings and declined afterwards for the final sampling at day 56. 
The fact that only slight differences in the number of embryos between the PC and the NC 
were observed might be a hint that a concentration of 40 ng∙L-1 E2 for this test system is 
not high enough and / or a more frequent application of E2 would have been needed. Min 
(2011) showed that 48 hours after an application of E2 to wetland microcosms only 10 % of 
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the applied E2 could be recovered in the water phase, due to sorption to the sediment. 
Jürgens et al. (2002) reported that in rivers bio- and photodegradation of E2 form only one 
estrogenic active compound, the short living estron (E1), in comparison to the degradation 
of 17α-ethinylestradiol. Anyhow the PC did show a higher initial reproduction as the NC 
and had slightly more offspring at the later sampling points. Aside from that the PC was the 
only treatment to be found in that all snails showed reproduction (Fig. 6.4), even if sample 
sizes were smaller than for the other treatments as there was only one replica. The 
standard operation procedure of the test system does not include a positive control 
(Schmitt et al. 2013) but in order to classify potential endocrine effects the authors of the 
present investigation strongly recommend such. Therefore, for further investigations a 
higher concentration of E2 with a more frequent application or the use of a more potent as 
well as stable positive control substance such as 17α-ethinylestradiol (Jobling et al. 2003) 
seems appropriate. 
The reproduction of the NC and the 4 mg∙L-1 treatments was very even and revealed a 
similar number in embryos, from day 42 on. The 20 mg∙L-1 group showed a relatively high 
initial reproduction, which exceeded that of the PC, and differed significantly from that of 
the NC. Even though embryo numbers were not higher (day 42) or even lower (day 56) 
towards the end of the test as in the other groups, the reproduction was more even among 
the snails in the 20 mg∙L-1 treatments, as the smaller boxes of the Whiskers-blot indicate 
(Fig. 6.4). 
The observation that the reproduction of P. antipodarum increased between the first two 
samplings for all treatments is a clue on a previous limitation in food, especially as the 
periphyton coverage at the start of the test was much lower than towards the end. 
Broekhuizen et al. (2001) have discovered that a high contamination with fine sediment of 
the food has a negative influence on P. antipodarum reproduction. Additionally 
zooplankton abundances were relatively high at the beginning of the study and daphnids 
showed signs of food limitation (epphipia), and thus were grazing on periphyton, a 
competition on food for this two species can be assumed (Fig. 6.3). After the biomass from 
periphyton increased food supply increased as well and reproduction was better. The 
decline in the embryo number for the 20 mg∙L-1 group at day 56 could be connected to a 
change in quantity respective quality of food as well. Siehoff et al. (2009) stated that 
grazing on periphyton by D. magna can reduce periphyton thickness and change the 
Chapter 6 – Discussion 
 
140 
composition of periphyton communities towards less edible species (e.g. blue algae). In the 
20 mg∙L-1 treated microcosms cyanobacteria represented the most evenly distributed class 
of periphyton and therefore were probably ingested mostly by the snails, exceptionally as 
according to Aberle et al. (2005) P. antipodarum tends to ingest the better distributed food 
source under competition rather than the preferred one. The increased ingestion of blue 
algae especially of toxin forming species can have a huge impact on the reproduction of 
snails and thus could be considered as the main reason for a decline in embryo number 
(Lance et al. 2007). This could have been also a reason for the remote increase in the 
reproduction for the PC between day 42 and day 56, as in those samples cyanobacteria 
were also the predominant and best distributed class in periphyton. But as cyanobacteria 
abundance did not reach the same level like in the 20 mg∙L-1 group the impact on 
reproduction might have been less strong than in those treatments. 
The increase of embryo numbers without a fully developed shell over the whole study 
period in the Bti-treatments as well as the NC could be a hint for reaching a maximum of 
reproduction after 56 days indicating that on later sampling dates the total embryo 
numbers would have been stagnating or even (further) decreasing. Nevertheless, for the 
PC no such trend could be observed indicating that the applied low dose of E2 still could 
have a slight impact on the reproduction of P. antipodarum. It also might be associated 
with the difference in the diet of the snails though, as the higher numbers of embryos 
without fully developed shells were mainly observed in those microcosms that showed a 
high abundance and a more equal distribution of cyanobacteria. 
Overall, the results indicate that under the conditions provided for the duration of the 
study, a specific conclusion on the endocrine activity of VectoBac® TP cannot be stated. An 
increased reproduction for high doses of Bti (20 mg∙L-1) could be observed after 14 days, 
but not along the further treatment. One of the main factors that influenced the 
reproduction of P. antipodarum and made the results equivocal was probably the quantity 
and quality of food, which according to our data could have been indirectly influenced by 
the addition of VectoBac® TP (e.g. shift in composition of phytoplankton- and periphyton-
communities). 
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6.5.5 Summary 
The collected data revealed an effect of high concentrations (20 mg∙L-1) of VectoBac® TP on 
the community of phytoplankton that could not be observed in a fivefold lower 
concentration of 4 mg∙L-1 Bti. Though, a similar effect in the two treatments was detected 
for the composition of periphyton communities. For both phytoplankton and periphyton a 
shift from green algae (Chlorophyta) to blue algae (Cyanobacteria) occurred, thus the exact 
nature of these changes could not be clarified. A promoting effect on cyanobacteria seems 
likely but the role of zooplanktic organisms like D. magna in this alteration remains unclear. 
The application of VectoBac® TP showed no impact on zooplankton communities. A slightly 
higher abundance of D. magna was seen for the 4 mg∙L-1 concentration, but differences to 
the NC were only significant for one sampling day. Since an increase in fecundity and 
growth rates for D. magna under the influence of VectoBac® 12AS was already reported, 
an effect on D. magna populations in the present investigation also cannot be excluded. 
A clear endocrine activity of VectoBac® TP could not be stated by the use of P. 
antipodarum. Even though the data of the reproduction indicated a significantly higher 
number of embryos in the 20 mg∙L-1 samples of day 14, this observation could not be 
certified along the rest of the study. After 56 rather a significant decrease in reproduction 
could be observed. Differences between the treatment-groups seemed to be more likely 
associated with quantity and quality of the available food, which might be indirectly related 
to the application of VectoBac® TP (e.g. community shifts in phytoplankton and 
periphyton). Nevertheless a longer treatment time or a post-sampling might have led to 
more hints on an endocrine effect as six weeks after the end of the study very high 
densities of P. antipodarum were observed in the former 20 mg∙L-1 treatments. Therefore, 
a longer study period and observation seem to be necessary. 
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6.6 Conclusion 
Based on the data of this microcosm study it is possible that the application of high 
concentrations of VectoBac® TP, or the accidental release of high amounts, to an aquatic 
fresh water system might have an impact on the community structure of algae and 
invertebrates. But a shift in the ecosystem structure in routinely treated areas seems 
unlikely, since maximum concentrations of VectoBac® TP utilized for mosquito control in the 
investigated areas do not exceed 0.4 mg∙L-1 (personal communication with Dr. Norbert 
Becker, German Association for Mosquito Control, Speyer, Germany) and therefore are 10 
respective 50 times lower than the concentrations used in this study. 
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7.1 Abstract 
A broad range of anthropogenic micropollutants enters the aquatic ecosystems via various 
paths. The main sources are sewage effluents, industrial plants, agricultural holdings and 
surface runoff. Among those micropollutants the class of pharmaceuticals is of increasing 
concern. Due to the possible adverse effects on wildlife and humans, degradation and 
removal of pharmaceuticals and their metabolites during wastewater treatment is an 
important task. The here presented study was part of a proof of concept study at a medium 
sized country hospital in western Germany that investigated efficiency of advanced 
treatment processes to remove toxic potencies from highly contaminated sewage prior to 
discharge in the public sewerage system. Specifically, the efficiency of the advanced 
treatment processes membrane bioreactor (MBR) and ozonation to remove endocrine 
disruptive potentials was assessed. Estrogenic effects were characterized with the two 
receptor-reporter in vitro transactivation assays, Lyticase Yeast Estrogen Screen (LYES) and 
Estrogen Receptor mediated Chemical Activated LUciferase gene eXpression (ER CALUX®). In 
addition, the H295R Steroidogenesis Assay (H295R) was utilized to detect potential 
disruption of steroidogenesis. For raw sewage estrogenic activity (determined as estrogen 
equivalents (EEQs)) up to 35.8±8.7 ng∙L-1 EEQ (1x concentration) was determined by use of 
the LYES. After treatment by MBR and ozone the activity was significantly reduced to 1.2±0.4 
ng∙L-1 EEQ and 2.3±0.3 ng∙L-1 EEQ, respectively. Results were confirmed by use of ER CALUX® 
which detected activities of 0.2±0.11 ng∙L-1 EEQ (MBR) and 0.01±0.02 ng∙L-1 EEQ (ozonation). 
In contrast, treatment with ozone resulted in higher estradiol production and aromatase 
activity at 3x and higher concentrations in H295R cells. It is hypothesized that this is partly 
due to formation of active by-products during ozonation. Substance-specific analyses 
demonstrated efficient removal of most of the measured estrogenic compounds by 
ozonation. A comparison of the ER-mediated responses measured by use of the LYES and ER 
CALUX® with those from the chemical analysis using a mass-balance approach revealed 
estrone (E1) to be the main compound that caused the estrogenic effects. Overall, treatment 
of sewage by use of MBR successfully reduced estrogenicity of hospital effluents. However, 
after ozonation, effluents should undergo further investigations regarding the formation of 
endocrine active metabolites. The results obtained as part of this study demonstrated 
applicability of the used in vitro assays for monitoring of endocrine-modulating potency of 
treated sewage. 
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7.2 Introduction 
Pharmaceuticals are designed to cure and prevent diseases as well as to enhance quality of 
life for humans and domestic animals. However, beside their beneficial properties these 
substances bear the risk of unintended harmful effects on non-target organisms in the 
environment and on humans. Chronic exposures as well as the presence of mixtures of 
pharmaceuticals and their metabolites in effluents might pose risks to aquatic organisms. Of 
particular toxicological concern are pharmaceuticals that were designed to exert their 
biological activity at small concentrations, like the synthetic hormone 17α-ethinylestradiol 
(EE2) (Caliman & Gavrilescu 2009, Cooper et al. 2008, Escher et al. 2011). 
The two main sources of pharmaceuticals in the environment are municipal sewage 
treatment plants (STPs) and livestock breeding in agriculture. In addition, effluents from 
industrial plants, surface runoff and hospitals are known to be sources for pharmaceuticals 
in aquatic ecosystems (Escher et al. 2011, Fent et al. 2006, Fick et al. 2010, Moltmann et al. 
2007, Ort et al. 2010, Sim et al. 2011, Ternes et al. 2004, Verlicchi et al. 2010).  
Previous studies have demonstrated that elimination of pharmaceuticals during 
conventional wastewater treatment is not always sufficient (Daughton & Ternes 1999, 
Heberer 2002, Kasprzyk-Hordern et al. 2009, Ternes et al. 1999, Zwiener et al. 2001): In STP 
effluents concentrations of EE2 as great as 42 ng∙L-1 have been detected (Ying et al. 2002). In 
general, median concentrations do not exceed 3 ng∙L-1 (Heberer 2002) but due to the fact 
that the lowest observed effect concentrations for aquatic organisms are as little as 1 ng∙L-1 
(endpoint: reproduction of Pimephales promelas) (Caldwell et al. 2008) there is the potential 
for adverse effects on certain biota in receiving water bodies. For a few smaller rivers the 
sewage proportion sums up to 90 % in dry season (Brooks et al. 2006). 
Therefore, different secondary wastewater treatment steps, such as membrane bioreactors 
(MBR), adsorption techniques like activated charcoal (AC) and advanced oxidation processes 
like ozonation (O3), are currently being evaluated with respect to their efficiency to reduce 
concentrations of micropollutants in STP effluents. The MBR technique combines biological 
sewage treatment with membrane filtration (Chapman et al. 2004) which has been shown to 
significantly decrease concentrations of most of the tested pharmaceuticals. Ozone reacts 
directly over oxidation or via hydroxyl radicals with micropollutants (Huber et al. 2005, 
Huber et al. 2004) which have been shown to be efficient chemical pathways to remove the 
estrogenic potential of pharmaceuticals from waste-water (Gunnarsson et al. 2009, Hu et al. 
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2007, Laven et al. 2009, Rosal et al. 2010, Snyder et al. 2007, Stalter et al. 2010a, Stalter et 
al. 2010b, Zwiener & Frimmel 2000, Zwiener et al. 2002). However, it has been also 
demonstrated that treatment with ozone can form toxic transformation products (Petala et 
al. 2008, Stalter et al. 2010a, Stalter et al. 2010b).  
The present study is part of a larger proof of concept study to evaluate effectiveness of 
advanced sewage treatment methods with regard to the removal of pharmaceuticals from 
hospital sewage before discharge into the public sewerage. Specifically, the efficiency of a 
full scale membrane bioreactor (MBR) was investigated. In addition, four different advanced 
treatment methods – nanofiltration (NF), reverse osmosis (RO), ozonation (O3) and 
granulated activated carbon filtration (GAC) – were adopted (Pinnekamp et al. 2009).  
 
Figure 7.1 Water treatment cycle at Hospital and city of Waldbröhl. MBR=membrane bioreactor; NF / 
RO=nanofiltration / reverse osmosis; O3=Ozonation; GAK=granulated active carbon; STP=municipal 
sewage treatment plant; 1-3=sampling sites for testing of endocrine activity. (redrawn and adapted 
from(Pinnekamp et al. 2009)). 
 
The objective of this study was to determine efficiency of the MBR and the subsequent 
ozonation to remove endocrine-active chemicals from hospital effluents (Fig. 7.1). Endocrine 
activities were assessed by use of three in vitro bioassays: Two receptor-mediated, 
transactivation assays, the Lyticase Yeast Estrogen Screen (LYES) and Estrogen Receptor 
mediated Chemical Activated LUciferase gene eXpression (ER CALUX®) assay, and the H295R 
Steroidogenesis Assay (H295R) that detects effects on the steroid synthesis pathway (see 
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also chapter 1.4.3.2 and 1.5). Previous studies have determined the applicability of the 
selected assays for the evaluation of endocrine activity in (waste-)water samples (Gracia et 
al. 2008, Hecker & Hollert 2009, Kase et al. 2009, Leusch 2008, Leusch et al. 2010). As 
previously reviewed by Hecker & Hollert (2011) combined use of receptor-mediated and 
non-receptor-mediated-methods is necessary to enable an objective assessment of 
endocrine potentials in complex samples. Grund et al (Grund et al. 2011) demonstrated that 
the combination of receptor-mediated and non-receptor-mediated assays such as the LYES 
and the H295R was appropriate for a holistic evaluation of potential endocrine activity of 
complex environmental samples. Furthermore, in vitro assays for detection of estrogen 
receptor binding are part of the Endocrine Disruptor Screening Program (EDSP; US 
Environmental Protection Agency) as well as the OECD Conceptual Framework for the 
Testing and Assessment of Endocrine Disrupting Chemicals. This also applies to the H295R 
Steroidogenesis Assay (Hecker et al. 2011). Both LYES and ER CALUX® are currently part of a 
survey of the German Institute for Standardization (DIN, NAW 119), whereas the H295R has 
recently been validated as an OECD test guideline (OECD 456). 
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7.3 Material & Methods 
7.3.1 Chemicals 
All chemicals were at least reagent grade and purchased from Sigma Aldrich (Schnelldorf, 
Germany). The SteadyLite® kit was purchased from Perkin Elmer (Wiesbaden, Germany). 
Cell culture media were obtained from Sigma Aldrich (Schnelldorf, Germany), Invitrogen 
(Darmstadt, Germany) and Otto Nordwald (Hamburg, Germany). Standards for the 
implemented bioassays were prepared by the actual laboratory in charge.  
 
7.3.2 Sewage treatment methods 
The sewage treatment plant was equipped with mechanical pre-treatment, aeration and 
nitrification and installed directly at a middle sized county hospital in western Germany. 
Membranes of the bioreactor were directly included in the activated sludge basin which 
ensured a microfiltration of the biologically treated sewage. The filtration basin contained 
5 membrane modules with an overall surface of 1600 m2, which was connected to the 
activated sludge tank (Pinnekamp et al. 2009). Three MBR samples (A, B, C) were collected 
directly before ozonation. Subsequently to MBR treatment, the waste water was treated 
with two concentrations of ozone over different duration times: AO (7.5 mg·L-1 / 7.5 min), 
BO (7.5 mg·L-1 / 15 min) and CO (12.5 mg·L-1 / 7.5 min) (Pinnekamp 2009). Ozone was 
produced on-site by a generator using air feed gas (ITT WEDECO, OCS GSO 30 / AS 12) and 
afterwards injected into the MBR-treated wastewater stream. Ozone destruction in the off-
gas was achieved by a catalytic ozone destructor. Ozone was measured on-site using 
mobile ozone analyzers (Orbisphere 410 / 510, Hach, Germany). Directly after ozonation 
three samples with different ozone concentrations and duration times (AO, BO, CO) were 
collected. 
 
7.3.3 Sampling 
Samples of sewage were collected by personnel of the Institute of Environmental 
Engineering (ISA), RWTH Aachen University, Germany. Sampling was conducted with 
cooled automatic sampling devices. Composite samples from the membrane bioreactor as 
well as untreated sewage samples were collected flow-proportionally over a period of 24 h 
on three different dates (A, B, C). Due to the operational mode of the ozonation unit, 
samples after this treatment step were collected over a period of 8 h (AO, BO, CO). Based 
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on the experience from previous investigations the difference in sampling durations of pre- 
and post-treatment samples (24 hours versus 8 hours) should not significantly affect the 
sample composition (Pinnekamp 2009). 
 
7.3.4 Preparation of extracts 
Samples were extracted by use of solid phase extraction (SPE) with Oasis HLB cartridges 
(Waters) according to previously described methods by Bratkowska et al. (Bratkowska et al. 
2010) and Cahill et al. (Cahill et al. 2004) at the ISA. Briefly 2000 ml of treated sewage were 
concentrated by passing approximately one third of the sample through one of three 
separate cartridges and dried under a constant stream of nitrogen. For untreated sewage 
500 ml were extracted. Extracted substances were desorbed from cartridges with 
methanol and pooled. Extracts were dried under a gentle stream of nitrogen and 
redissolved in ethanol for dosing in bioassays and in methanol for chemical analyses 
(Pinnekamp et al. 2009). Final concentrations of original samples in the resulting extracts 
were 1,000-fold for the raw sewage and 2,000-fold for treated samples. Prior to use in 
assays samples were stored at -20°C. Because of the relatively large dilution factor of 
1,000-fold for the ER CALUX® and H295R assays, extracts were concentrated as much as 
33,000-fold by repeated drying under nitrogen and reconstitution in a smaller amount of 
solvent.  
 
7.3.5 LYES 
For principle and general implementation of the LYES see chapter 1.4.3.2 and 1.5.1 as well 
as chapter 2.2.2. In the present investigation, yeast cells were exposed to a dilution series 
(33x, 10x, 3.3x, 1x, 0.33x and 0.1x concentration) of the extracted waste water samples. 
Samples were at least tested in independent duplicates. 
 
7.3.6 ER CALUX®  
For principle and general implementation of the ER CALUX® see chapter 1.4.3.2 and 1.5.2 
as well as chapter 2.2.3. In the present investigation, cells were exposed to a dilution series 
(33x, 10x, 3.3x, 1x, 0.33x and 0.1x concentration) of the extracted waste water samples. 
Samples were tested in independent duplicates. 
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7.3.7 H295R  
For principle and general implementation of the H295R see chapter 1.4.3.2 as well as 
chapter 2.2.4. In the present investigation, the cells were exposed to a dilution series (33x, 
10x, 3.3x, 1x, 0.33x and 0.1x concentration) of the extracted waste water samples as well 
as the two reference substances Forskolin and Prochloraz. The amount of estradiol (E2) and 
testosterone (T) was determined in an enzyme-linked immunosorbent assay (ELISA). 
Furthermore, Aromatase enzyme activity was measured using a tritiated water (3H)-release 
assay. Due to the small amount of the samples only one measurement with three internal 
replicates could be conducted. 
 
7.3.7.1 3H-release assay for measurement of aromatase activity 
The 3H-release assay was conducted according to Higley et al. (2010). After incubation to 
the samples for 48 h cells were washed twice with 250 µl PBS. Subsequently, 250 µl 
supplemented medium containing 54 nM 1β-3[H]-androstenedione (Perkin Elmer, Boston, 
USA) were added to each well. Cells were incubated at 37oC under a 5 % CO2 in air 
atmosphere for 1.5 h. To stop the reaction plates were put onto ice for 5 min. 200 µl 
medium per well were transferred to a 1.5 ml vial (Eppendorf, Hamburg, Germany) 
containing 500 µl chloroform. Each vial was vortexed for 15 s and spun at 11 rpm for 
2 min. 100 µl of each supernatant were transferred to 1.5 ml vials containing 100 µl 
dextran coated charcoal. The vials were vortexed for 15 seconds and allowed to stand for 
5 min. Subsequently each vial was spun at 11 rpm for 15 minutes. 125 µl of the 
supernatants were transferred to scintillation vials (Research Products International 
Corp., Mount Prospect, USA) containing 4 ml scintillation cocktail (Bio-Safe II, Research 
Products International Corp., Mount Prospect, USA). The activity was counted for 10 min 
in a scintillation counter (LS 6500 Multipurpose SC, Beckman Coulter, Brea, USA). 
 
7.3.8 Viability Assay 
A MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) cell viability assay 
(see chapter 2.2.1) was conducted to assure that the test items did not cause non-specific 
cytotoxic effects in mammalian cell lines.  
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7.3.9 Substance specific analysis 
Parallel to the biological analysis samples were screened for selected estrogenic chemicals. 
The following compounds were quantified by means of liquid chromatography-tandem 
mass spectrometry (LC-MS2): estrone (E1), 17β-estradiol (E2), 17α-ethinylestradiol (EE2), 
17ß-estradiol acetate (E2-ac), estriol (E3), bisphenol A (BPA), nonylphenol (t-NP) and 
medroxyprogesterone acetate (MPro-ac). E1, E2 and E3 are the three main estrogens that 
are produced by humans. EE2, MPro-ac and E2-ac are applied in hormonal therapy. T-NP 
and BPA are xenobiotics with endocrine activity. All analyses were conducted by use of a 
LTQ Orbitrap hybrid mass spectrometer (Thermo Electron) in the ESI(±)-MS and MSn 
modes (Gebhardt & Schröder 2007).  
EEQs for the chemical analytical data (chemEEQs) were calculated based on the substance-
specific relative estrogenic potencies (REP) for the above-described compounds 
determined in previous studies with the Yeast Estrogen Screen (YES), the LYES and the ER 
CALUX® (Tab. 7.1).  
 
Table 7.1 Relative estrogenic potencies (REP) determined with the Lyticase Yeast Estrogen Screen 
(LYES) and the Yeast Estrogen Screen (YES) as well as the ER CALUX® 
  Substance 
 E1 E2 E2-ac EE2 E3 BPA t-NP MPro-ac 
REP  
Yeast Screens 
1.3E-01
a
 1 n.a. 7.3E-01
a
 n.a. 1.2E-04
b
 1.1E-05
a
 n.a. 
REP  
ER CALUX® 
1.2E-01
c
 1 n.a. 1.12
c
 1.3E-01
c
 1.13E-05
c
 3.7E-05
c
 n.a. 
aSchultis & Metzger (2004), bBeck et al. (2006), cHoutman et al.(2004); n.a.=data not available; 
E1=estrone; E2=17β-estradiol; E2-ac=17ß-estradiol acetate; EE2=17α-ethinylestradiol; E3=estriol; 
BPA=bisphenol A; t-NP=nonylphenol; MPro-ac=medroxyprogesterone acetate. 
 
7.3.10 Statistical analysis 
Data were analyzed statistically by use of SigmaStat 3.5 (Systat Software, San José, USA). 
Results are presented as mean ± standard deviation (SD) or standard error of the mean 
(SEM). To enhance the comparability of the assays results were normalized to the average 
value of the solvent controls (SC) and are expressed as fold change relative to the SC. All 
data were tested for normality and homogeneity of variance using the Kolmogorov-
Smirnov and Levene’s test. For data fulfilling the parametric assumptions a one way 
analysis of variance (ANOVA) followed by Dunnett’s post hoc test was used to determine 
treatments that differed significantly from the SC. When data did not meet parametric 
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assumptions, the non-parametric Kruskall-Wallis test followed by Dunn’s post hoc test was 
used. Differences were considered significant at p<0.05. To set a threshold (minimum fold 
change) from which the inductions are considered for evaluation the coefficient of 
variation (cv) was calculated for each assay. Threshold for the ER CALUX® and H295R was 
set to 1.2, for the LYES to 1.3. 
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7.4. Results 
7.4.1 LYES 
There were significant differences in the estrogenic potentials among sewage extracts from 
the different treatment groups when measured by use of the LYES assay (Fig. 7.2).  
 
Figure 7.2 Comparison of the Estradiol Equivalents (EEQs) of the three different sewage samples 
Raw (raw sewage before treatment), MBR (sewage after membrane bioreactor treatment) and O3 
(sewage after MBR and ozone treatment) in the LYES. Bars represent mean values of three 
independent sampling dates with SEM (error bars); * = significant differences to the SC (p<0.05). 
 
Extracted raw sewage showed the highest estrogenic activity, which was 35.8±8.7 ng∙L-1 in 
the 1x concentration (concentration of the native raw sewage). Nevertheless, raw sewage 
concentrations greater or equal to 1x caused significant cytotoxicity to yeast cells, and 
therefore, were excluded from further investigations.  
Samples subjected to MBR exhibited a significant, concentration-dependent increase in 
estrogen potency (Fig. 7.3). However, this response was significantly less than that in 
untreated sewage. Estrogenicity measured in the 1x concentration of MBR effluents was 
2.3±0.4 ng∙L-1 (A), 1.6±0.6 ng∙L-1 (B) and 2.1±0.6 ng∙L-1 (C). Compared to the solvent controls 
(SC) the 1x concentration caused 2-fold inductions of estrogen potency. Significant 
differences to the SC were detected after exposure of cells to 33x, 10x, 3.3x and 1x 
concentrations of samples B and C, respectively. For sample A significant differences were 
detected for concentrations between 3.3x and 33x. 
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Figure 7.3 Changes of ß-galactosidase production relative to solvent controls (SC = 1, - - -) in the 
LYES. MBR = membrane bioreactor; A, B, C = samples after MBR treatment; AO, BO, CO = samples 
after ozonation; 0.1 to 33-fold = concentration of the native sewage. Bars represent mean values of 
two independent experiments with SEM (error bars); missing bars represent not detectable data 
points; * = significant differences to the SC (p<0.05). 
 
After ozonation, estrogenic activity in all extracts decreased to less than 3 ng∙L-1 EEQ. No 
significant induction of an estrogenic effect was observed at any of the extract 
concentrations of samples AO, BO and CO.  
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7.4.2 ER CALUX® 
The ER CALUX® assay generally confirmed estrogenic responses detected by the LYES 
screen. All MBR treated samples showed a statistically significant increase in estrogenicity 
at concentrations greater or equal to 3.3x (Fig. 7.4). 
 
Figure 7.4 Changes of luciferase production relative to solvent controls (SC = 1, - - -) in the ER 
CALUX®. MBR = membrane bioreactor; A, B, C = samples after MBR treatment; AO, BO, 
CO = samples after ozonation; 0.1 to 33-fold = concentration of the native sewage. Bars represent 
mean values of two independent experiments with SEM (error bars); * = significant differences to 
the SC (p<0.05); ** = significant differences to the SC (p<0.01). 
 
However, there were no concentration-dependent increases in response at greater 
concentrations tested, and there appeared to be a trend towards lesser estrogenicity at the 
greatest concentration (33x) tested. Estrogenic activity as measured in the 1x extract was 
between 0.37±0.09 and 1.23±0.24 ng∙L-1 corresponding to average inductions between 
2.2- and 6.9-fold.  
There were no statistically significant inductions of estrogenicity after exposure to any of 
the extracts or dilutions tested for the ozone-treated samples, and EEQs were mostly 
below the detection limit of the assay (3.4x10-2 ng∙L-1) (Fig. 7.4). At the highest 
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concentrations (33x) there was a trend towards greater EEQs with values between 
2.82±0.82 and 4.57±0.34 ng∙L-1 and induction factors between 2.0 and 3.8-fold. The 
decreasing trend at greater concentrations after MBR treatment was no longer observed.  
 
7.4.3 H295R 
For the two highest concentrations no cytotoxicity could be detected in any sample  
Exposure to the MBR samples resulted in significant dose-dependent increases in 
production of E2 (Fig. 7.5).  
 
Figure 7.5 Changes in estradiol (E2) production relative to solvent controls (SC = 1, - - -) in the 
H295R. MBR = membrane bioreactor; A, B, C = samples after MBR treatment; AO, BO, CO = samples 
after ozonation; 0.33 to 33-fold = concentration of the native sewage. Bars represent mean values 
of one independent experiment with SD or SEM (error bars); * = significant differences to the SC 
(p<0.05); ** = significant differences to the SC (p<0.01). 
 
In contrast to the estrogen receptor-mediated responses ozonation did not further 
ameliorate endocrine-modulating potential but resulted in greater production of E2 at to 
some extent even lesser concentrations with LOECS of 10x and 3.3x for samples A, B and C. 
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Furthermore, significant increases in fold change of E2 were observed at the 10x 
concentrations in the ozone treated effluent samples when compared to those only 
subjected to the MBR. 
Similar trends could be observed for aromatase activity (Fig. 7.6). Up to concentrations of 
3.3x no significant differences between MBR treated samples and samples treated by MBR 
and ozone occurred. At concentrations of 10-fold and greater aromatase activity 
significantly increased in the ozone treatment group. However, the overall induction was 
relatively low with a maximum induction of 2-fold. 
 
Figure 7.6 Changes of aromatase activity relative to solvent controls (SC = 1, - - -) in the H295R. 
MBR=membrane bioreactor; A, B, C = samples after MBR treatment; AO, BO, CO = samples after 
ozonation; 0.33 to 33-fold = concentration of the native sewage. Bars represent mean values of two 
independent experiments with SEM (error bars); * = significant differences to the SC (p<0.05). 
 
The effect of the MBR samples on the production of T was weak but partly significant 
(Fig. 7.7). The lowest concentration caused significant increases of T production in sample 
A and B. For sample B even the one fold concentration had a significant effect. Therefore, 
the LOEC of the tested samples is 0.33 fold. Nevertheless, beginning with the 3.3 fold 
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concentration the effect seems to be reversed. For the ozonated samples only the highest 
concentration of sample C showed a significant decrease in T production.  
 
Figure 7.7 Changes in testosterone (T) production relative to solvent controls (SC = 1, - - -) in the 
H295R. MBR=membrane bioreactor; A, B, C = samples after MBR treatment; AO, BO, CO = samples 
after ozonation; 0.33 to 33-fold = concentration of the native sewage. Bars represent mean values 
of two independent experiments with SEM (error bars); * = significant differences to the SC 
(p<0.05). 
 
7.4.4 Substance specific analysis 
There were differences in concentrations of investigated substances as a function of 
treatment type (Tab. 7.2). E2, EE2 and E3 could not be detected either in influents or 
effluents of the ozone reactor (signals were less than the limit of quantification (LOQ)).  
Concentrations of E1 were reduced from values between 12.15 ng∙L-1 and 18.24 ng∙L-1 in 
MBR samples to concentrations less than the LOQ by ozone treatment. E2-ac was not 
found either in the influents of MBR A and MBR B, or the effluents of AO and BO. In the CO 
treatment group E2-ac levels were reduced by 39 %. t-NP was reduced by 3 % in the AO 
treatment group. However, after being subjected to BO and CO concentrations of t-NP 
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decreased by 44 % and 35 %, respectively. Concentrations of MPro-ac were reduced by 
95 %, 96 % and 77 % after treatment by AO, BO and CO, respectively. In contrast, BPA 
concentrations increased by 723 % and 822 % in the AO and BO treatment groups but were 
reduced concentrations less than the LOQ in the CO experiment. 
 
Table 7.2 Concentrations of selected substances in hospital sewage water before (MBR) and after 
various ozone treatments (AO, BO, CO) (1xconcentration; values represent mean values of 3 
replicates; < indicates the limit of quantification) (Pinnekamp et al. 2009) 
Treatment Substance [ng∙L-1] 
E1 E2 E2-ac EE2 E3 BPA t-NP MPro-ac 
MBR A 18.24 < 5 < 5 < 5 < 5 40.67 1347.73 127.46 
AOa < 5 < 5 < 5 < 5 < 5 293.83 1308.9 6.66 
MBR B 16.6 < 5 < 5 < 5 < 5 36.96 1644.3 139.85 
BOb < 5 < 5 < 5 < 5 < 5 303.71 912.83 5.86 
MBR C 12.15 < 5 16.06 < 5 < 5 28.89 1632.78 56.33 
COc < 5 < 5 9.87 < 5 < 5 < 15 1054.01 13.05 
a(7.5 mg∙L-1 / 7.5 min), b(7.5 mg∙L-1 / 15 min), c(12.5 mg∙L-1 / 7.5 min) 
E1 = estrone; E2 = 17β-estradiol; E2-ac = 17ß-estradiol acetate; EE2 = 17α-ethinylestradiol; 
E3 = estriol; BPA = bisphenol A; t-NP = nonylphenol; MPro-ac = medroxyprogesterone acetate 
 
Regarding MBR treated samples, calculated chemical EEQs (Tab. 7.3 a) based on results 
from previous studies with the LYES / YES and the analytical data were almost similar to 
EEQs calculated in this study with the LYES (1-fold concentration = 2.0±0.2 ng·L-1 EEQ). E1 
was the main substance that contributed to the theoretical EEQ. For BPA and t-NP only low 
theoretical EEQs were calculated. Concentrations of E2 and EE2 were both less than the 
LOQ. No data was available for E2-ac, E3 and MPro-ac. In case of the ozonated samples 
theoretical EEQs were lower than EEQs calculated with the LYES (1-fold concentration = 
0.9±0.2 ng·L-1 EEQ). Only BPA and t-NP could contribute to the theoretical EEQs. 
Regarding MBR treated samples, calculated chemical EEQs (Tab. 7.3 b) based on results 
from previous studies with the ER CALUX® and the analytical data were higher than EEQs 
calculated in this study with the ER CALUX® (1-fold concentration = 0.8±0.3 ng·L-1 EEQ). 
Again E1 was the main substance that contributed to the theoretical EEQs. For BPA and t-
NP only low theoretical EEQs were calculated. Concentrations of E2, EE2 and E3 were less 
than the LOQ. No data was available for E2-ac and MPro-ac. In case of the ozonated 
samples theoretical EEQs were in the same range as EEQs calculated with the ER CALUX® 
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(1-fold concentration = 0.02±0.03 ng·L-1 EEQ). Again only BPA and t-NP could contribute to 
the theoretical EEQs. 
 
Table 7.3 Calculateda chemical estradiol equivalents (chemEEQs) in hospital sewage samples 
(a) LYES, 1-fold concentration 
Treatment 
Substance [ng∙L-1] Total 
E1 E2 E2-ac EE2 E3 BPA t-NP MPro-ac  
MBR A 2.371 < 5 n.a. < 3.65 n.a. 0.005 0.015 n.a. 2.391 
AO < 0.65 < 5 n.a. < 3.65 n.a. 0.035 0.014 n.a. 0.049 
MBR B 2.158 < 5 n.a. < 3.65 n.a. 0.004 0.018 n.a. 2.18 
BO < 0.65 < 5 n.a. < 3.65 n.a. 0.036 0.01 n.a. 0.046 
MBR C 1.58 < 5 n.a. < 3.65 n.a. 0.003 0.018 n.a. 1.601 
CO < 0.65 < 5 n.a. < 3.65 n.a. < 0.002 0.012 n.a. 0.012 
MBR A-C         2.057 
AO-CO         0.036 
 
(b) ER CALUX®, 1-fold concentration 
Treatment 
Substance [ng∙L-1] Total 
E1 E2 E2-ac EE2 E3 BPA t-NP MPro-ac  
MBR A 2.19 < 5 n.a. < 9.2 < 0.18 0,0005 0,050 n.a. 2,24 
AO < 0.08 < 5 n.a. < 9.2 < 0.18 0,003 0,048 n.a. 0,05 
MBR B 1.99 < 5 n.a. < 9.2 < 0.18 0,0004 0,061 n.a. 2,05 
BO < 0.08 < 5 n.a. < 9.2 < 0.18 0,003 0,034 n.a. 0,04 
MBR C 1.46 < 5 n.a. < 9.2 < 0.18 0,0003 0,060 n.a. 1,52 
CO < 0.08 < 5 n.a. < 9.2 < 0.18 < 0.0007 0,039 n.a. 0,04 
MBR A-C         1,94 
AO-CO         0,04 
aCalculated EEQ = Relative estrogenic potency x concentration [ng·L-1]; b”Total” calculated only from 
values that lay above the limit of quantification; n.a. = data not available; E1 = estrone; E2 = 17β-
estradiol; E2-ac = 17ß-estradiol acetate; EE2 = 17α-ethinylestradiol; E3 = estriol; BPA = bisphenol A; t-
NP = nonylphenol; MPro-ac = medroxyprogesterone acetate 
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7.5 Discussion 
Advanced waste-water treatment with MBR and ozonation significantly ameliorated 
estrogen potencies of hospital sewage effluents. Significant original estrogen activity of 
untreated sewage was mainly reduced after treatment by MBR as determined both by the 
LYES and ER CALUX®. These findings are consistent with those of several studies that focused 
on removal of estrogen agonists through MBR treatment (Coleman et al. 2009, Holbrook et 
al. 2002, Hu et al. 2007). Advantages of this technique with respect to the removal of 
endocrine disrupting compounds (EDCs) are (1) the ability to act as a barrier to solids which 
usually would bind a large number of EDCs, (2) the retention capacity of the membrane 
itself, and (3) the extended sludge retention duration which gives time for additional 
biological degradation (Caliman & Gavrilescu 2009). Subsequent treatment with ozone led to 
a further decrease of estrogenic activity as determined with the LYES and ER CALUX® assays 
(EEQ < 1 ng∙L-1). This is likely due to the fact that ozonation oxidizes phenolic moieties, which 
are critical for binding of compounds like E2, EE2 or E1 to the ER (Caliman & Gavrilescu 2009, 
Huber et al. 2004, von Gunten 2003). Other authors found similar reductions of estrogenic 
activity after treatment with ozone (Ternes et al. 2003).  
Both LYES and ER CALUX® were able to detect estrogenic activity at concentrations in the 
ng∙L-1 range. However, the concentrations which the assays were able to detect differed. 
With a calculated EC50 of 1.8±0.5 ng E2∙L
-1 the ER CALUX® was able to reliably detect very 
low concentrations of estrogenic active substances. For samples with higher concentrations 
of estrogenic active substances such as raw sewage extracts the LYES with a calculated EC50 
of 9.4±0.4 ng E2∙L-1 was more suitable. These findings correspond with findings of other 
studies that investigated the applicability of estrogen receptor-based in vitro assays for the 
detection of estrogenic substances (Kase et al. 2009, Leusch 2008, Leusch et al. 2010). 
Concentrations of EEQs determined by use of the LYES and ER CALUX® varied by as much as 
10-fold. Similar variations between these two assays have been described previously (Legler 
et al. 2002a, Leusch 2008, Leusch et al. 2010). There are several theories regarding causes 
for these differences. These include: (1) Mammalian cell lines such as T47Dluc are able to 
metabolize estrogenic active substances and therefore minimize their effects (Legler et al. 
1999), yeasts are lacking this ability (Connolly et al. 2011). (2) The yeast cell wall can act as a 
barrier for certain substances (Legler et al. 2002a). In a complex sample this could also apply 
to substances that inhibit ER binding. (3) It has been hypothesized that anti-estrogens can 
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act over down regulation of the ER in mammalian cell lines and that this mechanism does 
not occur in yeast cells (Dudley et al. 2000). It has been shown that some of these inhibitory 
substances, for example the selective ER modulator tamoxifen, act as ER antagonists in the 
ER CALUX® and as agonists in the YES (Legler et al. 2002a).  
The Yeast Estrogen Screen is a well-established and common in vitro assay for the detection 
of estrogenic active substances. Its advantages are the large data base for single substances 
as well as mixtures, that the test is easy to perform, relatively robust and comparatively 
cheap (Schultis & Metzger 2004). However, structural differences between yeast cell walls 
and cell membranes of animal cells have been hypothesized to cause differences in the 
permeability for some hazardous substances, thus, resulting in a potentially limited 
predictability to test systems using animal cells (Kase et al. 2009, Legler et al. 2002c). 
Furthermore, yeasts are not able to metabolize substances in the same way like some 
mammalian cell lines such as the here used T47D (Connolly et al. 2011, Legler et al. 1999). In 
addition, conventional YES systems have limited sensitivity as characterized by a relatively 
great lowest observed effect level (LOEL) of as much as 10 ng∙L-1 E2 as well as a method 
quantification limit (MQL) of as much as 5 ng∙L-1 (Kase et al. 2009, Leusch 2008, Leusch et al. 
2010). Therefore, the modified LYES with a LOEC of 0.5 ng∙L-1 (Schultis & Metzger 2004) was 
used in the present study. Whereas this version of the assay is significantly faster to perform 
and is up to 20-fold more sensitive than the conventional YES, there are only few chemicals 
and complex samples that have been tested so far. One issue that has been identified in 
context with all YES screens is their relatively great sensitivity to cytotoxic chemicals, which 
limits their utilization with certain compounds (Leusch et al. 2010). This issue could also be 
observed in the present study. But with regard to cytotoxicity of the raw sewage extract, the 
LYES was less sensitive than the ER CALUX® which could not be applied to extracted raw 
sewage at all. Furthermore, it was shown that the robustness of the LYES in the present 
study was limited due to high background activities of the negative control with tap water. 
The ER CALUX® is a commercially available assay with a harmonized standard operating 
protocol and a profound database. Amongst others, the assay has been successfully used to 
predict the estrogenic activity of sewage as well as surface waters (Bogers et al. 2007, 
Lamoree et al. 2010, Leusch et al. 2010, Murk et al. 2002, Van der Linden et al. 2008). It is 
easy to perform, robust and highly sensitive (LOEC <0.5 ng∙L-1, MQL 0.1 ng∙L-1) (Kase et al. 
2009, Leusch 2008, Leusch et al. 2010). As a human cell line, the T47Dluc cells are able to 
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identify samples which have the potential to interact with the mammalian estrogen 
receptor. Nevertheless, the transferability to aquatic organisms like fish and invertebrates is 
not always given. For example, the potency of E1 is similar to that of E2 in fish in vivo 
whereas the potency of E2 in the ER CALUX® is greater than that of E1. The distinctions may 
partly be linked to species differences regarding transcription factors as well as the 
regulation of ER binding and transactivation (Legler et al. 2002b, Petit et al. 1997). In the 
present study the ER CALUX® assay was stable and detected estrogenic potentials with great 
sensitivity.  
Though ozonation almost completely removed the estrogenic activity from the tested 
effluents, the H295R steroidogenesis assay indicated that ozonation could enhance the 
presence of compounds that stimulate endogenous estrogen production as well as 
aromatase activity. It is suggested that this could be due to generation of reactive 
metabolites. This clearly indicates that objective assessment of endocrine activity of 
effluents requires inclusion of endpoints other than estrogen receptor binding activity. To 
date, most in vitro assays for the detection of endocrine disruption focus on the steroid 
hormone receptors. Alteration of the endogenous synthesis pathways of sex steroids 
represents a particularly relevant mode of endocrine disruptors because induction of the 
formation of e.g. endogenous estrogens such as observed in this study has the potential to 
potentiate estrogenic effects by increasing the endogenous estrogen pool. Changes of 
testosterone production were only weak but partly significant. While the low extract 
concentrations of MBR treated sewage caused weak but significant increases of T production 
the effect seemed to be reversed in higher concentrations. But only the highest 
concentration of sample CO caused a significant decrease of T production. These outcomes 
correspond with the significant increase of aromatase and estradiol production after 
exposure to the higher concentrated samples. Nevertheless, as already mentioned the 
changes in T production were only weak and there was no clear dose-dependent 
relationship. 
The H295R Steroidogenesis Assay has been shown to be a reliable and relatively fast 
screening method with the potential to predict effects to higher organizational levels (see 
also chapter 3) (Hecker et al. 2011). However, considering that the H295R cells are of human 
origin (as in case of the T47Dluc cells), transferability to aquatic organisms like fish and 
invertebrates is not always given (Ji et al. 2010, Villeneuve et al. 2007). The increase of 
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estradiol production after ozonation could partly be linked to the increasing aromatase 
activity. The fact that ozonation of effluent increased estradiol production and aromatase 
activity compared to the MBR only treatment indicates that active metabolites that can 
stimulate aromatase activity may have been formed. One possible mechanism would be the 
induction of hormone-responsive adenylate cyclases. This would result in the increase of 
intracellular cyclic adenosine monophosphate (cAMP), which binds and up-regulates genes 
with cAMP responsive elements, like CYP19A1 (Higley et al. 2010, Watanabe & Nakajin 
2004). It is also possible, that metabolites and conjugates of aromatase inducers occurred in 
the MBR-treated sewage. Ozone might have oxidized those metabolites and conjugates back 
to the parent substances. However, further studies are required to investigate the specific 
mechanisms by which this stimulation occurred. Similar differential endocrine activities of 
environmental samples were reported by Grund et al. (Grund et al. 2011) who found 
endocrine effects in sediment samples that could not be detected in the LYES but in the 
H295R. Furthermore, Stalter et al. (Stalter et al. 2010a, Stalter et al. 2011, Stalter et al. 
2010b) demonstrated in several studies that ozone treatment of sewage reduced the 
estrogenicity but had negative effects on the reproduction of the oligochaete worm 
(Lumbriculus variegatus) as well as the development of rainbow trout (Oncorhynchus 
mykiss) in the fish early life stage toxicity test (FELST) which possibly could be linked to the 
formation of toxic metabolites during ozonation. However, it should be noted that, due to 
the small number of replicates (one independent replicate with three internal replicates), 
results obtained in this study should be confirmed by further investigations with at least two 
independent replicates. 
Despite the suboptimal limits of quantification, that make the interpretation of the results 
more difficult, several conclusions can be drawn from the substance-specific analysis. 
Sewage is a complex mixture of compounds and it is still too little known about potential 
cross effects that might have affected the ozonation process. For example, a greater 
quantity of anti-oxidants would influence ozonation and its elimination efficiency. The 
increase in concentrations of BPA in AO and BO (Tab. 1) might be attributed to dissolution of 
BPA from polycarbonate and polyvinyl chloride (PVC) plastic parts in the ozone reactor and 
pipes (Howdeshell et al. 2003) as the BPA concentration in the ozonated samples decreases 
with operation time of the reactor (BO>AO>CO). It is also possible, that metabolites of BPA 
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and conjugates occurred in the influents, but were not measured. Subsequently ozone might 
have oxidized those metabolites and conjugates back to BPA.  
Based on the results obtained during this study it became obvious that compounds such as 
BPA and t-NP that were present at the greatest concentrations only contributed a small 
proportion of the biologically determined estrogenic activities measured with the bioassays 
(Tab. 3). In contrast, compounds for which concentrations were consistently less than the 
LOQ (E2, EE2) might have represented a significant proportion of observed concentrations of 
EEQs since the LOQs for E2 and EE2 were in a range where effects in bioassays and on 
wildlife are to be expected (Caldwell et al. 2008, Legler et al. 1999). E1 is the only compound 
that was detectable at significant concentrations, and for which also chemical EEQs (chem 
EEQs) could be calculated. Concentrations of EEQs as determined by the LYES (Fig. 3) were in 
a similar range and directly comparable to the chemEEQ values calculated for E1 based on 
the chemical equivalency factors for this compound (Tab. 7.3 a), indicating that the majority 
of EEQs measured by this assay can be explained by this hormone. No relative estrogenic 
potencies are available for E2-ac and MPro-ac. E3 concentrations were less than the LOQ. 
Otherwise, calculated concentrations of chemEEQ as determined by use of the ER CALUX® 
(Tab. 7.3 b) were higher than estrogenic activity measured in the current study. This could be 
due to antiestrogenic substances that could be present in the complex samples. As already 
mentioned above, the selective ER modulator tamoxifen, acts as ER antagonists in the ER 
CALUX® and as agonists in the YES (Legler et al. 2002a). Therefore, it could have enhanced 
the estrogenic activity of the samples in the LYES while it inhibited the activity of estrogenic 
substances like E3 in the ER CALUX®. Again, potential effects caused by EE2 (< 9.2 ng L-1), E2 
(< 5 ng∙L-1), E2-ac (n.a.), E3 (< 0.18 ng∙L-1) and MPro-ac (n.a.) were not considered because 
chemical analytical values for these compounds were less than the method detection limit.  
Concentrations of chemEEQs (Tab. 3a) were less than 0.9±0.3 ng∙L-1 as determined in the 
LYES in ozonized effluents (AO-CO). However, most chemicals that could contribute to the 
concentration of chemEEQs were not detectable. Therefore, the inability to account for the 
biological effectiveness might be explained by the low sensitivity of the used analytical 
approach, which suggests that estrogens with greater endocrine-modulating potencies, such 
as EE2 and E2, could be present at concentrations less than the LOQ but in quantities 
potentially contributing to the positive response in the bioassay (Hollert et al. 2005). In 
Chapter 7 – Discussion 
 
170 
contrast, concentrations determined in the ER CALUX® (0.02±0.04 ng∙L-1) were in the range 
of the theoretical EEQ (Tab. 3b).  
The results of the instrumental quantifications as the results from the bioassays indicate that 
ozonation is an efficient method to remove most of estrogenic active substances. However, 
there was no trend towards greater efficiencies at greater ozone doses or longer ozonation 
times, and therefore, the recommended maximum dose and time for elimination of (xeno-) 
estrogens from hospital effluents based on the results of this study are 7.5 mg∙L-1 and 7.5 
minutes, respectively. 
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7.6 Conclusion 
Results of the present study confirmed the necessity of advanced sewage treatment 
processes to minimize the estrogenic burden of highly charged sewages such as hospital 
waste-waters. The advantage of membrane bioreactors as well as the suitability of ozone 
treatment could be verified with regard to this specific effect. However, assessment of 
endocrine activities based on the sole assessment of receptor based assays would have been 
insufficient to objectively characterize the overall endocrine potential of the analyzed 
samples. In fact, advanced treatment of effluents using ozonation appeared to result in 
greater endogenous estrogen production, potentially due to generation of reactive 
metabolites by this treatment step. Therefore, a combination of receptor mediated assays 
such as the LYES or ER CALUX® and non-receptor mediated assays assessing effects on 
hormone production such as the H295R Steroidogenesis Assay to enable objective 
assessment of the endocrine disrupting potential of complex samples is recommended. In 
addition, further expansion of endocrine bioassay batteries by inclusion of androgen and 
thyroid hormone receptor assays is necessary to screen for potential endocrine disruptors.  
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8.1 Suitability of the selected bioassays 
One important issue of the present study was the suitability of the bioassays due to the 
different sample matrices investigated. 
 
8.1.1 In vitro bioassays 
The selected in vitro bioassays were suitable for the detection of endocrine activity in 
different sample matrices from the aquatic environment. Additionally, single substances 
could be investigated regarding their potential to act as endocrine disruptors.  
The receptor mediated bioassay ER CALUX® was able to detect estrogenic activity in all 
matrices used. These included groundwater, surface water as well as sewage and therefore 
covered low to medium contaminated (fresh)water samples. Additionally, in case of the 
hetero-PAHS, the estrogenic activity of single substances which require metabolic 
activation could be detected. With the LYES investigation of medium to highly 
contaminated water samples was possible, low contaminated water samples could not be 
investigated due to the high limit of detection (LOD) as well as the relatively high 
estrogenicity of the negative control. The H295R was applicable for medium to highly 
contaminated samples as well as single substances. Surface water samples were not tested 
wherefore in this context a statement is not possible. Nevertheless, previous studies 
support the usefulness of the H295R even for such low contaminated samples (Gracia et al. 
2008). 
These findings are in accordance to further studies regarding the usefulness of the selected 
in vitro bioassays (Hecker & Hollert 2011, Kase et al. 2009, Leusch 2008, Leusch et al. 2010). 
 
8.1.2 Reproduction test with Potamopyrgus antipodarum 
To the best of our knowledge, the Pa-Repro was integrated into a microcosm study for the 
first time. Therefore, the adaption of the test organism to the artificial environment of the 
microcosm was not predictable. Considering the uncertainties of the present study, the 
suitability of the selected test species cannot be completely evaluated.  
Further studies have proven the suitability of the Pa-Repro for the detection of endocrine 
activity in the aquatic environment (Jobling et al. 2003, Mazurova et al. 2008, Schmitt et al. 
2011). 
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8.2 Performance of the selected bioassays 
Apart from the suitability to investigate different sample matrices, the performance of the 
selected bioassays in the present study was examined. Overall, performance was good but 
differed between the test systems.  
 
8.2.1 LYES 
Performance of the LYES in the present study ranged from moderate to good.  
The median EC50 of 82 ± 42 pM (22 ± 11 ng·L
-1 estradiol equivalents (EEQ)) is within in the 
range (48-147 pM) of other studies using (nearly) the same test system (Schmitt et al. 2008, 
Schultis & Metzger 2004, Wagner & Oehlmann 2009). The high SD of the calculated EC50 in 
the present study is a result of different time points of measurement after exposure to the 
CPRG solution. For the study dealing with the cleaning performance of sewage treatment 
techniques (Chapter 7) optimal curve parameters (low Bottom, high Top, high goodness of 
fit (R2)) were regularly reached at a point where the EC50 was around 40 pM. In case of the 
other two studies using the LYES (Chapter 4 and 5) optimal curve parameters were reached 
at a point where the EC50 was around 100 pM. This shift of the EC50 relating to different 
time points of measurement and incubation was already observed and discussed by 
Beresford et al (2000). Hence, for further studies a fixed time point of measurement and / 
or a fixed value for the EC50 of the standard should be set.  
In contrast to chapter 5 and 7, in chapter 4 calculations for the E2 standard and the tested 
chemicals were performed according to Villeneuve et al. (2000). Therefore, instead of EEQs 
relative potency estimates (EEFs) were calculated. Data were normalized by dividing the 
measured values by the maximum induction of the E2 standard (E2-max.) to scale all values 
from zero (solvent control) to one (E2-max.). Scaled values were then plotted and the 
standard curve was fitted where top and bottom of the curve were set to zero and one, 
respectively. In case of the EEQ calculations the top of the standard curves was 
interpolated from the measured values. Due to these changes in the standard curve 
calculation, EC50 values differed by a factor of two. From the same raw data set Brinkmann 
& Maletz et al. (2014) calculated an EC50 of 57.7 ± 0.7 pM while in the current study, to 
receive the mean EC50 of all included LYES assays, an EC50 of 108 ± 25 pM was calculated. 
This leads again to the recommendation that standardized analysis methods should be 
implemented for this test system. 
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The calculated LOD of 17.74 ± 6.73 pM (4.83 ± 1.8 ng·L-1 EEQ) as well as the LOQ of 
38.13 ± 5.6 pM (10.39 ± 1.53 ng·L-1 EEQ) are also in accordance with further studies using 
nearly the same (Schultis & Metzger 2004) or similar (Leusch 2008) test setups. 
Nevertheless, regarding the often very low concentrations of estrogenic active substances 
in the aquatic environment (for example 0.01-1.3 ng·L-1 E2 in groundwater (Vulliet et al. 
2008)) as well as the detected lowest observed effect concentrations (LOEC; for example 
0.5 ng·L-1 E2 for the fathead minnow (Miles-Richardson et al. 1999)) a LOD of around 5 ng·L-
1 is too high to detect all relevant estrogenic contaminations. 
One major drawback of the here used LYES is the high background noise of the solvent 
(negative) control. The mean of the control was in a range between 2.23 ± 0.99 ng·L-1 EEQ 
(chapter 7) and 4.45 ± 0.49 ng·L-1 EEQ (chapter 5). Therefore, samples with low but 
eventually significant estrogenic activity could be classified as negative because measured 
EEQs did not differ from the negative control. As the test system is designed to investigate 
water samples (Wagner & Oehlmann 2009), uncontaminated reference water for the 
control is necessary. Internal investigations of ultrapure water (data not shown), deionized 
water and tap water in our laboratories revealed that tap water is the least contaminated. 
This is also in accordance with the investigations of Wagner & Oehlmann (2009). 
Nevertheless, as already shown background noise (estrogenic effectiveness) of the tap 
water is still quite high. Contamination of the tap water as well as the even higher 
contamination of the ultrapure water and the deionized water could have been caused by 
plastic parts of the water pipes and / or the filter systems. Krishnan et al. (1993) as well as 
Howdeshell et al. (2003) could show that the xenoestrogen bisphenol A (BPA) is released 
from polycarbonate based material (flasks and cages) into water. Additionally Wagner & 
Oehlmann (2009, 2011) could show that estrogenic active substances are released from 
polyethylene (PET) bottles. Recently, Zhang et al. (2011) could show that comparatively 
high amounts of BPA leached from standard plastic laboratory equipment into the test 
medium of the H295R. Additionally, the xenoestrogen nonylphenol (NP) which is used as 
stabilizer and antioxidant in plastics, including polyvinyl chloride (PVC), polyethylene, 
polystyrene, and rubber-based products (Snedeker & Hay 2014) has been found to leach 
from standard plastic laboratory equipment as well (Soto et al. 1991).  
Another drawback of yeast based test systems such as the here used LYES, is the lack of 
vertebrate like metabolic capacities for xenoestrogens. As stated in chapter 4 the 
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estrogenic activity of hetero-PAHs could not be detected with the LYES because the activity 
was caused by metabolites only. For strains of the yeast species Saccharomyces cerevisiae, 
it is generally assumed that they lack the capability of xenoestrogen metabolism (Connolly 
et al. 2011). In contrast, Odum et al. (1997) stated that yeasts were capable for detecting 
the estrogenic potential of methoxychlor (MXC), which has only low affinity for the ERα 
itself (Gaido et al. 2000), due to a certain metabolic capacity. Additionally, a few other 
studies also detected estrogenic activity of MXC in yeast test systems (De Boever et al. 
2001, Folmar et al. 2002, Gaido et al. 1997). Nevertheless, other studies could not confirm 
this estrogenic activity (Rehmann et al. 1999, Shelby et al. 1996). Overall, the present study 
supports the assumption that yeasts of the species Saccharomyces cerevisiae are not 
capable for metabolism, at least not in case of the investigated hetero-PAHS. Therefore, a 
metabolic activation step, e.g. by adding of the rat liver S9 fraction, to detect estrogenic 
active substances and samples, is strongly recommended (Okuda et al. 2011). In case of 
other yeast species (e.g. Candida) biotransformation of polycyclic aromatic hydrocarbons 
(e.g. phenanthrene) has already been described (MacGillivray & Shiaris 1993). 
Further advantages and disadvantages of the LYES have already been discussed in chapter 
7 (see section 7.5). Overall, results of the present study revealed that this test system 
needs some improvements regarding implementation as well as data analysis (see also 
section 8.3). Currently, a working group on behalf of the German Institute for 
Standardization (DIN) is preparing a standard operation guideline (DIN standard) which also 
will be transformed to a standard of the International Organization for Standardization 
(ISO) (Kunz et al. 2014). As a part of the standardization the performance of the test system 
should be improved and the outcome should be validated by an accompanying round-robin 
study. 
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8.2.2 ER CALUX® 
Performance of the ER CALUX® in the present study could be evaluated as good to very 
good.  
The median EC50 of 7 ± 2 pM (2 ± 0.5 ng·L
-1 EEQ) is within the range (2-6 pM) of other 
studies using the same test system (Legler et al. 1999, Leusch 2008, Murk et al. 2002). 
Together with the mean LOD of 0.6 ± 0.3 pM (0.2 ± 0.1 ng·L-1 EEQ) as well as the mean LOQ 
of 1.2± 0.6 pM (0.3 ± 0.2 ng·L-1 EEQ), which are also in the range of further studies (Legler 
et al. 1999, Leusch 2008, Murk et al. 2002), this confirms the applicability of the ER CALUX® 
for measurement of estrogenic activity in the low ng·L-1 range. Again, the data analysis in 
chapter 4 revealed data which differed from the data analysis used in chapter 5 and 7. But 
in case of the EC50 of the ER CALUX® the differences were much lower than for the LYES. 
From the same data set Brinkmann & Maletz et al. (2014) calculated an EC50 of 10 ± 8 pM 
(3 ± 2 ng·L-1 EEQ) while the EC50 calculated for the comparison of all data in this chapter 
was 9 ± 4 pM (3 ± 1 ng·L-1 EEQ). This observation leads to the conclusion that the higher 
stability of the mammalian cell based test system, in contrast to the yeast cell based test 
system, generates more reliable data, even when different ways of analysis are applied.  
In chapter 4, it could be shown that the ER CALUX® with the T47Dluc cell line is capable of 
transforming non-estrogenic active substances (in this case hetero-PAHs) to estrogenic 
active metabolites. As already described by several authors (Kuil et al. 1998, Legler et al. 
1999, Piao et al. 1997, Spink et al. 1998), the T47D cell line expresses at least some 
metabolic enzymes (e.g. CYP1A and CYP1B as well as 17ß-HSD) and therefore is capable for 
metabolism of xenoestrogens. Nevertheless, to enhance the predictive character of this in 
vitro test system for effects in vivo (see also section 8.4) an additional biotransformation 
step such as the pre-incubation of the samples with rat liver fraction S9 could prove 
necessary (Legler et al. 2002).  
Further advantages and disadvantages of the ER CALUX® have already been discussed in 
chapter 7 (see section 7.5). Overall, results of the present study revealed that this test 
system is a sensitive and reliable tool to detect estrogenic active substances in the whole 
aquatic environment. Additionally, also for this test system a working group on behalf of 
the German Institute for Standardization (DIN) is preparing a standard operation guideline 
(DIN standard) which also will be transformed to a standard of the International 
Organization for Standardization (ISO) (Kunz et al. 2014). 
Chapter 8 – Performance of the selected bioassays 
 
180 
8.2.3 H295R 
Overall, performance of the H295R in the present study was good. 
Actual quality criteria of the H295R are given in the OECD guideline (OECD 2011). However, 
during the application of the test system in the current study prior to publication of the 
guideline quality criteria according to the standard operating procedure of the Aquatic 
Toxicology Laboratory, Michigan State University, USA (Hecker et al. 2007c) were followed. 
Criteria for the induction (inhibition) of estradiol or testosterone production by the 
standard substances prochloraz and forskolin were always met. Additionally, criteria for the 
coefficient of variation (CV) within and between the replicas were met for the majority of 
the samples. Basal hormone production of the cells was always ≥ 2000 ng·L-1 (testosterone) 
or ≥ 50 ng·L-1 (estradiol), respectively. 
Nevertheless, data revealed for the production of testosterone in chapter 7 did not follow 
clear dose-response relationships but undulated through the tested concentrations. While 
U-shaped or biphasic dose-response relationships are frequently observed in toxicological 
studies (Calabrese & Baldwin 2003) undulating curves are quite problematic to interpret. 
So far, the source of this effect is not confessed and therefore, parts of the data revealed 
with the H295R in the current study are not suitable for a reliable risk assessment. 
 
8.2.4 Pa-Repro 
Overall, performance of the Pa-Repro in the present study was only moderate. This is most 
likely a consequence of the introduction of the species into a multispecies-microcosm 
system without external food supply. While the nutritional requirements for laboratory 
breeding in glass vessels are defined in the standard operating procedure (Schmitt et al. 
2013) knowledge about the appropriate amount of periphyton cover per adult snail in the 
presence of competitors like D. magna is lacking. As a consequence, the food supply 
seemed to be limited and therefore also the reproduction of P. antipodarum. Prior to 
further studies, the nutritional requirements of the test species in complex microcosm 
systems have to be investigated. Additionally, the use of 17ß-Estradiol (E2) as positive 
control in the test system hast to be reconsidered. The absence of a significant effect on 
the reproduction could be due to the fast biodegradation of E2. For further studies the use 
of the much more resistant synthetic estrogen 17α-Ethinylestradiol (Jürgens et al. 2002) is 
recommended.  
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8.3 Data analysis 
According to Wagner et al. (2013) there are three common mathematical models to derive 
estradiol equivalents from bioassay data: Linear interpolations, nonlinear interpolations and 
ratios of effect concentrations (ECx ratio). In the present study the nonlinear as well as the 
ECx ratio model to determine estrogenic activities have been applied.  
In chapter 5 and 7 estradiol equivalents (EEQs) were calculated using the nonlinear model 
(see chapter 2.2.1.3 and 2.2.2.3). Therefore, measured values for the regarding sample 
concentrations were inserted into a conversion of the corresponding standard curve (Eq. 8.1 
and 8.2).  
 
𝐸𝐸𝑄 (𝑀) = 10
(𝑙𝑜𝑔𝐸𝐶50𝐸2 – 
𝑙𝑜𝑔(
𝑇𝑂𝑃𝐸2 – 𝐵𝑂𝑇𝑇𝑂𝑀𝐸2
𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 𝑂𝐷540𝑆𝑎𝑚𝑝𝑙𝑒 – 𝐵𝑂𝑇𝑇𝑂𝑀𝐸2
 − 1)
𝑆𝐿𝑂𝑃𝐸𝐸2
)
  Equation 8.1 (LYES) 
 
𝐸𝐸𝑄 (𝑝𝑀) = 𝐸𝐶50𝐸2 (((
𝑀𝑎𝑥𝐸2
𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 𝑅𝐿𝑈𝑆𝑎𝑚𝑝𝑙𝑒
) − 1)
1
𝑆𝑙𝑜𝑝𝑒𝐸2
)  Equation 8.2 (ER CALUX®) 
 
The equivalent concentration of every single sample concentration tested can therefore be 
calculated. This method to determine EEQs has been applied in several studies for different 
test systems (Behr et al. 2011, Bogers et al. 2007, Brand et al. 2013, Lamoree et al. 2010, 
Maletz et al. 2013, Stalter et al. 2011, Van der Linden et al. 2008, Wagner & Oehlmann 
2009). In case of this analysis method it has to be kept in mind that only values within the 
linear range of the standard curve should be considered. Additionally, this method requires a 
similar curve progression of standard and sample. Therefore, concentrations ranges which 
cover the whole dose-response relationship should be tested to confirm this similarity. 
Another common analysis method to determine EEQs depends on the ECx ratio model 
originally used for the calculation of TCDD equivalents for dioxin-like activity (Eadon et al. 
1986). In this case, at first the estradiol equivalent factor (EEF) is calculated by dividing the 
ECx of the standard (E2) by the concentration of the sample which induces the same 
response as the ECx of the standard (Eq. 8.3). To calculate the EEQ the EEF is multiplied by 
the initial concentration of the sample (Houtman et al. 2006, Keiter et al. 2006) (Eq. 8.4).  
 
𝐸𝐸𝐹 =
𝐸𝐶𝑥𝐸2
𝐸𝐶𝑥𝑆𝑎𝑚𝑝𝑙𝑒
  Equation 8.3 
 
𝐸𝐸𝑄 = 𝐸𝐸𝐹 ∙ 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛𝑆𝑎𝑚𝑝𝑙𝑒   Equation 8.4 
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In most studies the EEQ is calculated for only one concentration of the tested sample. 
Depending on the potency of the sample, the ECs between 50 % and 10 % are calculated. 
Again, to achieve reliable data the curves of standard and sample have to be parallel and 
should exhibit equal efficacy. As this is not true for most cases a single point estimate of the 
EEF is not sufficient because equivalent factors at different ECs would be quite different. 
According to Villeneuve et al (2000) for non-parallel curves a relative equivalent factor range 
should therefore be applied. Therefore, multiple point estimates (EC20, EC50 and EC80) are 
calculated for each sample tested. The derived relative potencies (REP) are then used to 
reveal the REP20-80 range (Villeneuve et al. 2000) (Eq. 8.5). 
 
𝑅𝐸𝑃20 − 80 𝑟𝑎𝑛𝑔𝑒 = 𝑚𝑖𝑛𝑖𝑚𝑢𝑚 𝑅𝐸𝑃 𝑡𝑜 𝑚𝑎𝑥𝑖𝑚𝑢𝑚 𝑅𝐸𝑃  Equation 8.5 
 
This method was also used in chapter 4 to determine EEF ranges for the tested hetero-PAHS. 
To compare the approaches a LYES Bti data set from chapter 5 was analyzed in both ways to 
calculate the EEQs as well as the EEFs (Tab. 8.1). 
 
Table 8.1 Comparison of EEQs derived from the nonlinear as well as the ECx ratio based model 
VectoBac® TP [x fold 
concentration] 
EEQ [ng·L-1] 
Nonlinear model 
EEFEC50 
EEQ [ng·L-1] 
EC50 ratio model 
1 1,14 3.47·10
-7
 1,18 
3 3,90  3,54 
9 11,74  10,62 
18 22,77  21,24 
 
In case of the here analyzed dataset the results from the different models coincide almost 
perfectly for all concentrations tested. This is also true for EEQs which are derived from the 
EC20 as well as the EC80 ratios (data not shown). Considering the shape of the related curves 
this is probably a result of the similar curve progression (Fig. 8.1). 
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Figure 8.1 Curve progression of 17ß-Estradiol (E2) and VectoBac® TP in the LYES given as relative 
estrogenic activity (Bottom = 0; Top = 1). 
 
Nevertheless, it has to be kept in mind that the TP concentrations tested did not show a 
whole does-response curve and therefore, data had to be interpolated from the standard 
curve. The maximum response was set to the maximum response of E2 which is most likely 
not true. However, since higher concentrations could not be tested due to the limited water 
solubility this assumption was inevitable.  
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8.4 Development of a bioanalytical test system to screen for EDCs 
8.4.1 Development of the H295R 
In 1998 the OECD started a program to revise existing test guidelines as well as to develop 
new test systems to screen for EDCs. As a result several new test systems have been 
developed or still are in development. The existing as well as new developed test systems 
are listed in the “Guidance Document on Standardized Test Guidelines for Evaluating 
Chemicals for Endocrine Disruption” (OECD 2012). While there are many test systems 
covering the field of receptor binding and / or activating only few are dealing with 
steroidogenic pathways (Hecker et al. 2006). Additionally, the available test systems mostly 
only exhibit one single endpoint. To screen a large set of substances for their potential to 
disrupt the endocrine system, it would be useful to have more test systems covering a set 
of significant endpoints. Currently, a research group of the Department of Ecosystem 
Analysis (RWTH Aachen University) is working on this field (data not shown). 
In the current study chapter 3 describes the development and validation of the H295R 
Steroidogenesis assay (Hecker et al. 2011). From the first descriptions of the characteristics 
of the NCI-H295 cell line (Gazdar et al. 1990) to the development of the H295R 
Steroidogenesis assay (Hecker & Giesy 2008, Hecker et al. 2006) more than 15 years have 
passed. The validation and preparation of a OECD guideline for the test system took 
another 5 years (OECD 2011). In the meantime several research groups worked on 
different usages of the H295R cell line (Tab. 8.2). The number of working groups as well as 
different usages clearly shows that the cell line or the bioassay, respectively, is widely 
spread among the scientific community. Nevertheless, by now the cell line is approximately 
35 years old and due to the fast increase of hormone production during cell culture it is 
questionable how long the initial cell line will be usable for the test system. Therefore, 
additional improvements in the test system seem necessary. 
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Table 8.2 Research groups working with the H295R cell line between 2000 and 2011 
Working group Usage References 
Aquatic Ecology and Toxicology Section, 
Department of Zoology, University of 
Heidelberg, Heidelberg, Germany 
Steroid production (Grund et al. 2011) 
Center for Integrative Toxicology, National 
Food Safety and Toxicology Center, 
Department of Zoology, Michigan State 
University, Michigan, USA 
Expression of steroidogenic 
genes; Steroid production 
(Gracia et al. 2007, Gracia et al. 
2006, Gracia et al. 2008, 
Hecker et al. 2006, Hilscherova 
et al. 2004, Zhang et al. 2005) 
Centre for Coastal Pollution and 
Conservation, Department of Biology and 
Chemistry, City University of Hong Kong, 
Kowloon, Hong Kong SAR, China 
Expression of steroidogenic 
genes 
(Xu et al. 2006) 
Department for Ecosystem Analysis, 
Institute for Environmental Research, RWTH 
Aachen University, Aachen, Germany 
Steroid production (Hecker et al. 2007a, Maletz et 
al. 2010) 
Department of Basic Veterinary Science, 
The United Graduate School of Veterinary 
Sciences, Gifu University, Gifu, Japan 
Expression of steroidogenic 
genes; Steroid production; 
Proliferation 
(Furuta et al. 2008, Jaroenporn 
et al. 2008) 
Department of Biochemistry, Hoshi 
University School of Pharmacy and 
Pharmaceutical Sciences, Shinagawa, Tokyo, 
Japan 
Aromatase activity; Expression 
of steroidogenic genes; 
Steroid production; 
Steroidogenic acute 
regulatory (StAR) protein 
promoter activity 
(Nakajin et al. 2001, Ohno et 
al. 2002, Sugawara et al. 2001, 
Watanabe & Nakajin 2004, 
Watanabe et al. 2006) 
Department of Medicine and Bioregulatory 
Science, Graduate School of Medical 
Science, Kyushu University, Fukuoka, Japan 
Aromatase activity (Fan et al. 2007) 
Division of Environmental Health and 
Occupational Medicine, National Health 
Research Institutes, Kaohsiung, Taiwan 
Steroid production; Expression 
of steroidogenic genes 
(Li & Wang 2005, Li et al. 
2004a, Li et al. 2004b) 
Pharmaceutical and Medicinal Chemistry, 
Saarland University, Saarbrucken, Germany 
Enzyme inhibition (Muller-Vieira et al. 2005) 
Research Centre for Toxic Compounds in 
the Environment (RECETOX), Masaryk 
University, Brno, Czech Republic 
Steroid production (Blaha et al. 2006) 
Research Institute of Toxicology / Institute 
for Risk Assessment Sciences (IRAS), 
University of Utrecht, Utrecht, The 
Netherlands  
Aromatase activity; Expression 
of steroidogenic genes 
(Cantón et al. 2005, Heneweer 
et al. 2004, Sanderson et al. 
2002, Sanderson et al. 2004, 
Sanderson et al. 2001a, 
Sanderson et al. 2000, 
Sanderson et al. 2001b, 
Sanderson et al. 2003) 
School of Biomedical and Molecular 
Sciences, University of Surrey, Guildford, 
Surrey, UK 
Expression of steroidogenic 
genes 
(Oskarsson et al. 2006) 
State Key Laboratory of Freshwater Ecology 
and Biotechnology, Institute of 
Hydrobiology, Chinese Academy of 
Sciences, Wuhan, People’s Republic of 
China 
Expression of steroidogenic 
genes 
(Ding et al. 2007) 
Toxicology Centre, University of 
Saskatchewan, Saskatoon, Canada 
Steroid production (Hecker & Giesy 2008, Hecker 
et al. 2007a, Hecker et al. 
2007c, Higley et al. 2010) 
US Environmental Protection Agency, Office 
of Research and Development, National 
Health and Environmental Effects Research 
Laboratory, Mid-Continent Ecology Division, 
Duluth, MN, USA 
Steroid production (Villeneuve et al. 2007) 
Chapter 8 – Further development of established test systems 
 
186 
8.4.2 Further development of established test systems 
As already mentioned in chapter 3 as well as paragraph 8.3 the culturing process of the 
H295R cell line exhibits some problems due to a relatively fast increase of steroid 
production through cell culturing (Hecker et al. 2011). Therefore, the cells are only usable 
within a short time slot (approximately 10 passages). For example, during this study basal 
E2 concentrations in the solvent control increased by a factor of 5 from passage three to 
passage seven (36 ng·L-1 to 180 ng·L-1). Consequential, data from different approaches are 
only comparable by transforming the measured steroid concentrations into fold changes 
relative to the control. Additionally, the natural kinetics of hormone production (in this 
case estrogen production via conversion through aromatase) at the beginning show an 
increase that is more or less linear but diminishes over time and results in a steady state 
condition (Sohl & Guengerich 2010). Due to this, changes in steroid production after 
exposure to a steroidogenic substance are strongly depending on the time point of 
exposure and the actual growth phase. Furthermore, there is a natural limit of steroid 
concentration within the cells. Cells that are exposed to a steroidogenic substance at the 
beginning of the growth phase therefore are capable of higher increases in steroid 
production than cells that are in the late growth phase. Taking into account the limited 
available amount as well as the age of the original cell line this will sooner or later lead to 
severe problems as far as the unfeasibility of the test system.  
Recently, at our laboratories there have been different approaches to enhance the usability 
of the H295R. In a first approach, the cells were brought into suspension culture. At first 
the cells genomic DNA was demethylated with 5-Aza-2′-deoxycytidine (5-Aza-dc) to 
presumably reactivate silenced genes. Approximately 20 % of the cells were indeed 
brought into suspension but after a few passages insufficient proliferation and finally 
complete cell death were discovered. Therefore, this approach was skipped. The observed 
growth arrest may be caused by the reactivation of tumor suppressor genes like CDKN2A 
and SCGB3A1 (Fonseca et al. 2012). In a second step the standard cell culture medium 
(DMEM F12 / Hams) containing fetal bovine serum (FBS) was replaced by serum free or 
chemical defined medium. There are several drawbacks related to the usage of FBS in cell 
culture. First, there is the issue of animal welfare and the claim to save the lives of 
laboratory animals by use of alternative in vitro methods. FBS is a common supplement of 
cell culture media and includes several essential components for growth, homeostasis and 
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survival of the cells (Barnes & Sato 1980, Even et al. 2006). The amounts of FBS that are 
used for in vitro methods are increasing mostly due to large scale manufacturing of cell 
therapy processes and biotechnology (Brindley et al. 2012) and to a certain extent even to 
the increasing number of in vitro test systems that are used for toxicity testing (e.g. for 
REACH purposes) (Hecker & Hollert 2011). While in vitro methods are a sufficient way to 
reduce suffering of laboratory animals the collection of FBS from fetal calves after 
slaughtering of the pregnant cow may cause severe suffering of the fetuses. This seems to 
be contradictory to the 3R (replace, reduce, refine) principle (Russell et al. 1959) and is 
more than ethical questionable. Beside the ethical problems regarding to the use of FBS, 
there are also scientifically issues. On the one hand, FBS is a mixture of unknown 
composition which could lead to reduced reproducibility of different experimental 
approaches. For bioassays on endocrine disruption, for example, different steroid contents 
in the used FBS could influence the steroidogenesis within the cells. Therefore, in most 
cases stripping of FBS prior to use in the exposure medium is necessary. On the other hand, 
there is the risk of disease transmission because FBS could be contaminated with fungi, 
viruses, bacteria, mycoplasmas and prions. To overcome the problems related to the use of 
FBS as well as for the manufacture of biological products for human use, several serum free 
and chemical defined media have already been developed. Nevertheless, in contrast to 
media supplemented with FBS the alternative media are more cell type specific. Therefore, 
a special medium has to be used for most of the cell types used (Even et al. 2006, Van der 
Valk et al. 2004). Additionally, culture medium without FBS leads to suspension cell 
cultures in most cases (Barnes & Sato 1980), which was a desired side effect in the present 
study. Replacement of the standard culture medium of the H295R cell line by the serum-
free medium ProVero™1 (Lonza, Cologne, Germany) showed sufficient cell growth as well 
as a suspension rate of about 20 %. Unfortunately, there were issues regarding the quality 
between different batches, most likely due to the use of plant derived protein 
hydrolysates, wherefore an alternative medium was needed. In contrast, the replacement 
of the standard media by a chemical defined media for biopharmaceutical production 
without proteins and steroids (working title: CDM5) was overall successful. The H295R cells 
grew in suspension with a stable cell viability of ≥95 % over 12 days without passage. Cell 
density increased in a linear manner from 0.5·106 cells·ml-1 to 2·106 cells·ml-1, a reaction 
that was already described by Logie et al. (1999). Hence, the total cell density was higher 
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than achieved in adherent cultures in tissue culture flasks. With this modification it is now 
possible to study the effect of a substance (or a mixture as well as environmental sample) 
on the steroidogenesis over a time period of up to 10 days. Within this period, medium 
samples can be taken and analyzed at a daily rate without changing the exposure medium. 
Additionally, the basal testosterone (T) production was higher compared to the adherent 
cells (Logie et al. 1999) but basal production of E2 was much lower (approximately 50 ng·L-1 
after 16 passages; data not shown). The quality criteria of the OECD guideline (OECD 456), 
however, were met by the suspension cells. The high level of T and at the same time low 
level of E2 could be explained by the lack of growth factors such as the epidermal growth 
factor (EGF). In the presence of the EGF, expression of aromatase is upregulated in H295R 
cells (Watanabe et al. 2006) which leads to an increased transformation of T to E2. In 
addition, the fast increase of steroid production over time could be decelerated (data not 
shown). 
After the successful adaption of the H295R cell line to chemical-defined medium the next 
steps will be to adapt further cell lines such as the T47D cell line which is used for the ER 
CALUX®. Since T47D cells are human breast carcinoma cells it is possible to refer to existing 
protocols for the adaption of the MCF-7 cell line to serum-free media (Barnes & Sato 1979).  
Recently, at our laboratories, a new ELISA method to measure the steroid concentration in 
the exposure medium was developed (data not shown). Thereby, it was possible to replace 
the so far used ELISA kits from Cayman Chemicals (Cayman Chemicals Europe, Tallinn, 
Estonia) which are the largest matters of expense of the whole test system (expect 
personnel costs). Moreover, the detection of steroids in the exposure medium spares the 
extraction step which again not only saves costs but time and resources. 
Overall, with the already adapted and further designed improvements the H295R could be 
significantly upgraded. For the other cell based assays used within this study, planned 
improvements are still in the process of development.  
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8.5 Comparison between in vitro and in vivo test systems 
At the time the term endocrine disruptor (ED) should exclusively be used for substances that 
have been tested in in vivo test systems (WHO 2002). Nevertheless, to classify a substance as 
a possible ED the usage of in vitro test system data is permitted (Kortenkamp et al. 2011). 
Furthermore, since the introduction of the 3R principle (replace, reduce, refine) of Russel et 
al. (1959) there have been a number of approaches to replace in vivo with in vitro biotests 
(Hecker & Hollert 2011, Leist et al. 2008, Ukelis et al. 2008). By means of this, it is necessary 
to compare data obtained by in vitro test systems with data obtained by in vivo test systems 
to detect significant correlations and, at best, replace the in vivo test with an in vitro test.  
For the yeast systems (YES and LYES, respectively) correlations for estrogenic activity of 
sediments and single substances have been reported with P. antipodarum (Schmitt et al. 
2010, Schmitt et al. 2008) but the cell based system was up to tenfold less sensitive to single 
substances. In the present study the biological larvicide VectoBac® TP was tested with both 
LYES and Pa-Repro (see chapter 5 and 6). In the LYES significant increased estrogenic activity 
beginning with a concentration of approximately 20 mg∙L-1 (6-fold concentration) TP was 
detected. In the microcosm study with P. antipodarum a concentration of 18 mg∙L-1 caused a 
significant increase of embryo production after 14 days of exposure. Therefore, the 
comparability could be proofed even for the microcosm approach. Nevertheless, after 42 
days embryo production decreased. But this was most likely associated with quantity and 
quality of the available food, which again might be indirectly related to the application of TP 
(e.g. community shifts in phytoplankton and periphyton). Consequently, to verify the 
correlation the approach should be repeated with continuous external feeding of the adult 
snails during exposure. Similar correlations could be observed for the investigation of 
riverine sediments with both the ER-Luc (Rogers & Denison 1999) assay and the Pa-Repro 
(Schmitt et al. 2011). Fractions containing bisphenol A and phtalates led to a significant 
increase in reproduction of P. antipodarum as well as significantly increased estrogenic 
activity in the ER-Luc assay. In the present study, significant differences in estrogenic activity 
could only be observed from the 12-fold concentration (or 41 mg∙L-1) on. But since the 
processing of the sample led to a distinct decline in estrogenic activity (see chapter 5.4.3.1) it 
cannot be concluded that the ER CALUX® was less sensitive than the LYES or the Pa-Repro. 
So far no comparative studies with the Pa-Repro and the H29R have been performed but 
Gust et al. (2010) could show that the specific vertebrate aromatase inhibitor fadrozole led 
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to a significant decrease in the reproduction of P. antipodarum with a LOEC of 6.2 μg L−1 
(2.8·10-2 µM). Fadrozole has also been shown to significantly inhibit aromatase activity 
(Heneweer et al. 2004) and to significantly decrease E2 production in H295R cells with a 
LOEC of 1 µM (Hecker et al. 2006). Consequential, the effect measured with the Pa-Repro 
was more sensitive by a factor of 36. In the present study TP had no clear effect on the 
H295R cells wherefore no convincing comparison was possible.  
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8.6 Usability of the tests systems for risk assessment and regulation 
In the EU there are different legislations which cover the field of EDCs regulation. Under 
REACH (European Commission 2006) the relevant endpoints for environmental risk 
assessment are acute toxicity, chronic toxicity, bioaccumulation and endocrine disruption. 
Generally, the advised test systems cover OECD test guidelines for animal testing. But it is 
also stated that testing of chemicals on animals should only be accomplished when no 
reliable alternative ways of testing are possible. While at the moment there are only few 
validated alternative test systems (e.g. in vitro bioassays such as the H295R) the provided 
ecotoxicological information are gained from alternative methods in more than three-
quarters of the in 2011 registered substances (Scholz et al. 2013). In the Water Framework 
Directive (WFD) assessment of the chemical status of water bodies is generally based on 
chemical analysis (European Commission 2000). Environmental Quality Standards (EQS) for 
priority substances are set for all EU member states, whereas, EQS for other pollutants are 
set by the member states themselves. As stated by the European Commission (EC) the list of 
priority substances covers substances and preparations as well as metabolites that possess 
carcinogenic, mutagenic and endocrine disruptive properties. But for the entirety of the 
enormous number of chemicals found in the aquatic environment setting of individuals EQS 
is almost impossible. Therefore, the European Commission elaborated a technical report on 
potential aquatic effect-based monitoring tools to be used as links between chemical and 
ecological status assessment (Hecker & Hollert 2011, Wernersson et al. 2015). In this report, 
use of effect-based tools is recommended for several objectives, for example: (1) 
Prioritization of water bodies for further monitoring; (2) Early warning systems to discover 
effects related to chemical substances before significant effects on population level occur; 
(3) Effects of mixtures and not analyzed chemicals; (4) Water and sediment quality 
assessment. The technical report also recommends the use of bioassay batteries to cover 
substances with a certain mode of action (e.g. estrogenic activity) which are not included in 
the chemical analysis. Two of the mentioned test systems are the ER CALUX® and the YES 
which are currently also standardized and validated for preparing a standard of the 
International Organization for Standardization (ISO) (European Commission 2014, Kunz et al. 
2014). The outcomes of the present study support the usefulness of in vitro bioassays for 
screening of water samples for endocrine active samples. In addition to the in the technical 
report mentioned receptor reporter gene assays a test system that covers the steroidogenic 
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pathway as well as a in vivo test system to cover adverse outcomes on whole organisms and 
to a certain extent populations are also strongly recommended. Nevertheless, depending on 
the samples to be tested the test battery should be adapted (Fig. 8.2). 
 
Figure 8.2 Applicability of the examined bioassays depending on the sample matrix as well as the 
sample preparation and statements to be made from the investigation.  
 
Depending on the information expected from the analysis different approaches should be 
considered. If a comprehensive view on the ecotoxicological relevance of a sample is 
required it should be tested as a native sample preferably with the whole bioassay battery 
(Hecker & Hollert 2011). If, on the other hand, a sample is to be screened for a certain mode 
of action in comparison or addition to data from chemical analysis the application of 
receptor reporter gene assays should be sufficient (Brand et al. 2013). In this case, usage of 
the ERα CALUX® which depends on the cell line U2OS and has the advantage of being even 
more selective to ligands interacting with the estrogen receptor (Sonneveld et al. 2005, van 
der Burg et al. 2010) should be considered. But since the U2OS cells are lacking the ability to 
metabolize the ER CALUX® depending on the cell line T47D (Legler et al. 1999) should be 
used for a more comprehensive risk assessment.  
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Water is a prerequisite for life. Only 2.5 % of earth’s water resources are freshwater, from 
which’s accessible part to date over 50 % are already used by mankind. Concurrently, 
accessible freshwater is not only crucial for humanity but also for the ecosystems functions 
in general. Even though, freshwater resources are exposed to an increasing number of 
(anthropogenic) pollutants like fertilizers, pesticides, pharmaceuticals, personal care 
products, metals and other industrial chemicals. One important and heavy discussed group 
of pollutants are the endocrine disruptive compounds (EDCs), which include natural as well 
as synthetic steroids, pharmaceuticals, pesticides, organotin compounds, polychlorinated 
biphenyls (PCBs) and phthalates, dioxins, phenol derivatives etc. In the last years more and 
more (potential) EDCs have been detected in the environment as well as organic tissues of 
humans and wildlife. To screen samples for known EDCs, chemical analysis is a fast and 
sensitive approach. However, to detect an unknown endocrine active potential of a 
substance or to screen an environmental sample with unknown composition, a sensitive and 
reliable bioassay battery is needed. 
In the present study, the applicability of four different bioassays to detect EDCs in the 
aquatic environment was investigated. Therefore, the test systems have been applied with 
the different sample matrices groundwater, surface water and sewage as well as single 
substances. All three in vitro test systems could proof their suitability for the detection of 
EDCs. Performance of the bioassays varied within the categorizations (1) good to very good: 
ER CALUX®; (2) good: H295R; (3) moderate to good: LYES. While the LYES was suitable to 
detect estrogenic activity even in extracts from highly contaminated raw sewage as well as in 
native samples, it was not suitable to detect low estrogenic activity (≤ 5 ng·L-1) because of its 
high background activity. In contrast, the ER CALUX® was suitable to detect low to medium 
estrogenic activity in extracts from complex samples (e.g. treated sewage) as well as single 
substances. Furthermore, the here used T47Dluc cell line showed significant metabolic 
capacity and therefore was even applicable to detect substances that needed metabolic 
activation to act as xenoestrogens. Depending on the samples to be tested, it can be 
concluded that in most cases a combination of both receptor-mediated bioassays should be 
used. Highly contaminated native samples such as sewage can be analyzed by the LYES 
without any further extraction steps. Therefore, an investigation of unchanged samples, 
which is strongly recommended by the ISO standard on biotesting of samples (ISO 5667-
16:1998), is possible. In addition, samples with low but potentially environmentally relevant 
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concentrations of EDCs such as groundwater can be investigated by the ER CALUX®. With the 
H295R, extracts from complex samples as well as single substances could be investigated for 
their potential to disrupt the steroidogenesis. Complementary to the receptor-mediated test 
systems, the H295R allows an investigation of samples for their effects on the vertebrate 
steroidogenesis. With the application of this test system a much broader analyses of the 
potential endocrine disrupting effects of samples is feasible. Altogether, the here used in 
vitro bioassay battery is most suitable to investigate a broad range of samples with different 
endpoints and sensitivities. It therefore can be recommended as a fast and relatively 
inexpensive screening of (water)samples prior or even alternatively to in vivo tests.  
The suitability of the in vivo test with P. antipodarum in a complex microcosm system could 
not be proofed in the present study. In contrast to the standard protocol for the Pa-Repro, 
which was recently applied for a number of studies regarding EDCs in the environment (see 
also chapter 8.1.2), to the best of one's knowledge an introduction of this test species into a 
multispecies-microcosm without external feeding to test for EDCs was performed for the 
first time. As limited food supply strongly impacts the reproductive outcome of any test 
species, limited conclusions on the direct effect of the sample could be drawn only. 
Consequently, the performance of P. antipodarum in the microcosm study was moderate 
only. Nevertheless, referring to the WHO's definition a substance has to be tested in an in 
vivo study to be declared as an EDC. As test systems using vertebrates such as fish should be 
reduced to a minimum and the Pa-Repro has proven its suitability in previously performed 
studies on EDCs the test system is still the first choice for the completion of the here 
presented bioassay battery. 
Concluding, it can be stated that the established bioassay battery is qualified for the analysis 
of different sample matrices with high relevance to endocrine disruption in the aquatic 
environment. Nevertheless, biological test systems are no ultimate but rather developing 
techniques which almost always could be improved. The completion of the present study 
therefore presents not the end of the establishing process but rather an interim goal of the 
ongoing research.  
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